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Abstract 
Lipase B from Pseudozyma antarctica (PalB), had been expressed in several recombinant protein hosts 
and showed very good transesterification activity for biodiesel production. However, the functional 
expression could not be demonstrated until recently in the most popular recombinant protein expression 
system, e.g. Escherichia coli, and the expression performance stands improvement. The probable reason 
is that PalB is a lipase with more hydrophobic surface and three disulfide bonds and thus may not be 
easily expressed in E. coli functionally. This thesis focuses on the identification of factors limiting 
heterologous expression of PalB in E. coli through a systematic study by using several strategies, 
including the different expression compartments, fusion tags, folding factors, and host strains. 
Functional expression of PalB in the cytoplasm of E. coli was explored using BL21(DE3) and its 
mutant derivative Origami B(DE3) as the host. Bioactive PalB was obtained in the reduced cytoplasm of 
BL21(DE3), implying that the formation of disulfide bond was not strictly required for functional 
expression. However, the expression was ineffective and was primarily limited by formation of PalB 
inclusion bodies and growth arrest, both of which were associated with PalB misfolding and deteriorated 
physiology. The culture performance in terms of cell growth and PalB expression level could be 
significantly improved by simultaneous coexpression of multiple chaperones of trigger factor and 
GroEL/ES, but not individual coexpression of either one of them. It was proposed that the two chaperones 
mediate the early stage and late stage of cytoplasmic PalB folding and would be required simultaneously 
for boosting both the overall PalB synthesis rate and the cytoplasmic folding efficiency. On the other 
hand, a much higher bioactive PalB was produced in Origami B(DE3) harboring the same PalB 
expression vector. Furthermore, the significant high bioactive PalB was produced by coexpression of 
periplasmic folding factor without a signal peptide (e.g., coexpression of DsbA, and DsbC). Coexpression 
of DsbA was found to be effective in enhancing PalB expression and such an improvement was more 
pronounced in Origami B(DE3), suggesting that both folding and disulfide bond formation could be the 
major factors limiting PalB expression. The fusion tag technique was also explored by constructing 
several PalB fusions for the evaluation of their expression performance. While the solubility was 
enhanced for most PalB fusions, only the DsbA tag was effective in boosting PalB activity possibly via 
both enhanced solubility and correct disulfide bond formation. Our results suggest that solubilization of 
PalB fusions did not necessarily result in the development of PalB activity which could be closely 
associated with correct disulfide bond formation. 
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While PalB was stably expressed in the cytoplasm, most of the expressed gene product aggregated 
in cells as inactive inclusion bodies. In contrast, PalB was extremely unstable when expressed in the 
periplasm, also leading to poor expression performance. Such unstable PalB can be rescued by 
coexpression of several periplasmic folding factors, such as DegP, FkpA, DsbA, and DsbC, but not 
cytoplasmic chaperones. As a result, the performance for functional PalB expression in the periplasm was 
significantly improved. This is the first report demonstrating the use of folding factors to rescue the 
extremely unstable gene product that is otherwise completely degradable. On the other hand, functional 
expression of PalB in the periplasm was explored using four fusion tags, e.g., DsbC, DsbA, maltose 
binding protein (MBP), and FLAG in the sequence of increasing expression efficacy. Amongst these 
fusion tags for functional expression of PalB, FLAG and MBP appear to be the most effective ones in 
terms of boosting enzyme activity and enhancing solubility of gene products, respectively. 
Overexpression of these PalB fusions often resulted in concomitant formation of insoluble inclusion 
bodies. Coexpression of a selection of periplasmic folding factors, including DegP (and its mutant variant 
of DegPS210A), FkpA, DsbA, DsbC, and a cocktail of SurA, FkpA, DsbA, and DsbC, could improve the 
expression performance. Coexpression of DsbA appeared to be the most effective in reducing the 
formation of inclusion bodies for the four PalB fusions, implying that functional expression of PalB could 
be limited by initial bridging of disulfide bonds. Culture performance for functional expression of PalB 
was optimized by overexpressing FLAG-PalB with DsbA coexpression, resulting in a high volumetric 
PalB activity of 360 U/liter. 
Without extracting protein from cells the whole cell can be directly used as a platform for the 
immobilized enzyme. Proof-of-concept experimentation was conducted by PalB display on the E. coli cell 
surface. By fusing the palB gene in between the signal peptide phoA and an autotransporter Protein 
EstA’s gene under the lac promoter, PalB was successfully displayed on the E. coli cell surface. However, 
cells encountered a severe physiological stress. Coexpression of various periplasmic folding factors, e.g., 
DegP, SurA, DsbA and DsbC could erease the physiological stress, but only DsbA was demonstrated to 
be effective to restore cell physiology and increase PalB expression level. 
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The depletion and recent skyrocketing prices of fossil fuels make the search for alternative and renewable 
energy sources imperative [1]. Bioethanol has been rapidly advancing worldwide in the last decade 
although the process is still open for improvement*. Biodiesel is the other biofuel and is on the road to 
commercial use. Biodiesel is a mixture of fatty esters made by transesterification of animal fats or plant 
oils with methanol or ethanol. As a renewable fuel, biodiesel is considered to be environment-friendly 
since it reduces exhaust emissions upon burning, particularly carbon monoxide, black smoke, smog-
causing particulate matter, odor, harmful carcinogens, and even sulphur dioxide [2, 3]. Due to the 
characteristics of the biodiesel, it can be directly used in diesel engines as a 6~20% mixture with 
conventional diesel fuel†.  
Currently, most biodiesel production via transesterification reaction are catalyzed by alkaline or 
acidic catalysts or with supercritical methanol at high temperatures and pressures [2, 4, 5]. However, 
chemical processes generally are high energy-consuming, require harsh reaction conditions and suffer 
various separation issues caused by side reactions [2, 4, 6-9]. With several attractive features, such as 
mild reaction conditions and high reaction specificity, biocatalysts are gaining more and more attention 
nowadays and have the potential to outperform chemical catalysts in the future [10, 11]. There are three 
major advantages for biocatalyst: (1) mild reaction conditions. Usually the reaction is catalyzed at room 
temperature; (2) high specificity. For enzymatic reaction, the enzyme works with substrate in a lock and 
key function, so high quality can be reached; (3) no unwanted byproduct formation. It makes the biodiesel 
production more environmental friendly. On the other hand, there are also some disadvantages, such as 
low biocatalyst activities, and frequent inactivation and denaturation by alcohol [10, 12]. To make the 
bioprocess more competitive, it is imperative to develop an effective biocatalyst production system.  
Innovative design of genetically-engineered strains can significantly increase the recombinant 
protein yield with minimum investment in capital and operating costs. For developing recombinant 
enzyme production using microorganisms, generally three steps should be included (1) generating a 
                                                   
* Net Energy Balance for Bioethanol Production and Use. U.S. Department of Energy. Available Online: 
http://www1.eere.energy.gov/biomass/net_energy_balance.html [2007, Dec. 08] 
† Available Online: http://www.biodiesel.org/ [2007, Dec. 08] 
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robust microbial strain, (2) developing a cultivation process with high-level gene expression and high-
cell-density, and (3) optimizing a purification process. First and foremost importance is engineering a 
microbial host. Once a microorganism is chosen, the cultivation conditions are predetermined, and fine 
tuning can be done in a very rational manner. In addition, the purification process is also depending on the 
characteristics of the microbe and the enzyme. 
Lipases (triacylglycerol acylhydrolase, E.C.3.1.1.3) are enzymes that catalyze the synthesis or 
hydrolysis of glycerol esters (e.g., triglycerides), such as fats and oils [13, 14]. Several microorganisms, 
such as bacteria, fungi, and yeasts, have been found to produce lipases, including Pseudomonas 
fluorescens [15, 16], Pseudomonas cepacia [17], Rhizopus oryzae [18], Rhizomucor miehei (e.g., the 
immobilized form commercially available from Lipozyme RM IM, Bagsvaerd, Demark) [18], 
Thermomyces lanuginosus (e.g., the immobilized form commercially available from Lipozyme TL IM, 
Bagsvaerd, Demark) [19], Candida rugosa (ex. Candida cylindracea), and Pseudozyma antarctica (ex. 
Candida antarctica). These lipases have numerous applications in organic chemistry and biotechnology 
[20, 21]. Apparently, P. antarctica lipase B (PalB, ex. CalB [22]) has been found to be the most active 
microbial lipase with good transesterification activity. The enzyme and its corresponding immobilized 
form (e.g., Novozyme 435) are commercially available from Novozyme A/S, Bagsvaerd, Demark. This 
enzyme has been the most common biocatalyst for biodiesel production [17, 23, 24]. While the 
biocatalyst is gaining more attention and has a potential to outperform chemical catalysts, extensive 
application remains impractical due to its high cost and several technical issues (e.g., inactivation by 
alcohol). To make the bioprocess economically feasible, there is a motivation to overproduce PalB.  
Previously, recombinant PalB was expressed heterologously in Aspergillus oryzae [25], Pichia 
pastoris [26], and Saccharomyces cerevisiae [27]. However, the productivities of PalB from these 
microorganisms could not meet the quantity requirement for biodiesel production. Given the popularity of 
Escherichia coli as a workhorse for recombinant protein production, functional expression of PalB in this 
host was not demonstrated until recently [28, 29] and the expression performance stands improvement. A 
major technical issue limiting the PalB expression level in E. coli is associated with its intracellular 
misfolding. PalB is a lipase destined to be secreted extracellularly in the original psychrophilic and 
eukaryotic source of P. antarctica. Consequently, the intracellular overexpression might prevent it from 
being structurally adaptable to the mesophilic and prokaryotic expression system of E. coli, resulting in 
protein misfolding. In addition, wild-type PalB has three intermolecular disulfide bonds potentially 
associated with its folding process although these disulfide bonds might not be strictly required for 
bioactivity. Finally, cell growth is often arrested due to deterioration in cell physiology associated with 
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high-level expression and misfolding of PalB. Considering PalB’s potential application and all the pros 
and cons of different expression systems, this thesis focused on identification of factors limiting 
recombinant PalB expression in E. coli.  
 
By using molecular biological techniques, twenty-five expression plasmids, e.g., eighteen of them 
for cytoplasmic expressions, five for periplasmic expressions, and two for cell surface display, were made 
during the course of this study for identifying the limiting factors for recombinant PalB expression in E. 
coli (Table 1.1). 
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Table 1.1 Twenty-five expression plasmids for recombinant PalB expression in E. coli 
No.      Name      Vector Promoter Fusion tag 
Cytoplasmic expression plasmid    
1 pTrcG pTrc99A trc – 
2 pETKnL pETKn 20b(+) T7 – 
3 pETL pET 20b(+) T7 – 
4 pGEXC4S-M pGEXC4S trc GST 
5 pSkp-G pDest556 T7-lacO Strep-II-SKP 
6 pT7PK-G pDest555 T7-lacO Strep-II-T7PK 
7 pRset-G pRSET T7-lacO 6×His 
8 pMBP-G pMGWA T7-lacO MBP 
9 pHMBP-G pHMGWA T7-lacO 6×His-MBP 
10 pGST-G pGGWA T7-lacO GST 
11 pHGST-G pHGGWA T7-lacO 6×His-GST 
12 pNusA-G pNGWA T7-lacO NusA 
13 pHNusA-G pHNGWA T7-lacO 6×His-NusA 
14 pTRX-G pXGWA T7-lacO TRX 
15 pHTRX-G pHXGWA T7-lacO 6×His-TRX 
16 pHisMBP-G pDEST-HisMBP tac 6×His-MBP 
17 pETllDsbA-G pET52A T7-lacO DsbA-6×His 
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18 pETllDsbC-G pETM82 T7 DsbC-6×His 
Periplasmic expression plasmid    
19 pETG pET 20b(+) T7 – 
20 pFlag-P pFLAG trc FLAG 
21 pETDsbA-G pET50A T7-lacO DsbA-6×His 
22 pETDsbC-O pETM80 T7 DsbC-6×His 
23 pHisperiMBP-G pDEST-periHisMBP trc 6×His-MBP 
Cell surface display plasmid   
24 pEstCmN pEST100 lac EstA 
25 pEstKnN pEST100 lac EstA 
 
In order to systematically study the functional PalB expression in E. coli, the following strategies 
were applied in designing the expression plasmids. First, targeting PalB in different compartments by 
constructing appropriate expression plasmids, including cytoplasmic expression plasmids (#1~3), and a 
periplasmic expression plasmid (#19). In addition, cell surface display of PalB was conducted to 
determine the feasibility of whole cell biocatalyst. Second, adding a fusion tag for improving the 
solubility of PalB. The hydrophilic tags were included His (#7), GST (#4, 10, and 11), MBP (#8, 9and 
16), NusA (#12 and 13), TRX (#14, and 15), Skp (#5), T7PK (#6), llDsbA (#17), and llDsbC (#18) for 
the cytoplasmic expression, and Flag (#20), DsbA (#21), DsbC (#22), and MBP (#23) for the periplasmic 
expression. Third, coexpression of folding factors, e.g., chaperones, proteases, and catalysts, for 
mediating misfolded PalB. In principle, the constructs listed in Table 1.1 can be coexpressed with 
cytoplasmic chaperones or periplasmic folding factors. The cytoplasmic chaperones included the trigger 
factor (TF), DnaK/J-GrpE, GroEL/ES, leaderless DsbA (llDsbA), and llDsbC, and the combinations of 
TF and GroEL/ES, and GroEL/ES and DnaK/J-GrpE. The periplasmic folding factors were DegP, 
DegPS210A, FkpA, SkP, SurA DsbA, DsbC, and a cocktail (SurA, FkpA, DsbA, and DsbC).  
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1.2 Research Objectives 
The overall objectives of this thesis are to 
1. Explore PalB expression in E. coli system, including the construction of the PalB expression 
plasmids in the cytoplasm, periplasm, and for cell surface display.  
2. Systematically study the expression systems. 
3. Study the expression systems mediated by fusion tags 
4. Study the effect of cytoplasmic chaperones and periplasmic folding factors on PalB expression. 
5. Based on the above studies, identify the factors limiting the PalB expression in E. coli and 
provide comments for the further improvement of PalB expression.  
1.3 Outline of the Thesis 
This thesis consists of eight chapters. The scope of each chapter is as follows: 
Chapter 1 gives an introduction to this thesis, including an overview of biodiesel production, 
advantages and disadvantages of biocatalyst for biodiesel production. The hypothesis, objectives and the 
scope of the thesis are also given in this chapter. 
Chapter 2 reviews the recombinant protein production in E. coli. Why is it suitable for PalB 
expression and what are the potential challenges for this study? 
Chapter 3 presents the construction of PalB expression plasmid and expression results for 
identification of factors limiting heterologous production of PalB in the cytoplasm. 
Chapter 4 presents the improvement of PalB cytoplasmic expression by using a mutant host strain 
and/or by adding a fusion tag. 
Chapter 5 presents the construction of PalB expression plasmid and expression results for showing 
the effect of folding factors in rescuing unstable PalB to enhance its overexpression in the periplasm.  
Chapter 6 presents the construction of PalB fusion expression plasmids and expression results for 
improvement of solubility and bioactivity of PalB by addition of fusion tag in the periplasm. 
Chapter 7 presents PalB displaying on E. coli cell surface and the potential application. 
Chapter 8 presents the conclusions of this study, contributions of this research and 
recommendations for future work. 
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Chapter 2 
Literature Review 
2.1 Choice of Host Strain for Recombinant Protein Production 
Among various protein expression systems, such as bacteria (both gram-positive or gram-negative), fungi, 
insect cells, mammalian cells, plant cells and even whole (transgenic) animals/plants, the gram-negative 
bacterium of Escherichia coli is the most widely used as host for biotechnological and pharmaceutical 
applications [30]. Generally, E. coli is used for cost-efficient production of large amounts of proteins that 
are limited in size and have a relatively simple structure. However, even for therapeutic protein 
production, which typically has several options in selecting the expression system [31, 32], nine out of the 
31 EPA approved biopharmaceuticals during 2003 and 2006 were produced in E. coli, which is second 
only to mammalian cell systems [33]. In addition, approximately 80% of the proteins used to solve 3-
dimensional structures submitted to the protein data bank (PDB) in 2003 were prepared in E. coli 
expression systems [34]. Therefore, E. coli is always one of the first choices as a host for recombinant 
protein research and production.  
Three major factors result in the popularity of E. coli used as a host for recombinant protein 
research and production. First, its genetics are far better characterized than any other microorganism and 
the mature technologies (in genetic engineering, metabolic engineering, and protein engineering) for 
manipulation and construction of the host/vector system make it possible for a variety of attempts to 
improve the expression performance. Second, the fast growth rate with simple nutritional requirements 
and easy cultivation technology for E. coli make it suitable for many biomanufacturing applications [35, 
36]. Third, the successful applications of recombinant protein production in E. coli inspire and motivate 
more in-depth exploration to improve the E. coli expression system and investigate potential applications. 
Theoretically, the maximum cell density that can be reached is approximately 200 g-dry-cell-weight 
(DCW)/liter in fed-batch cultivation [37] and accumulation of intracellular recombinant proteins can be 
up to 50% of total cellular protein by using a strong promoter [38]. Therefore, E. coli already is a well 
established protein overproducer but potential improvements are possible.  
Several drawbacks need to be paid attention to when choosing E. coli as a host for recombinant 
protein production, such as the pathogenicity of this microorganism, lack of posttranslational processing 
abilities (particularly glycosylation) which required for many eukaryotic proteins [32], lack of a secretion 
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mechanism for the efficient release of protein into the culture medium [39], and limited ability to 
facilitate extensive disulfide bond formation [40]. 
Considering the global demand to produce large quantities of PalB with high activity at low cost for 
competing with chemical catalysts for biodiesel production, this work focuses on heterologous expression 
of PalB in the E. coli systems. 
 
2.2 Genetic Strategies for Recombinant Protein Expression in E. coli  
As mentioned before, innovative design of genetically engineered strains can greatly increase the 
recombinant protein yield with minimum investment in capital and operating costs [41]. Based on the 
central dogma of molecular biology that DNA makes RNA makes protein (although RNA can also 
“make” DNA), the strategies for high level gene expression in E. coli are: (i) gene replication, (ii) 
transcriptional regulation, (iii) translational regulation, (iv) protein targeting, (v) folding factor (e.g., 
molecular chaperone, protease, and foldase), (vi) fusion tag, and (vii) adjustment of cultivation conditions 
(e.g., temperature, oxygen level, pH, induction time, inducer concentration, and medium) [38, 42]. The 
idea is that in addition to improving the efficiency of each gene expression step, a ‘balanced’ protein 
synthesis flux throughout these steps should be properly maintained to avoid the accumulation of any 
protein species along the formation pathway of targeted protein. Steps (v) to (vii) are commonly used for 
mediating high level protein expression and will be reviewed later. In this section the review focuses only 
on the essential elements in design of recombinant expression systems, including steps (i) to (iv) 
techniques (Table 2.1) [42-44]. 
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Table 2.1 Techniques for genetically optimizing recombinant protein overexpression in E. coli  
Techniques Comments 
Plasmid copy number Gene dosage, as manipulated through plasmid copy number, affects expression 
Selection antibiotic Choice of antibiotic resistance on the expression plasmid can influence 
heterologous protein expression 
Promoter Strong/weak, inducible/constitutive, promoter and regulation is a major influence 
on protein expression, which is also affected by relative orientation and strength 
of promoters on the plasmid 
Transcription 
termination 
Effectiveness and spacing of transcription terminators affect expression 
mRNA stability The stability of the mRNA impacts yield. Secondary structure, especially at the 5´ 
end of the message, often plays a critical role 
Translation signal  The ribosome-binding site affects the level of ribosome loading and clearance, and 
hence, expression. Secondary structure at the 5´ end of the message can affect the 
accessibility of the ribosome binding site 
 
For replication, the gene dosage can be increased with the use of high-copy-number plasmids [45, 
46] or “runaway” plasmids [47, 48]. Using the plasmids with high-copy-number always mean high 
efficiency, e.g., pUC (copy number 500~700) in the cloning application. However, the primary carbon 
and energy metabolism in the host cell are significantly affected by gene expression with high-copy-
number plasmids [49-52] and the metabolic overload not only exhausts the cell itself but also causes the 
loss of plasmid and decreases protein yield dramatically [53]. For protein expression, therefore, it is 
necessary to not use the high-copy-number plasmids [54, 55], e.g., the plasmids derived from pBR322 
(copy number 15~20) [56, 57] or pACYC (copy number 10~12) [50, 58]. When the design includes two 
plasmids coexisting in a host for coexpression of genes (e.g., one for target gene, and another for 
chaperone), they should be compatible for replication (e.g., one from pBR322 and another from pACYC) 
and also should have different antibiotic resistance markers. However, it was recently reported that 
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incompatible plasmids carrying the same replicon coexisted stably and coexpressed two proteins 
efficiently with different selection marker [59, 60]. 
Antibiotic resistance marker (or selection marker) is designed for screening the plasmid in the cell. 
Generally used antibiotics are ampicillin, tetracycline, chloramphenicol, and kanamycin. Ampicillin binds 
to and inhibits a number of enzymes in the bacterial membrane that are involved in the synthesis of the 
cell wall. Tetracycline binds to a protein of the 30S subunit of the ribosome and inhibits ribosomal 
translocation. Chloramophenicol binds to the ribosomal 50S subunit and inhibits protein synthesis. 
Kanamycin binds to ribosomal components and inhibits protein synthesis [61]. Only the cells containing 
the plasmids, in which the resistance marker confers resistance to the drug, can survive in the culture 
supplemented with the corresponding drug. When the design involves two plasmids coexisting in a host 
for coexpression of genes (e.g., one for target gene, and another for chaperone), they should be 
compatible in replication origin (e.g., one from pBR322 and another from pACYC), and also should have 
different antibiotic resistance markers.  
 
2.2.1 Transcription is the Major Step Limiting the Overall Gene Expression.  
In the ensuing section the lac operon is used as an example to depict how transcription works (Figure 
2.1). It consists of the control sequences lacP and lacO followed by the tandem arranged genes for β-
galactosidase (lacZ), galactoside permease (lacY), and thiogalactoside transacetlylase (lacA). In the 
absence of an inducer, for example the physiological allolactose such as IPTG, the lac repressor, the 
product of the lacI gene, binds to operator (lacO) so as to prevent the transcription of the lac operon by 
RNA polymerase. The binding of the inducer causes the repressor to release the operator that allows the 
lac structural genes to be transcribed to a single polycistronic mRNA. The mRNAs transiently associate 
with the ribosome so as to direct them to synthesize the encoded polypeptides. The E. coli RNA 
polymerase has the σ subunit, which initiates transcription on the sense strand of a gene at a position 
designated by its promoter. The most conserved region of the promoter is -10 and -35 region. After the 
initiation of RNA synthesis, the σ subunit dissociates from the RNA polymerase, which then 
autonomously catalyzes chain elongation in the 5’→3’ direction. RNA synthesis is terminated by a 
segment of the transcript that forms a G+C rich hairpin. Therefore, a strong promoter is the key for 
increasing the efficiency of transcription.  
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Figure 2.1 Schematic presentation of the salient features and sequence elements of E. coli 
expression vector. (Modified after [42]) Shown as an example is the hybrid tac promoter (P) 
consisting of the -35 and -10 sequences, which are separated by a 17-base spacer. The arrow 
indicates the direction of transcription. The lacO is a short region lies partially within the promoter 
and interacts with repressor that controls the transcription of the operon. The ribosome-binding 
site (RBS) consists of the Shine-Dalgarno (SD) sequence, followed by an A+T rich translational 
spacer, which has an optimal length of approximately 8 bases. The SD sequence interacts with the 
3’ end of the 16S rRNA during translational initiation, as shown. The three start codons are shown, 
along with the frequency of their usage in E. coli. The repressor is encoded by a regulatory gene 
(R), lacI, or lacIq, modulates the activity of the promoter. The transcription terminator (TT) serves 
to stabilize the mRNA and the vector. An antibiotic resistance gene, e.g., for ampicillin (ApR), 
facilitates phenotypic selection of the vector. The origin of replication (Ori) determines the vector 
copy number. The coding sequence, e.g., lacZ, lacY, and lacA, is the gene(s) for protein(s) of 
interest. 
 
A useful promoter should exhibit several desirable features: (i) be strong, resulting in the 
accumulation of protein making up 10-30% or more of the total cellular protein; (ii) exhibit a minimal 
level of basal transcriptional activity; (iii) possess inducibility in a simple and cost-effective manner. To 
render it suitable for high-level protein synthesis, generally speaking, recombinant expression plasmid 
requires a strong transcriptional promoter. A number of strong promoter systems are available for gene 
expression in E. coli with various induction factors, such as chemicals (e.g., IPTG, arabinose or 
tetracycline), heat, and pH, to increase the transcriptional efficiency (perhaps translational efficiency as 
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well) and, in turn, to increase the expression level (Table 2.2) [38, 62]. The first three promoters in Table 
2.2 are the most prominent and have frequently been used for the E. coli system, lac is a natural promoter 
[63], and tac/trc are synthetic promoters, which only differ by 1-bp in the length of spacer domain [64-
66]. They are regulated by lacI, lacIq by induction of isopropyl-β-D-thiogalactopyranoside (IPTG), and 
also regulated by catabolite repression and the metabolic state, which is represented by the cyclic AMP 
level. Therefore significant variations of the level of expression from a given vector may be observed 
depending on the host strain used. The tac/trc promoters are at least 5-fold more efficient than lacUV5 
promoter and allow the accumulation of up to 15~30% of total cell protein. There are many recombinant 
proteins successfully expressed under these promoters, e.g., penicillin acylase [67-69], PalB [28], human 
CD83 [70].  
 
Table 2.2 Commonly used promoters for recombinant protein expression  
Promoter Induction Characteristics 
lac (lacUV5) IPTG, thermal  
(0.05-2.0 mM) 
Low-level expression; leaky expression 
tac/trc IPTG, thermal 
(0.05-2.0 mM) 
High-level, but lower than T7; leaky expression 
T7 IPTG, thermal 
(0.05-2.0 mM) 
High-level expression, leaky expression; difficult to 
achieve high cell densities 
T7/lacO IPTG, thermal 
(0.05-2.0 mM) 
High-level expression, tighly controlled expression; 
difficult to achieve high cell densities 
λpL Thermal 
From 30-42 °C 
Induction cannot be performed at low temperatures; 
partial induction cannot be achieved 
cspA Thermal 
From 15-29 °C 
High-level expression, tightly controlled expression; 
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tetA Anhydrotetracycline 
200 μg/l 
Tightly controlled expression 
araBAD L-Arabinose 
(0.001-5%) 
Expression level can be controlled in a dose-dependent 
manner; catabolite repressed by glucose; few vectors 
available 
 
The T7 gene expression system is the most used in recombinant protein production. It is based on 
bacteriophage T7 RNA polymerase, which elongates chains about 5 times faster than the native E. coli 
RNA polymerase. In order to produce T7 polymerase, the gene of the T7 RNA polymerase, T7 gene 1, is 
embedded in the E. coli chromosome under the control of a lac promoter derivate lacUV5, which genetic 
modification is called DE3. This lacUV5 promoter, which has three point mutations to the wild-type lac 
promoter, increases the promoter strength and decreases its dependence on cyclic AMP, and less sensitive 
to glucose. T7 RNA polymerase is highly selective for its own promoters, which do not occur naturally in 
E. coli. A relatively small amount of a T7 RNA polymerase is sufficient to direct high-level transcription 
from a T7 promoter in a multicopy plasmid. Such transcription can proceed several times around the 
plasmid without terminating. Due to T7 polymerase activity the transcription by E. coli RNA polymerase 
is greatly decreased. A specific mRNA produced by T7 RNA polymerase can rapidly saturate the 
translational machinery of E. coli, such that the rate of protein synthesis from such an mRNA will depend 
primarily on the efficiency of its translation. When the mRNA is efficiently translated, a target protein can 
accumulate to greater than 50% of the total cell protein in three hours or less. The T7 RNA polymerase 
seems to be capable of transcribing almost any DNA linked to T7 promoter, so that T7 expression system 
should be capable of transcribing almost any gene or its complement in E. coli. There are thousands of 
recombinant proteins successfully expressed in BL21(DE3) under the control of T7 promoter, e.g., 
penicillin acylase [71], CalB [29], [72]. 
The λpL is a tightly regulated phage promoter by the cI repressor. By up-shift the growth 
temperature, from 30 to 42 °C, the repressor is inactivated, and the gene expression is induced. The more 
interesting thing is that when the cultivation is at low temperature, λpL becomes constitutive and the gene 
can be expressed. In contrast, cspA promoter is a cold-shock promoter directing recombinant protein 
production at low temperature [73]. pColdTM is cold-shock expression vector under cspA promoter [74]. 
PalB was constructed in pColdIII and functionally expressed in cytoplasm of E. coli at 15 °C [29].  
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Unlike the above on/off promoters, araBAD promoter is an inducer-control promoter, which means 
that the expression level is a function of L-arabinose concentration, and is tightly shut off in media 
containing glucose but lacking arabinose. For full induction of araBAD, the L-arabinose concentration 
varied from 0.001~5% [75, 76]. This promoter is used in many applications to control gene expression, 
e.g., penicillin acylase [77], chaperone coexpression [67, 68, 71]. In this study, it is used for coexpressing 
the folding factor for mediating the expression of PalB. 
The tetA promoter is useful for the tightly regulated high-level synthesis of a foreign gene product 
in variety of E. coli strains [78]. Its strength was comparable to that of lacUV5, but it overcomes the 
weakness of lac promoter. Anhydrotetercycline binds the promoter about 35-fold higher than tetracycline 
and its antibiotic activity is 100-fold lower. In contrast to other systems, the basal level is very low and 
independent on the E. coli strain and the metabolic state [79]. All chaperones and proteases in this study 
were constructed under the control of araBAD promoter or tetA promoter. There are many other 
promoters used in E. coli system for recombinant protein productions. For example, the pH promoter is 
very strong promoter and recombinant proteins are produced at levels of up to 40~50% of the total 
cellular protein [80]. It also overcomes the concern of toxicity of the inducer, such as IPTG in the 
applications of final protein product. However, none of them is ideal for recombinant protein expression 
in E. coli. For a particular application, one still needs to do extensive screening in order to find the best 
promoter [42]. 
2.2.2 Translation Regulation is also Important for the Overall Gene Expression.  
Translation can be limited by several factors, such as the initiation efficiency, the number of available 
ribosomes and/or tRNAs, the secondary structure and/or stability of mRNAs and the presence of rare 
codons. Genetic modification of the regulatory elements has been proved to be effective for improving the 
translational efficiency [42, 81, 82]. Due to the expression vectors used in this study that were either 
purchased or supplied as gifts, it is assumed that the most parameters, except rare codons, have been 
optimized already. In addition, the effect of rare codons in palB gene expression is beyond the scope of 
this study. 
2.2.3 Expression Vector 
An expression vector, usually a man-made bacterial plasmid, is a double-stranded closed circular DNA 
molecule and is used for expressing a gene encoding the protein of interest [61, 83]. It contains all of the 
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features shown in Figure 2.1, and replication origin (Ori) [for controlling the copy number], and multiple 
cloning sites [for inserting the target gene in frame] (Figure 3.1).  
For most ready-for-use plasmid expression vectors, the systems have been optimized for different 
purposes and choosing the appropriate systems is needed. For example, the plasmids with pUC (copy 
number 500~700) origin is suitable for cloning work, while the plasmids derived from pBR322 (copy 
number 15~20) or pACYC (copy number 10~12) are good for gene expression.  
There are also some other considerations for choosing expression vectors. First, depending on the 
protein targeting, the expression vector should contain a signal peptide for leading the recombinant 
protein translocate into the periplasm or secrete into the medium. A signal peptide plays an important role 
in protein export [84]. It is highly hydrophobic but with some positively charged residues and it generally 
contains 3~60 amino acid residues, most often between 15~30. After directing the nascent polypeptide 
chain translocation, it is removed and rapidly degraded. Many eukaryotic proteins have signal peptides, 
but most of those signal peptides do not efficiently translocate nascent proteins when they are expressed 
in E. coli [28]. For the heterologous expression in the periplasm of E. coli, the most well-characterized 
signal peptides are pelB (the signal peptide region of PelB of Erwinia carotovora), ompA (the signal 
peptide of a major outer membrane protein, OmpA, of E. coli), phoA (the signal peptide of alkaline 
phosphatase of E. coli). In this study, five signal peptides are used, including pelB for pETG, ompA for 
pFlag-P, mbp for pHisperiMBP-G, dsbA for pETDsbA-G, and dsbC for pETDsbC-O. 
Second, leakiness frequently results in the overgrowth of plasmid-free segregants and/or segregants 
that have a reduced capacity for high-level expression, an impediment for high-level protein production. 
For overexpression of recombinant protein in E. coli, the multicopy plasmids are generally desired for 
maximum gene expressions: (i) they are small size, usually less than 5 kbp, and easily manipulated for 
controlled gene expression; (ii) high copy number generally results a good expression. However, the 
metabolic burden, resulted from the overexpression of gene, is detrimental for maximum productivity. 
Furthermore, the presence of a high copy plasmid may also cause a significant shift in the normal 
metabolism of the host cell, which can increase the risk of plasmid instability. A novel type of expression 
vectors with a dual regulation of both the plasmid copy number and gene expression are described [85]. 
When they are not induced, they are maintained as a single-copy plasmid. 
Third, downstream processing is another major issue that should be taken into the account when 
designing the expression vector. Several affinity tags, such as 6×His, GST, FLAG, MBP. have been 
developed to facilitate downstream purification of recombinant proteins [86, 87]. The expression vector is 
specifically designed so that the target protein would be expressed as a protein-tag fusion, which can be 
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easily recovered using the proper affinity chromatography. The target protein moiety can be released 
using a specific protease to cleave the junction between the target protein and the tag.  
Upon designing the expression plasmid, the above genetic strategies can be integrated to 
simultaneously enhance gene expression and protein purification. In conclusion, most of the technical 
strategies developed for recombinant protein production in E. coli focus on innovative design of the 
expression plasmids. For the most ready-for-use plasmid expression vectors, the systems have been 
optimized for different purposes. 
2.3 Protein Targeting in E. coli Expression System 
E. coli consists of a cytoplasm surrounded by a lipid bilayer called the cytoplasmic membrane (or inner 
membrane) and a cell envelope, which consists of a comparatively thin peptidoglycan layer, the periplasm 
membrane (or outer membrane). Therefore, the two membranes provide E. coli three possible 
compartments for the expression of recombinant protein, the cytoplasm, periplasm, and cell surface 
display [88-91]. The major biological steps involved for recombinant protein expression in E. coli are 
replication of the gene encoding the protein of interest, transcription of DNA to mRNA, translation of 
mRNA to polypeptide, and posttranslational processing (Figure 2.2) [38, 92]. Each of the compartments 
offers advantages and disadvantages for gene expression, depending on the experimental objectives and 
the characteristics of the targeted protein. 
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Figure 2.2 The major biological steps involved for recombinant protein synthesis in E. coli. The 
expression plasmid, e.g., palB gene, is duplicated with the cell replication. After induction, the RNA 
polymerase binds to the operator on the sense strand of plasmid to transcript palB gene into 
mRNA, e.g., palB mRNA. The translation starts when the ribosome attaching the mRNA, which is 
decoded to produce a polypeptide, e.g., preproPalB (with a signal peptide), or proPalB (w/o a signal 
peptide). If the expression is designed in the cytoplasm, the proPalB will be folded into PalB. If the 
expression is in the periplasm, the preproPalB will translocate into the periplasm with the leading 
of the signal peptide, and be folded into PalB. If the destination is surface display, the translocated 
PalB will be carried out of the cell wall with a specific carrier. 
 
2.3.1 Cytoplasmic Compartment  
Cytoplasm is the compartment where all recombinant proteins are first synthesized and are possibly 
located as its final expression destination [93]. Related to periplasmic expression, it is simpler for plasmid 
construction (e.g., no signal peptide is required), and generally higher protein expression is reached [94]. 
However, the proteins at concentrations of 200~300 mg/ml in the cytoplasm suggests a highly crowded 
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and unfavorable protein folding environment, especially during the recombinant protein overexpression, 
in which accumulation of intracellular recombinant proteins at a level up to 50% of total cellular protein 
[38]. Therefore it is not surprising that the formation of inclusion bodies remains a significant barrier for 
recombinant protein expression in the cytoplasm.  
Several experimental approaches have been developed to reduce inclusion body formation. For 
example, (1) Reduction of the rate of protein synthesis by lowering cultivation temperature or using a 
moderately strong promoter [38, 92, 95]; (2) Coexpression of chaperones [96]; (3) Addition of fusion tag 
[87]; (4) Substitution of amino acids in the polypeptide chain [97-99]; (5) Reduction of acetate’s effect by 
changing chemicals  in the growth medium[100, 101]; (6) Alteration of the pH [102, 103]; or (7) 
Replacement of the bacterial strain [104]. 
Due to disulfide bond formation in E. coli requiring the disulfide bond formation catalyst, which 
could not be found in the reduced environment, the disulfide bond formation is strongly disfavored in the 
cytoplasm [105, 106]. But Robinson and King found the transient disulfide bonds were presented in a 
folding intermediate of a non-disulfide bonded protein, P22 tailspike endorhamnosidase [107]. Jonathan 
Beckwith’ group in Harvard Medical School identified two thioredoxins, TrxA and TrxC, and three 
glutaredoxins in E. coli cytoplasm. The oxidized form of these proteins can catalyze the formation of 
disulfide bonds in peptides. However, in the cytosol, both the thioredoxins and the glutaredoxins are 
maintained in a reduced state by the action of thioredoxin reductase (TrxB) and glutathione, respectively. 
In a trxB mutant, the two thioredoxins are oxidized and serve as catalysts for the formation of disulfide 
bonds [104]. They found that a protein with multiple disulfide bonds can be fully expressed actively in 
the host strain with gshA, or gor and trxB mutated [108]. In E. coli, glutathione is synthesized by gshA 
and gshB gene products and the enzyme glutathione oxidoreductases, the product of the gor gene, is 
required to reduce oxidized glutathione and complete the catalytic cycle of the glutathione-glutaredoxin 
system. However, the growth was very poor for the double mutants with gshA and trxB. The strains 
FA112 (trxB gor supp) and FA113 (trxB gshA supp) almost reached the same growth rate as the wild-type 
strain bearing a secretion plasmid, e.g., human tissue plasminogen activator [109] and the single chain 
variable fragment antibiotics [110]. Novagen took over the technology and developed a series of 
commercial strains called OrigamiTM, which are used widely for recombinant protein expression in the 
cytoplasm and was used in this study. Coexpression of chaperones in mutant strain were studied and it 
was found that the effect was limited, e.g., Fab antibody fragment [111], PalB [29].  
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2.3.2 Periplasmic Compartment  
Periplasmic expression of recombinant proteins provides several advantages compared to cytoplasmic 
expression. First, an authentic N-terminal amino acid protein can be obtained after cleavage of the signal 
sequence by a specific signal peptidase. Second, there is much less protease activity in the periplasmic 
space than in the cytoplasm. Third, recombinant protein purification is simpler due to less contaminating 
proteins in the periplasm. Fourth, oxidative environment and existing catalysts facilitate the disulfide 
bonds formation.  
There are several advantages for expressing eukaryotic proteins in the periplasm because its 
oxidative environment is suitable for disulfide bond formation and it is feasible to obtaining proteins with 
authentic N-termini. This compartment also contains fewer proteins such that downstream purification 
will be facilitated. Microbial cell surface display has been extensively explored due to its significant 
impact on various biotechnological and industrial applications, such as vaccine development, biosensor 
development, high-throughput screening of macromolecular libraries and preparation of whole-cell 
biocatalysts [91]. Extracellular release of gene products offers an alternative for recombinant protein 
production in E. coli [90] and this approach is particularly valid for periplasmic proteins. The proteins 
released are less subject to intracellular proteolysis and selective secretion of the target protein would 
facilitate downstream purification. Also, reducing the local protein concentration via protein release can 
alleviate intracellular protein misfolding. 
Generally proteins found in the periplasm are synthesized in the cytoplasm as premature proteins, 
which contain a signal peptide in front of the mature proteins. With the leading of the signal peptide, the 
protein is translocated through the inner membrane into the periplasm for folding and maturation [89]. 
The efficiency of protein secretion varies depending on the host, the signal peptide, and the type of 
protein to be secreted. To date, there is no general rule in selecting a proper signal sequence for a given 
recombinant protein to guarantee its successful secretion. 
The main problems in secretarial recombinant protein expression are: (i) incomplete translocation 
across the inner membrane [92], (ii) insufficient capacity of the export machinery [112], (iii) low or 
undetectable amounts of recombinant protein secretion, (iv) formation of inclusion bodies in the 
cytoplasm and periplasm when using strong promoters, and (v) incorrect formation of disulfide bonds, 
(vi) proteolytic degradation [113]. However, without trial-and-error, it is somewhat difficult to select a 
proper host/vector system and a signal sequence for the secretion of a desired protein [88].  
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2.3.3 Cell Surface Display 
Recently microbial surface display has been extensively studied due to its significant impact on various 
biotechnological and industrial applications, including vaccine, biosensor, screening of macromolecular 
library, and whole-cell biocatalyst [91, 114-116]. Except a signal peptide, it needs a carrier (or anchoring 
motif), which usually is an outer membrane protein possessing unique membrane-spanning structure, e.g., 
OmpA, OmpF, OmpS, and LamB. Depending on the properties of the carrier and the passenger (or 
displayed protein), the protein can be fused at an N-terminus, a C-terminus, or sandwiches fused at both 
N- and C-termini to expose the passenger protein to extracellular environment with its bioactive 
formation.  
The passenger protein should be maintained in an unfolded or translocation-competent form until it 
is displayed [117]. The misfolded passenger-carrier-related proteins could induce periplasmic stress. In 
addition, overexpression of cell surface display could generate much higher cell stress than the 
cytoplasmic or periplasmic overexpression, because the outer membrane becomes fragile or even 
disintegrated upon frequent insertion of passenger-carrier fusions [118]. Therefore the cell defense system 
could sense the stresses, most likely react to the periplasmic stress, through σE and Cpx, which are 
partially overlapping [119-122]. The response to the extracytoplasmic stress is driven by synthesizing the 
proteins, e.g., DegP, FkpA, and DsbA, Skp, and SurA, who are in charge of releasing the stresses through 
degradation of misfolded proteins and/or mediation of misfolded proteins folding. 
Cell surface display was interested for whole cell biocatalyst, PalB. In this way, the cell surface 
displayed PalB could be directly used in enzyme immobilization, and don’t need to go through the 
purification process. 
2.4 Technical Limitations for Production of Recombinant Protein 
Some often encountered problems of recombinant protein expression in E. coli and possible solutions for 
those problems are summarized in Table 2.3. Theoretically, all the biological steps, depicted in Figure 
2.2, have to be effective to result in a high recombinant protein yield. The step limiting the overall gene 
overexpression should be targeted for improving expression performance. However, enhancing the 
efficiency of the original limiting step could imply that another step becomes limiting. A typical example 
is that protein folding becomes limiting, resulting in the formation of misfolded protein, when strong 
promoters are used for boosting transcription. This raises an important issue that, for the overproduction 
of recombinant proteins, a 'balanced' protein synthesis flux throughout all the gene expression steps (e.g., 
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transcription, translation and post-translational steps) should be properly maintained to avoid the 
accumulation of polypeptide intermediates in addition to boosting the individual limiting step. 
Misfolding of the target gene products can result in the formation of insoluble protein aggregates as 
non-bioactive inclusion bodies. This represents a major technical hurdle for recombinant protein 
production in E. coli [123]. One of the reasons for inclusion body formation is that the overexpressed 
gene products cannot be suitably processed by folding modulators to develop the proper protein structure 
[43]. Inclusion bodies can be observed by optical microscopy as refractile particles of up to about 2 μm3 
[124]. Most inclusion bodies are found in the cytoplasm but the secreted proteins can also form 
aggregates in the periplasm. Inclusion bodies do offer several advantages, such like facile isolation of 
protein in high purity and concentration, target protein protected from proteases, desirable for production 
of proteins that if active are lethal to host cell. In principle, these insoluble aggregates can be easily 
purified and refolding can be explored to regain the protein's biological activity [125]. However, the 
potential of this approach is often limited since renaturation of these misfolded proteins is often 
ineffective [38, 123]. Therefore, in vitro protein refolding is a choice only if all the efforts to solubilize 
the aggregates and gain the native conformation in vivo were unsuccessful. In other words, the formation 
of inclusion bodies keeps recombinant protein away from proteolytic degradation, and refolding can 
recover active proteins from inactive inclusion bodies, the initial expression of soluble, correctly folded 
recombinant protein is ideal [126].  
High-level gene expression can also induce a stress response [127]. The major physiological 
stresses include heat shock, starvation and stationary-phase stress, pH stress, and oxidative stress. The 
overexpressed heterologous gene products can challenge cells with different levels of toxicity and 
metabolic burden, and cell growth is hindered. In general the specific growth rate of cells expressing a 
product correlates inversely with the rate of recombinant protein synthesis [127, 128]. On the other hand, 
due to the limitation in nutrient and/or oxygen availability, cells in dense cultures often have lower 
cellular activities and metabolic energy that are required for effective biosynthesis. A compromise in 
balancing the levels of gene expression and cell growth needs to be reached at a certain point to maximize 
the volumetric recombinant protein productivity. Studies have been conducted to characterize cellular 
responses to recombinant protein overproduction [129, 130]. Stress can be reduced by slow adaptation of 
cells to a specific production task, by gradually increasing the level of inducer, or by slowly increasing 
the plasmid copy number during cultivation.  
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Table 2.3 Some problems of recombinant protein production in E. coli and possible solutions 
(modified after [79]) 
Symptom Possible problems Solutions 
Cell death or no 
colonies 
Toxic protein, high 
basal expression 
More stringent control over basal expression 
Tightly controlled promoter system 
Weaker promoter 
Lowering temperature 






Minimize reduction in cytoplasm 
Accumulation in the periplasm 
Insoluble protein 
(inclusion bodies) 
Too much expression Attenuate expression by weaker promoter, lowering 
temperature, or inducer concentration, decrease 
plasmid copy number, adding fusion tag 
No activity Misfolded protein, 
fusion tag can 
decrease activity 
Minimize reduction in cytoplasm 
Accumulation in the periplasm 
Attenuate expression 
Change fusion tag 
No protein, truncated 
protein 
E. coli codon usage 
(codon bias) 
Supply rare tRNAs 
Stronger promoter 
Increase plasmid copy number 
Lower temperature 
Tightly controlled promoter system 
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In a conclusion, most of the technical strategies developed for recombinant protein production in E. 
coli focus on innovative design of the expression vectors. However, the physiological deterioration 
associated with gene overexpression can result in a number of negative cellular responses, such as growth 
inhibition, cell lysis or even death, which are detrimental to protein productivity. To maximize the protein 
productivity, emphasis should also be given for high-cell-density cultivation by improving cell 
physiology upon gene overexpression. The integrative approaches in the aspects of both strain and 
bioprocess development for effective biomanufacturing form the major scope of a new recombinant 
protein production in E. coli. 
2.5 Resolutions for the Recombinant Protein Overexpression in E. coli 
The goal for recombinant protein production in E. coli is to simultaneously achieve a high-level gene 
expression and high-cell density. However, this goal is really difficult to reach because high-level gene 
expression and high-cell-density always conflict with each other. The resolution is making compromise 
that to optimize each gene expression step based on a ‘balanced’ protein synthesis flux being properly 
maintained to avoid the accumulation of any protein species along the protein formation pathway. 
Therefore the inclusion body formation and the deteriorated cell caused by the overexpression of the 
recombinant protein could be prevented or mediated by coexpression of the periplasmic folding factor, 
adding fusion tag, and/or the techniques mentioned in the section of 2.3. 
2.5.1 Fusion Tag is a Tool to Assist Heterologous Protein Expression  
Recombinant proteins with low or no structural content can often be produced in E. coli whereas proteins 
containing both structured and large unstructured regions always encounter problems, especially for the 
eukaryotic proteins. It is reported that only 22.7% of heterologous proteins of they have expressed in E. 
coli are soluble (1452 in total of 6386 proteins) [126]. Among the strategies for improving expression of 
recombinant protein in E. coli, including choosing strong promoter, coexpressing chaperone, using fusion 
tag, and adjusting cultivation conditions, no other technology has been as effective at improving the 
solubility of recombinant proteins as fusion tag does, especially for difficult-to-express protein [126].  
Fusion tag technology is able to improve heterologous expression by overcoming many challenges, 
including the low translation rate, the proteolytic degradation of target proteins, protein misfolding, poor 
solubility, and the necessity for good purification methodologies [87, 126]. The ribosomes can efficiently 
initiate translation at the N-terminus methionine residue of the fusion tag. Attachment of a highly evolved 
translational frame at the N-terminus of an inefficiently translated protein improves the latter’s efficiency 
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of translation [131], which inefficiency is often caused by a secondary structure in the mRNA interfering 
with the binding of ribosomes [87, 132, 133].  
It is not uncommon that the overexpressed heterologous proteins are attacked by the proteases in 
the cell defense system [134, 135]. Proteolysis is highly regulated and plays critical roles in maintaining 
cellular homeostasis, including removing unwanted or incorrectly folded proteins from the cell [136]. 
Fusion protein could protect the target protein from being degraded by solubilizing the fused protein and 
improving folding to avoid it off-productive pathway and aggregation [38, 86, 137].  
How the fusion tags improve solubility, promote protein folding and enhance recombinant protein 
expression is unknown, maybe because the fusion tag efficiently and rapidly reaches a native 
conformation as it emerges from the ribosome (or soon after its release), and this the highly conserved 
structure of the fusion tag acts as chaperone to stabilize and promote the acquisition of correct structure in 
downstream folding units by favoring on-pathway isomerization reactions [92, 137]. 
More excited about fusion tag is that some bifunctional fusion tags (e.g., MBP, FLAG, and GST) 
not only are the solubility enhancer to improve the target protein production, but also offer the 
opportunities to facilitate purification and detection of recombinant proteins. However, fusion tag 
technology also has disadvantages.  
The major disadvantage of protein fusion technology is proteolytic cleavage. Generally it is low 
yield for generating free protein from fusion protein, the protein of interest could be precipitated after 
cleaving from the fusion tag, optimization of cleavage conditions is labor-intensive, expense of protease is 
high, and it may fail for recovering the active, structurally intact protein. Another problem is the 
generation of non-native N-terminal amino acids. Finally, the large fusion partners impose a high 
metabolic cost on the cells, resulting in cell deterioration or even lysis. The improved fusion tag 
technology by using the Ubiquitin and SUMO fusion tag systems can overcome the disadvantages 
resulting efficient, accurate cleavage, and authentic N-terminus of target protein [126]. 
2.5.2 N-Terminus Fusion Tag is More Powerful 
Originally it was believed that virtually any highly soluble protein could act as a solubility enhancer, but 
this seems not true [138-140]. Both N-terminus and C-terminus fusion tags are reported successfully 
improving the fused protein’s solubility and enhancing the recombinant protein expression in E. coli. N-
terminus fusion tags are even more effective [141] because translational efficiency is known depending 
on the mRNA sequence around the ribosome binding site including the 5’ end of the coding sequence. 
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Therefore, sequence encoding the N-terminus protein fusion provides good translation initiation 
properties to generate a high expression level [137, 138]. 
An N-terminus fusion tag can help to alleviate two obstacles at once by enhancing translation 
initiation and improving solubility to reach high activity and productivity for recombinant protein 
expression in E. coli [87]. However, the abilities for solubility enhancement are different for the N-
terminus fusion tags [142]. For the same fusion tag, the effect depends on the fused protein’s properties, 
generally on the size of the target protein. The larger target protein (e.g., above 25 kDa), the less amount 
of soluble protein even though the total expression levels are unchanged. Many published papers show the 
comparisons about the solubility capacities between the fusion tags for same target protein and/or for 
different proteins [72, 138, 142, 143]. For example, Hammarstrom et al., overexpressed 43 genes for 
eukaryotic proteins with four fusion tags (e.g., His, TRX+His, GST+His, GBI+His) in E. coli resulted that 
14 of them were predominantly insoluble, six predominantly soluble with all four fusion tags, indicating 
the complexity of heterologous proteins expressed in E. coli [138].  
The properties of the N-terminus fusion tags used in this study for expression of PalB are 
summarized in Table 2.4. His-tag and GST tag are commonly used as purification purpose,  not expecting 
the solubility enhancement [72, 144, 145]. Tags of MBP, NusA, and TRX earned very high reputations 
for improving the solubility and enhancing the stability and bioactivity of the fused proteins [93, 94, 137, 
139, 140, 146]. Thioredoxin (TRX), [94], DsbA and DsbC [72], are used specifically for improving 
disulfide bonds formation. 
The larger fusion tags can be more efficient for improving solubility, but generate more metabolic 
burden. In contrast, smaller fusion tags could be directly used without being removed if the fused protein 
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Table 2.4 The properties of the N-terminal fusion tags used in this study 






6×His A-, C+ F-, D- 0.84 Ni-NTA [87] 
Strep-II A-, C+, F+ D-, E+, G+, 1 Strep-Tactin [87] 
DsbA B+, D+ A+, C- 21  [72] 
DsbC  A+, C- 23.4  [72] 
FLAG A-, B+; C+, D+; F+ E+, G+ 1 Anti-Flag 
antibodies 
[87] 
GST B+, C+, E-,G- A+, D- 27.3 Glutathione-
Sepharose 
[87] 
MBP B+, C+, E-, D+, G- A+ 45 Amylose  [87] 
NusA B+, D+ A+, C- 55  [87] 
Skp A- C- 21  [147] 
T7PK B+ A+, C- 30  [147] 
TRX B+, D+ C- 14.3 ThioBond [87] 
 
*Symbols in the table represent for 
+: Positive effect;   -: Negative effect;  
A: Metabolic burden;   B: Efficient translation initiation;   C: affinity tag;  
D: Enhances solubility;   E: Expensive affinity resin;    F: High specificity;  
G: Mild elution conditions;  
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2.5.3 Coexpression of Cytoplasmic Chaperone to Mediate the Misfolded Protein in the 
Cytoplasm  
As mentioned before, the cytoplasm is a really crowded compartment. About 10~20% of newly 
synthesized polypeptides require interaction with the molecular chaperones to prevent their misfolding 
and aggregation, and to promot their folding [135]. The well-characterized cytoplasmic chaperones are 
TF, DnaK/J-GrpE, and GroEL/ES (Figure 2.3) [43, 148, 149].  
 
 
Figure 2.3 Cytoplasmic chaperone-assisted protein folding in the cytoplasm of E. coli (modified 
after[43]). The newly synthesized polypeptides require the assistance of TF or DnaK/J-GrpE to 
avoid the solvent and each other in vitro. A native conformation could be reached after releasing 
from TF and DnaK. The misfolded proteins are transferred to GroEL for unfolding. Some of them 
will be back to the productive pathway, others will be degraded.  
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TF is composed of three domains: an N-terminal domain for association with the large ribosomal 
subunit, a central substrate binding and peptidyl-prolyl-cis-trans-isomerase (PPIase) domain, and an 
unknown function C-terminal domain [150-152]. A recent paper reported that all of three domain of TF 
interact with nascent chains during translation [153]. TF is the first chaperone that interacts moderately 
and stabilizes elongating nascent peptide chain protruding from 50S ribosome in a non-aggregated state 
[152, 154]. In contrast to DnaK/J-GrpE and GroEL/ES, TF is not a heat-shock induced chaperone. 
Deletion of the tig gene encoding TF does not impair cell growth [155].  
DnaK (Hsp70), DnaJ (Hsp40) (involved in substrate binding and presentation) and GrpE, (a 
nucleotide-exchange factor) always collaborate together as DnaK/J-GrpE because overexpression of DnaJ 
does not affect protein folding, but overexpression of DnaK in the absence of DnaJ may result in cell 
death [156]. DnaK/J-GrpE cooperated in folding of newly synthesized proteins and possessed overlapping 
substrate pools and binding specificities with TF [157, 158]. 
The polypeptide chains could be folded after released from TF or DnaK/J-GrpE, or are transferred 
to GroEL/ES [43, 154]. Together with GroES, GroEL (Hsp60) provides a physically defined 
compartment in which interacts hydrophobically with the captured an aggregation-prone intermediates or 
misfolded proteins and facilitates their unfolding or refolding in an ATP-dependent manner while they are 
sequestered from the cytoplasm [149, 159].  
Coexpression of TF and GroEL/ES or DnaK/J-GrpE and GroEL/ES form a cooperative team and 
apply a synergetic effect on folding intermediates or at later folding stages and maximizing recovery of 
the target protein in a soluble form [160, 161]. It was reported that coexpression of TF and GroEL/ES is 
more effective [76] because on the basis of further association with GroEL, TF can strengthen its function 
for facilitating protein folding through efficient binding to GroEL substrates [157, 162, 163].   
It was observed in penicillin acylase (PAC) studies [68] that all three cytoplasmic chaperones 
enhanced the proPAC solubilization process. TF not only had the most prominent solubilization effect but 
also significantly increased PAC activity, suggesting that TF might be helpful for preserving the specific 
folding state for PAC maturation [164]. It appeared difficult for the misfolded proPAC to be reshifted 
back into the productive pathway for PAC maturation, even though it could be solubilized by DnaK/J-
GrpE or GroEL/ES possibly due to the failure in recovering the critical folding state (mediated by TF) of 
newly synthesized proPAC. In the long-term run experiment (50 h after induction in a batch fermenter) of 
the same study, the effect of proPAC solubilization was rather prominent upon coexpression of DnaK/J-
GrpE, particularly in the exponential phase. Both soluble proPAC and mature PAC were protected from 
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intracellular proteolysis by DnaK/J-GrpE, and GroEL/ES, but not TF, particular during the stationary 
phase. The chaperone team of TF and GroEL/ES acted collaboratively and applied a significant effect in 
facilitating the proper folding of proPAC, protecting proPAC from proteolysis, and improving PAC 
maturation in the cytoplasm [67].  
Another function, at least for most, if not all, of chaperones is for responding to cell stress. The 
amount of a native protein reflects an equilibrium status of protein synthesis, folding and stability. Stress, 
from overexpression of protein, or elevated temperature, causes an imbalance in this equilibrium, 
resulting cell control system initiating stress response. The heat shock response controls levels of 
chaperones and proteases to ensure a proper cellular environment for protein folding. In the cytoplasm of 
E. coli, this response is mediated by the classic heat-shock regulon σ32 (or σH or RpoH), a heat-shock 
transcription factor regulating the expression of many cytoplasmic heat-shock gene and its production is 
only induced through the σ32 pathway [165]. DnaK chaperone regulates both the amount and activity of 
σ32 [166-170]. DnaK cooperated with ClpB to resolubilize the protein aggregation, and mediate them 
back to the productive pathway [171]. GroEL/ES is an additional regulator of σ32 [172]. The degradation 
of aggregates also requires chaperones[136], e.g., DnaK, probably function in substrate recognition [113], 
or GroEL/ES, for maintaining substrates in a soluble easily digestible state [135, 162, 163]. 
2.5.4 Coexpression of Periplasmic Folding Factor to Assist Recombinant Protein 
Expression in the Periplasm of E. coli 
Periplasmic folding factors function in an ATP-independent manner, in contrast to their cytoplasmic 
counterparts, because ATP is not present in the periplasm. It has been reported that several folding factors 
interact with secreted proteins for functional expression [88, 96, 173, 174]. There are more than 10 
different folding factors characterized in the periplasm, but here only the folding factors used in this study 
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Table 2.5 Properties of the periplasmic folding factors and the cytoplasmic chaperones used in this 
study 
Protein No. of amino acids 
of mature protein 
Molecular weight 
of monomer (kDa) 
Oligomeric 
state 
pI PDB code 
Periplasmic folding factor    
DegP 443 46 Hexamer 7.9 1ky9 
Skp 180 21 Trimer 11.9 1sg2, 1u2m 
SurA 408 45 Monomer 6.1 1m5y 
FkpA 245 26 Dimer 6.7 1q6u, 1qq6h, 1q6i 
DsbA 181 21 Monomer 5.4 2b3s, 1a2i 
DsbC 223 23 Dimer 5.9 1jzo 
Cytoplasmic chaperone     
TF  48 monomer  1i1p, 1oms 
DnaK-J/GrpE  72   1q5i, 1bpr, 1bqz 
GroEL/GroES  60   1kpo, 1fy9 
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Figure 2.4 Export and periplasmic folding pathways in E. coli (modified after[43]). Preproteins 
with less hydrophobic signal sequence (lavender) undergo Sec-dependent export. After cleavage the 
signal sequence, partially folded periplasmic proteins may aggregate (1), undergo proteolysis (2) or 
reach a native conformation, possibly with the aid of folding factors (3), (4) and (5). 
 
There are two different stress response pathways (σE and Cpx) in the envelope space of E. coli, but 
overlapped in both regulations and functions [174-177]. For the folding factors used in this study, degP, 
skp are under the control of both the σE and Cpx [174, 178]; fkpA is under the control of σE [120, 179]; 
surA is not a member of σE or Cpx regulons, but lack of SurA activates σE [173]; dsbA is under the control 
of Cpx [174], and dsbC is under control of σE [178]. Among these folding factors, Skp is the only 
chaperone. DegP possesses protease or chaperone activity. FkpA and SurA are PPIases and chaperones, 
but they belong to different PPIase. DsbA and DsbC are catalysts for disulfide bond formation and 
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isomerization, and may have chaperone activities. In addition, the functions of DsbA and DsbC are 
overlapped in certain situations.  
2.5.4.1 DegP 
DegP is essential for E. coli survival in high temperature [180, 181]. DegP also degrades transiently 
denatured or unfolded proteins which accumulate in the periplasm following heat shock or other stress 
conditions, and/or newly secreted proteins prior to folding and disulfide bond formation [182]. With 
temperature shift a downward, DegP changes its role from protease to chaperone [182, 183]. DegP 
function in the periplasm could be similar to that of TF in the cytoplasm, namely, having an interaction 
with newly synthesized (or newly translocated) protein, since DegP is often located on the side of the 
cytoplasmic membrane facing the periplasm [184]. DegP deficient strain is useful for the protease-
sensitive recombinant proteins production [185, 186]. In contrast, DegP is required and even need to be 
coexpressed with the target protein. For example, for efficient export of overexpressed alkaline 
phosphatase (PhoA), DegP functioned as a 'translocation channel cleaner' which degrades misfolded 
proteins accumulated near the periplasmic side of the channel upon extracytoplasmic stresses (e.g., gene 
overexpression resulting overloading on protein export machinery) [184]. 
In this lab, the results from penicillin acylase (PAC) studies showed DegP protease activity was 
primarily accountable for the enhancement of the periplasmic processing for PAC maturation. While the 
culture performance for production of PAC, particularly the volumetric PAC activity, was improved by 
degPS210A coexpression, the mutant DegP (only having chaperone activity without protease activity) 
could not suppress several negative cellular responses caused by pac overexpression (e.g., inclusion 
body formation, growth arrest, and cell lysis) as effectively as the wild-type DegP could. The results 
suggest that both protease and chaperone activities are required for DegP to effectively improve the 
production of PAC [187, 188]. 
2.5.4.2 FkpA 
FkpA is another periplasmic heat-shock protein with both PPIase and chaperone activities [189-192]. It is 
reported that FkpA assisted MalE31 formation [189], and increased antibiotic fragment expression 
dramatically by interacting with early folding intermediate for preventing their aggregation, or by reacting 
with aggregated protein, and unfolding and releasing them on a productive pathway [193, 194]. FkpA was 
used in penicillin acylase (PAC) study in this lab, and found that it neither reduced the amount of PAC 
inclusion bodies nor increased the pac expression level. However, coexpression of FkpA released cell 
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stress and improved cell physiology upon pac overexpression, so the overall productivity was increased 
[195]. 
2.5.4.3 Skp 
Skp is a characterized periplasmic chaperone [196, 197] that interacts with unfolded proteins translocated 
into the periplasm via Sec secretion system [179] for generating and maintaining the solubility of early 
folding intermediates [198]. Skp plays a key role in proper biogenesis of the envelope by mediating the 
folding and targeting of several outer membrane proteins to the membrane [199-202]. On the other hand, 
Skp has been shown to improve the folding of recombinant proteins or antibody fragments in the 
periplasm of E. coli [111, 203-205]. 
2.5.4.4 SurA 
As a more important component in the biogenesis of OMPs, SurA possesses PPIase and chaperone 
activity. Recent study showed its main function is as the primary chaperone responsible for the 
periplasmic transit of the bulk mass of OMPs to the YasT complex [206] or even to later OMPs 
maturation [207]. Its substrate specificity relates to the certain secreted OMPs [208] and to the chaperone 
domain, not PPIase [209].  
2.5.4.5 DsbA and DsbC  
While all above are general folding factors for assisting recombinant protein expression in the periplasm 
of E. coli, DsbA and DsbB, as oxidoreductases, specifically mediate the recombinant protein with 
multiple disulfide bonds [40, 210]. DsbA and DsbC are well-characterized members of Dsb-family [40, 
211]. DsbA is essential for direct bridging of disulfide bonds in newly translocated proteins and DsbC 
assists subsequent rearrangement of aberrant disulfide bonds because the newly formed disulfide bonds 
can be formed among incorrectly paired cysteines, trapping substrate proteins in a misfolded 
conformation [40]. Recent studies revealed that the overexpression of Dsb proteins increased secretion 
efficiency, folding, and the solubility of recombinant proteins in the periplasmic space [212-214]. 
Although they have defined roles in the formation of disulfide bonds, DsbA and DsbC might share certain 
biological functions in some particular conditions [104, 215-217]. In addition, DsbC may also have 
chaperone activity [218]. 
The redundant periplasmic chaperones actually do function in parallel or work as a team. For 
example, the role of DegP/Skp was amplified in the absence of SurA, but in the normal situation, DegP 
and Skp worked for rescuing OMPs that fall off the SurA pathway [206]. SurA and FkpA are helpful for 
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disulfide bond formation [219]. DsbA and DegP have overlapping effect on the MalS folding process 
[183].  
2.6 The Recombinant PalB Expression System 
Lipase (E.C.3.1.1.3) belongs to the α/β-hydrolase-fold superfamily (E.C.3.X.X.X) which contains 
enzymes to catalyze reactions such as hydrolysis ester, thioesters, peptides, epoxides, and alkyl halides or 
cleavage of carbon bonds in hydroxynitriles. PalB is built up of 317 amino acids and the molecular 
weight is 33 kDa without glycosylation [220] (Table 2.6). It contains the catalytic triad Ser105-His224-
Asp187, common to all serine hydrolases (Figure 2.5) [220]. There are six cysteine residues in the 
sequence of PalB and all involved in disulfide bonds, Cys22-Cys64, Cys216-Cys258, and Cys293-Cys311 for 
stabilizing the N-terminal, the surface, and the C-terminal respectively. The central β–sheet is composed 
of seven strands of which the last six are parallel, most connections between strands are formed by the 
right handed β-α-β structural motif (Figure 2.5) [221, 222]. PalB has a large hydrophobic surface 
surrounding the entrance of the active site channel, so that it has no interfacial activity, which means PalB 
activity in the solvent is similar to that in water. 





            35 






            36 




Figure 2.5 The structure diagram of α/β-hydrolase fold of lipase. Panel A is the secondary structure 
of a general lipase (Panel A1) and PalB (Panel A2). α-helix and β-sheet are drawn as red cylinder 
and blue arrows respectively. The central β-sheet is composed of six are parallel, and most 
connections between strands are formed by the right handed β-α-β structural motif. The amino 
acids (Ser, Asp, His) belonging to the catalytic triad are shown in orange solid oval. The big 
differences of PalB with general lipase are in the pink boxes, which might be the cause for the 
specific PalB characteristics. Three disulfide bonds (green bar) in PalB are for stabilizing the N-
terminal, the surface, and the C-terminal respectively. Panel B is the three dimensional structure of 
PalB. 
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Due to the unique properties of PalB in catalyzing hydrolysis of triacylglycerols, and 
transesterification and other organic synthetic reactions to produce new kinds of lipids [223, 224], it is 
widely used in organic chemistry (e.g., cosmetics, food) [225, 226]. However, the PalB product from the 
original microbe is really low. Previously, recombinant PalB was expressed heterologously in Aspergillus 
oryzae [25], Pichia pastoris [26], and Saccharomyces cerevisiae [27, 227]. Intensive studies of PalB have 
been focused on characterizing the structures [221, 222, 225, 228], investigating thermal stability, 
enantioselectivity and activity [223, 225, 226, 229]. and improving PalB activity by applying fusion tag 
(e.g., cellulose-bind domain) [26] and mutagenesis [227, 230, 231].  
PalB is an attractive enzyme for biodiesel production for catalyzing the transesterification reaction 
of vegetable oil or animal fat with methanol. It is inspired and motivated to investigate the feasibility of E. 
coli as host because of its capability of massive production of recombinant protein. First, the concern of 
pathogenicity, or endotoxin of this host is not a problem for PalB quality used as biocatalyst in biodiesel 
production. Second, although the expression performance stands improvement, the functional expression 
of PalB in E. coli [28, 29] sparks a light. The glycosylation is not essential for PalB bioactivity [28, 29] 
and disulfide bond formation can be mediated by biochemical and genetic means. 
A major technical issue limiting the PalB expression level in E. coli is associated with its 
intracellular misfolding. PalB is a cold active lipase destined to be secreted extracellularly in the original 
psychrophilic and eukaryotic source of P. antarctica. Consequently, the intracellular overexpression 
might prevent it from being structurally adaptable to the mesophilic and prokaryotic expression system of 
E. coli, resulting in protein misfolding. In addition, wild-type PalB has three intermolecular disulfide 
bonds (Figure2.5) potentially associated with its folding process though they might not be strictly 
required for developing the bioactivity. Finally, cell growth is often arrested due to deteriorated cell 
physiology associated with high-level expression and misfolding of PalB.  
Considering the PalB’s application purpose and the benefit of different expression systems, a 
systematic study of recombinant PalB expression in E. coli system was focused on, including promoter, 
expression vector in different compartments, fusion tag, chaperone, folding factor, and cultivation 
condition.  
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Chapter 3* 
Identification of Factors Limiting Heterologous production of Lipase 
in the Cytoplasm of Escherichia coli 
3.1 Introduction 
The bacterium Escherichia coli remains popular as a workhorse for recombinant protein production. 
Formation of active proteins involves a series of intracellular steps for gene expression (e.g., transcription 
and translation) and posttranslational processing (e.g., folding, translocation and others). Strategies based 
on boosting gene expression steps are often adopted to enhance recombinant protein production [31, 38, 
92]. However, it is not uncommon that the overexpressed gene products cannot be suitably processed 
during posttranslational processing, resulting in the formation of insoluble protein aggregates known as 
inclusion bodies [43, 232]. Theoretically, the precursors, intermediates, or final gene products can 
possibly form inclusion bodies in the cytoplasm and/or periplasm particularly during the course of gene 
overexpression. This brings up a technical issue that, in addition to improving the efficiency of each gene 
expression step, a ‘balanced’ protein synthesis flux throughout these steps should be properly maintained 
to avoid the accumulation of any protein species along the protein formation pathway. 
Lipases (triacylglycerol acylhydrolase, E.C.3.1.1.3) are enzymes that catalyze the synthesis or 
hydrolysis of glycerol esters (e.g., triglycerides), such as fats and oils [14]. Microbial cells, including 
bacteria, fungi, and yeasts, are the major source for lipases with various enzymatic characteristics, such as 
synthetic and hydrolytic activity, stability, substrate specificity, for numerous applications in organic 
chemistry and biotechnology [20, 21]. Our interest in lipase arises from its application on 
biotransformation as an alternative to chemical conversion for biodiesel production. Lipase B from 
Pseudozyma antarctica (PalB) is a cold active microbial lipase with the transesterification activity and its 
corresponding immobilized form (e.g., Novozyme 435 commercially available from Novozyme A/S, 
Bagsvaerd, Demark) has been recognized as the most common biocatalyst for biodiesel production. While 
the biocatalyst is gaining more attention and has a potential to outperform chemical catalysts, extensive 
application remains impractical due to its high cost and several technical issues (e.g., inactivation by 
alcohol). To make the bioprocess economically feasible, there is a motivation to overproduce PalB.  
                                                   
* This chapter is based on a paper “Y. Xu, M. Scharer, M. Moo-Young, C. P. Chou, Identification of Factors 
Limiting Heterologous Production of Lipase in the Cytoplasm of Escherichia coli. 2008.” (under review). 
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Previously, recombinant PalB was expressed heterologously in Aspergillus oryzae [25], Pichia 
pastoris [26], and Saccharomyces cerevisiae [27]. Given the popularity of E. coli as a workhorse for 
recombinant protein production, functional expression of PalB in this host was not demonstrated until 
recently [28, 29] and the expression performance stands improvement. A major technical issue limiting 
the PalB expression level in E. coli is associated with its intracellular misfolding. PalB is a cold active 
lipase destined to be secreted extracellularly in the original psychrophilic and eukaryotic source of P. 
antarctica. Consequently, the intracellular overexpression might prevent it from being structurally 
adaptable to the mesophilic and prokaryotic expression system of E. coli, resulting in protein misfolding. 
In addition, wild-type PalB has three intermolecular disulfide bonds potentially associated with its folding 
process though they might not be strictly required for developing the bioactivity. Finally, cell growth is 
often arrested due to deteriorated cell physiology associated with high-level expression and misfolding of 
PalB. 
In this study, we explored functional PalB expression in the cytoplasm of E. coli to gain more 
insight on relevant technical issues limiting the production of PalB. A selection of cytoplasmic 
chaperones, including TF, GroEL/ES, and DnaK/J-GrpE, were coexpressed with PalB for investigation of 
their individual and synergistic effect on the production of active PalB. 
 
3.2 Materials and Methods 
3.2.1 Strains and Plasmids 
The strains, plasmids and oligonucleotides used in this study are summarized in Table 3.1 and briefly 
described here. BL21(DE3) was used as the host strain for PalB expression. Molecular cloning was 
performed according to standard protocols [61] using XL10-Gold® (Stratagene, Dedar Creek, TX, USA) 
as the cloning host. P. antarctica strain ATCC 32657 containing the palB source gene was purchased 
from ATCC (Manassas, VA, USA). P. antarctica chromosomal DNA was extracted and purified by using 
DNeasy® tissue Kit (Qiagen, Valencia, CA, USA). PCR was performed in an automated thermal cycler 
(GeneAmp® PCR System 9700; Applied Biosystems, Foster City, CA, USA). The PCR product was 
purified by StrataPrep® PCR purification kit (Stratagene). Restriction enzymes were purchased from New 
England Biolabs (Ipswich, MA, USA). Plasmid DNAs were purified using a spin column kit (Clontech, 
Mountain View, CA, USA). Plasmid transformation was carried out using an electroporator (Bio-Rad, 
Hercules, CA, USA). All the chemicals used in this study were purchased from Sigma-Aldrich (Oakville, 
ON, Canada) unless otherwise specified.  
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Relevant genotype or phenotype^ 
Source and 
reference 
E. coli   
   BL21(DE3) E. coli B, F– ompT [dcm][lon] hsdSB(rB– mB–) gal 
(λcIts857 ind1 Sam7 nin5 lacUV5-T7 gene 1) 
Novagen 
   XL10-Gold® TetR Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 
supE44 thi-1 recA1 gyrA96 relA1 lac Hte [F’ proAB 
lacIqZΔM15 Tn10 (TetR) Amy CmR] 
Stratagene 
P. antarctica   
   ATCC 32657 The source of palB gene ATCC 
Plasmid   
   pAR3KJ ParaB::dnaK/J::grpE, Ori (pACYC184), CmR [233] 
   pAR3GRO ParaB::groEL/ES, Ori (pACYC184), CmR [233] 
   pETKn-20b(+) A PT7-expression vector derived from pET-20b(+), Ori 
(pBR322), KnR 
This lab [71] 
   pETKnL PT7::palB, Ori (pBR322), KnR This study 
   pG-KJE8 ParaB::dnaK/J::grpE, Pzt-lp::groEL/ES, Ori (pACYC184), 
CmR 
T. Yura [76] 
   pG-Tf2 Pzt-lp:: grpE::groEL/ES::tig, Ori (pACYC184), CmR T. Yura [76] 
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   pG-Tf3 ParaB::tig, Pzt-lp::groEL/ES, Ori (pACYC184), CmR T. Yura [76] 
   pTf16 ParaB::tig, Ori (pACYC184), CmR T. Yura [76] 
Oligonucleotide   
   P17 and P11 5'-TGCATATGCTACCTTCCGGTTCGG-3' and  
5'-CTGAATTCTCAGGGGGTGACGATGCCGGAGCAGG-3' 
primer pair for amplification of palB 
This study 
^ Designed restriction sites are underlined and the introduced mutations are in italic. 
 
The leaderless palB gene was PCR-amplified using Pfu DNA polymerase (Stratagene), the primer pair of 
P17 and P11 (Table 3.1), and P. antarctica chromosomal DNA as the template. The 970-bp PCR product 
flanked with NdeI and EcoRI was purified and cloned into the corresponding restriction sites of pETKn-
20b(+) [71], respectively, resulting in a transcriptional fusion of pETKnL (Figure 3.1). DNA sequencing 
was performed to ensure no mutations occurred during PCR. The coexpression plasmids containing a 
selection of cytoplasmic chaperone gene(s) were derivatives of pAR3 [233]. pAR3GRO and pAR3KJ 
[233], and pTf16 [76] contain the gene of groEL/ES, dnaK/J-grpE, and tig (encoding TF), respectively, 
fused with the araB promoter. pG-Tf2 [76] contains the groES/EL::tig fused with the zt-lp promoter. pG-
Tf3 [76] contains tig and groES/EL, fused with the araB and zt-lp promoters, respectively. pG-KJE8 [76] 
contains the dnaK/J-grpE and groES/EL, fused with the araB and zt-lp promoters, respectively. All the 
chaperone-gene-containing plasmids have a pACYC184 replication origin and a chloramphenicol-
resistant (CmR) marker and are, therefore, compatible with pETKnL which have a pBR322 replication 
origin and a kanamycin-resistant (KnR) marker. 
3.2.2 Cultivation 
Cells were revived by streaking the stock culture stored at -80 °C on a Luria-Bertani (LB) agar plate (5 
g/liter NaCl, 5 g/liter Bacto yeast extract, 10 g/liter Bacto tryptone, 15 g/liter Bacto agar). The plate was 
incubated at 37 °C for approximately 15 h. An isolated single colony was picked and inoculated with 25 
ml of LB medium in an Erlenmeyer flask, which was then incubated on a rotary shaker at 37 °C and 200 
rpm for approximately 15 h to form a seed culture. The medium was supplemented with 50 µg/ml 
kanamycin and/or 34 µg/ml chloramphenicol when necessary. Erlenmeyer flasks containing 25 ml of LB 
medium were inoculated with 1 ml of seed culture and were incubated in a rotary shaker at 37 °C and 200 
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rpm. When the cell density reached approximately 0.5 OD600, the culture was chilled on ice and 
supplemented with isopropyl β-D-thiogalactopyranoside (IPTG), arabinose, and/or tetracycline for 
induction of the gene regulated by the T7, araB, and/or zt-lp promoters, respectively. After induction, the 
Erlenmeyer flasks were further shaken for another 4 h at 28 °C or 24 h at 15 °C. All cultivations were 
conducted at least in duplicate.  
3.2.3 Analytical Methods 
The culture sample was appropriately diluted with saline solution for measuring cell density at OD600 with 
a spectrophotometer (DU 520; Beckman Coulter, Fullerton, CA, USA). For the preparation of the cell 
extract, cells at 20 OD600 units (defined as OD600 × ml) were centrifuged at 4 °C and 12,000 × g for one 
min. The cell pellet was resuspended in 0.75 ml of sodium phosphate buffer (PB buffer, 0.05 M, pH 7.5). 
The cell suspension was sonicated for 4 min (0.5 s/0.5 s pulse on/off) using an ultrasonic processor 
(Misonix, Farmingdale, NY, USA) and then centrifuged at 4 °C and 12,000 × g for 15 min. The 
supernatant containing soluble proteins was assayed for PalB activity. The pellet containing insoluble 
proteins and cell debris was washed with PB buffer, resuspended in TE-SDS buffer (10 mM Tris HCl, pH 
8.0, 1 mM EDTA, 1% sodium dodecyl sulfate), and heated to 100 °C for 5 min. The supernatant and the 
protein content of the pellet were analyzed as the soluble and insoluble fractions, respectively. 
PalB activity was qualitatively evaluated by the size and the transparency of the halo formed on a 
tributyrin agar plate (LB agar plate containing 1% emulsified tributyrin). The soluble fraction of cell 
lysate at 25 µl was loaded on the plate and incubated at 37 °C for overnight. In addition, PalB was 
assayed at 37 °C using p-nitrophenyl palmitate (pNPP) as a substrate [234]. The 0.5 mM pNPP solution 
was prepared by emulsifying 5 mg pNPP into 1 ml of β-propanol by sonication, and adding it dropwise 
into 25 ml of 50 mM Tris HCl (pH 8.0) and 0.1% Triton X-100 solution along with the emulsification. 
The enzymatic reaction was started by adding lysate sample (20~100 µl) to the pNPP solution. The 
amount of enzymatic reaction product of p-nitrophenol (pNP) was quantified colorimetrically with the 
absorbance at 410 nm (A410). One unit was defined as the amount of enzyme that hydrolyzed pNPP to 
produce 1 µmole of pNP per min at 37 °C. The reaction was carried out in a shaker at 37 °C and 200 rpm. 
All assays were conducted in duplicate. 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was performed in a Mini-PROTEIN®III 
electrophoresis cell (Bio-Rad) using a 12.5% polyacrylamide separating gel stacked with a 4% 
polyacrylamide stacking gel. Protein samples of the cell extract from cells of 0.008 OD600 unit for the 
soluble fraction and 0.005 OD600 unit for insoluble fractions, respectively, were loaded for SDS-PAGE 
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and Western blotting analysis. Electrophoresis was conducted under a constant voltage of 200 V for 45 
min. The gel was stained with Coomassie blue and dried in a hood. The dried gel was then scanned. 
To conduct Western blotting, proteins on the polyacrylamide gel were electroblotted to a 
polyvinylidene difluoride membrane using a Mini Trans-Blot cell (Bio-Rad) according to a standard 
protocol [235]. The electrophoretic transfer was conducted at a constant voltage of 100 V for 1 h. Primary 
anti-PalB antibodies were raised in a rabbit intermittently immunized with the antigen of recombinant 
PalB expressed from A. oryzae (Sigma-Aldrich). It was further purified by SDS-PAGE and PalB used for 
immunization was obtained by polypeptide elution of the corresponding band in the polyacrylamide gel 
slice using an Electro-Eluter (model 422; Bio-Rad). The secondary antibody was goat anti-rabbit 
immunoglobulin G conjugated with horseradish peroxidase (HRP). PalB-related polypeptides were 
probed by a colorimetric method using 3,3΄-diaminobenzidine tetrahydrochloride (DAB) as the substrate. 
The processed membrane was scanned.  
3.3 Results 
3.3.1 Functional Expression of PalB in BL21(DE3) Harboring pETKnL  
Figure 3.1 shows the construction of pETKnL both containing the leaderless palB gene from P. antarctica 
ATCC 32657 and the expression of which was under the regulation of the T7 promoter. With this design, 
the gene product is expected to contain an extra methionine in the N terminus and, presumably, this won’t 
affect PalB activity. Various recombinant BL21(DE3) strains, either single-plasmid or binary-plasmid, 
were cultivated under designated culture conditions for PalB expression. Qualitative visualization of PalB 
activity was conducted using tributyrin plates and the results are summarized in Figure 3.2. Halos were 
developed for all the lysate samples corresponding to various BL21(DE3) strains containing pETKnL 
except the two control strains [e.g., BL21(DE3) and BL21(DE3) harboring pETKn-20b(+)], indicating 
PalB was functionally expressed in the cytoplasm of E. coli. In general, the area and transparency of the 
halo corresponding to the lysate sample potentially correlate with the expressed PalB activity. However, 
the expressed PalB cannot be secreted since halos were not observed for the whole cells growing on 
tributyrin plates (data not shown). 
 
 




Figure 3.1 Construction of palB expression plasmid of pETKnL. Panel A: The DNA region from 
nucleotides 76 to 1029 of the wild-type palB gene on the chromosome of P. antarctica strain ATCC 
32657 was PCR-amplified with primer pair P17 and P11. The PCR product was cloned into 
pETKn-20b(+) using NdeI and EcoRI to form a transcriptional fusion of pETKnL. Due to the lack 
of a signal peptide, pETKnL is used for cytoplasmic expression of PalB and the heterologously 
expressed PalB has an extra methionine at the N-terminus. MCS, multiple cloning sites. RBS, 
ribosome binding site. Panel B: pETKnL contains the leaderless palB gene in-frame fused with the 
T7 promoter. It has a pBR322 replication origin and a kanamycin-resistant (KnR) marker and is 
compatible with various chaperone-coexpression plasmids with a pACYC184 replication origin and 
a chloramphenicol-resistant (CmR) marker.  
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Figure 3.2 Qualitative visualization of PalB activity using the tributyrin plate. Preparation of the 
plate for halo development is described in Materials and Methods. The area and intensity of the 
halo corresponding to the lysate sample correlates with the PalB expression level. Cultivation 
conditions are: 0.05 mM IPTG, 15 °C (Panel A), 0.1 mM IPTG, 15 °C (Panel B), and 0.05 mM 
IPTG, 28 °C (Panel C). Additional 5 g/l of arabinose and/or 0.02 mg/l of tetracycline were 
supplemented for induction of the araB and/or zt-lp promoters that were used for regulation of 
chaperone coexpression (see Table 1). Lysate samples from the following expression systems were 
used for the test: (1) BL21(DE3); (2) BL21(DE3) (pETKn-20b(+)); (3) BL21(DE3) (pETKnL); (4) 
BL21(DE3) (pETKnL, pTf16), (5) BL21(DE3) (pETKnL, pG-Tf2); (6) BL21(DE3) (pETKnL, pG-
Tf3); (7) BL21(DE3) (pETKnL, pG-KJE8); (8) BL21(DE3) (pETKnL, pAR3KJ); (9) BL21(DE3) 
(pETKnL, pAR3GRO). 
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Using BL21(DE3) harboring pETKnL, the results of cultivation performance for PalB expression 
under various culture conditions and their corresponding Western blotting analysis are summarized in 
Figure 3.3 and Figure 3.4, respectively. Apparently, heterologous PalB expression favored the non-
productive pathway for inclusion body formation. Cell growth was arrested upon the induction for PalB 
expression and such deterioration in cell physiology could be caused by the accumulation of inclusion 
bodies, particularly in the case of 28 °C. Comparing the two expression runs with 0.05 mM IPTG at 15 °C 
and 28 °C, while the PalB solubility was somewhat improved at a lower temperature (Figure 3.4), the 
specific PalB expression level decreased, resulting in a lower total PalB activity (Figure 3.3). Though 
increasing the IPTG concentration to 0.1 mM could boost the PalB expression level at 15 °C, cells 
appeared to suffer more growth arrest due to an increase amount of PalB inclusion bodies. Nevertheless, 
the results demonstrated the feasibility of using a relatively high cultivation temperature at 28 °C for 
functional expression of the cold active PalB in E. coli. 
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Figure 3.3 Cultivation performance for PalB expression for various host/vector systems under 
different culture conditions. Cell density (Panel A) and specific PalB activity (Panel B) are 
presented. BL21(DE3) and pETKnL were used as PalB expression host and vector, respectively 
(e.g., group N/A). Various chaperones were also coexpressed in different groups: “TF” for group 
pTf16; “TF and GroEL/ES” for groups pG-Tf2 and pG-Tf3; “DnaK/J-GrpE and GroEL/ES” for 
group pG-KJE8; “DnaK/J-GrpE” for group pAR3KJ; “GroEL/ES” for group pAR3GRO. The 
error bar represents a range of the data variance. 
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Figure 3.4 Western blotting analysis of soluble (S) and insoluble (I) fractions of BL21(DE3) 
harboring pETKnL under various culture conditions for PalB expression: (0) 0 mM IPTG, (1) 0.05 
mM IPTG, and (2) 0.1 mM IPTG.  
 
3.3.2 Effect of Chaperon Coexpression on PalB Expression 
Since protein folding appeared to be the major factor limiting PalB expression, a selection of cytoplasmic 
chaperones, including TF, GroEL/ES, and DnaK/J-GrpE, were coexpressed and the results are 
summarized in Figure 3.3 and Figure 3.5. Coexpression of a single chaperone (e.g., TF from pTf16, 
DnaK/J-GrpE from pAR3KJ or GroEL/ES from pAR3GRO) had almost no effect on alleviating growth 
inhibition at 15 °C, but a slight improvement at 28 °C. On the other hand, the specific PalB activity was 
significantly increased at 15 °C, but the expression level remained more or less the same at 28 °C. Note 
that, though the total PalB expression (e.g., the sum of soluble and insoluble fractions) was significantly 
increased upon coexpression of TF, most of the expressed PalB went to the non-productive pathway to 
form inclusion bodies. This resulted in an even higher amount of inclusion bodies compared to the control 
experiment, particularly for the case of 0.05 mM IPTG and 15 °C. On the other hand, the amount of 
inclusion bodies was significantly reduced upon coexpression of DnaK/J-GrpE or GroEL/ES. 
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Figure 3.5 Western blotting (Panel A~C) and SDS-PAGE (Panel D) analysis of soluble (S) and 
insoluble (I) fractions of BL21(DE3) harboring pETKnL and chaperone-coexpression plasmid 
under various culture conditions for PalB expression. Panel A and Panel D: 0.05 mM IPTG, 15 °C; 
Panel B: 0.1 mM IPTG, 15 °C; Panel C: 0.05 mM IPTG, 28 °C. Designation of chaperone groups is 
the same as that of Figure 3.3. Lane M, protein marker.  
 
The culture performance for PalB expression had a significant improvement upon simultaneous 
coexpression of TF and GroEL/ES (based on the use of either pG-Tf2 or pG-Tf3); reflected by enhanced 
cell growth, less amounts of inclusion bodies, and higher specific PalB expression levels under almost all 
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the culture conditions. Such synergistic effect was also significant upon simultaneous coexpression of 
DnaK/J-GrpE and GroEL/ES based on the use of pG-KJE8 at 15 °C, but less observable at 28 °C. 
3.4 Discussion 
PalB is a cold active lipase destined to be secreted extracellularly in the original psychrophilic and 
eukaryotic source of P. antarctica. Consequently, the intracellular overexpression might prevent it from 
being structurally adaptable to the mesophilic and prokaryotic expression system of E. coli, resulting in 
protein misfolding. This could be the reason why cultivation was conducted at low temperatures via the 
use of a cold-inducible expression system for functional expression of PalB [29]. Practical application 
with this host/vector system could be limited due to arrested cell growth and low PalB synthesis rate 
under low temperatures. In this study, functional expression of PalB was demonstrated in the cytoplasm 
of BL21(DE3), a regular host with a reduced cytoplasm, implying that disulfide bond formation might not 
be strictly required to develop PalB bioactivity. This result was not previously reported. In addition, 
cultivation temperature for such functional expression can be as high as 28 °C, a common temperature for 
recombinant protein production. Nevertheless, culture performance stands improvement due to the two 
technical issues, e.g., growth arrest and intracellular PalB misfolding, which are interrelated.  
PalB misfolding could result from the overwhelming of the cytoplasmic folding machinery due to a 
fast protein synthesis rate associated with the use of the strong T7 promoter system at a relatively high 
temperature of 28 °C. Hence, lowering the cultivation temperature to 15 °C to substantially reduce protein 
synthesis rate, but not protein folding rate, was explored to test this hypothesis. In general, the amount of 
insoluble inclusion bodies was significantly reduced upon temperature lowering (Figure 3.4), implying a 
more balanced flux into the productive pathway for protein formation. However, the solubility of PalB 
was enhanced at an expense of a decrease in the total amount of PalB synthesis, suggesting that this 
operational strategy might not be practically feasible. 
The overexpression of PalB resulted in growth arrest which could be alleviated to some extent by 
chaperone coexpression. In general, it appears that coexpression of single chaperone had a minimum 
effect on improving PalB expression performance. On the other hand, simultaneous coexpression of TF 
and GroEL/ES was effective in restoration of cell growth by maintaining or even boosting the specific 
lipase activity, resulting in significant improvement in total lipase activity. The positive effect based on 
simultaneous coexpression of DnaK/J-GrpE and GroEL/ES was also observable at 15 °C possibly 
because TF and DnaK could share certain improving functions by possessing overlapping substrate pools 
and binding specificities [158]. The results suggest that an appropriate chaperone cocktail is required for 
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not only alleviation of physiological deterioration but also more soluble PalB overexpression. The 
enhancement in recombinant protein production based on the synergistic effect of multiple chaperones 
was previously reported [68, 76].  
With the peptidyl-prolyl cis/trans isomerase (PPIase) activity, TF plays a role in vivo as a ribosome-
associated chaperone through the interaction with newly synthesized proteins and 50S ribosome [152]. In 
this study, coexpression of TF resulted in more accumulation of insoluble PalB without restoring cell 
growth or increasing the specific lipase activity, particularly for the expression at 15 °C. The results 
suggest that coexpression of TF could have actually boosted the overall PalB synthesis rate via the 
enhanced interaction with the nascent PalB. Nevertheless, these PalB folding intermediates could 
overwhelm the subsequent folding machinery, such as GroEL/ES, resulting in more accumulation of 
insoluble PalB. On the other hand, coexpression of another single chaperone, either GroEL/ES or 
DnaK/J-GrpE which mediates the subsequent folding event in the cytoplasm, improved the PalB 
solubility without increasing the overall PalB synthesis rate. It was proposed that protein synthesis on 
ribosome should be coordinated with the activities of various chaperone systems for not only stabilizing 
nascent polypeptides but also promoting subsequent folding [149]. In addition, by further association with 
GroEL, TF can strengthen its function for facilitating protein folding through efficient binding to GroEL-
substrates [157]. The results of this study lead to a conclusion that, in order to effectively enhance PalB 
expression performance, both TF and GroEL/ES respectively mediating the early stage and late stage of 
cytoplasmic PalB folding would be simultaneously required for boosting both the overall PalB synthesis 
rate and the cytoplasmic folding efficiency. 
3.5 Abstract of the submitted paper 
Lipase B from Pseudozyma antarctica (PalB) was actively expressed in the reduced cytoplasm of a 
regular Escherichia coli strain of BL21(DE3), implying that disulfide bond formation was not strictly 
required for functional expression. However, the expression was ineffective and was primarily limited by 
the formation of PalB inclusion bodies and growth arrest, both of which were associated with PalB 
misfolding and deteriorated physiology. The culture performance in terms of cell growth and PalB 
expression level could be significantly improved by simultaneous coexpression of multiple chaperones of 
trigger factor and GroEL/ES, but not individual coexpression of either one of them. It was proposed that 
the two chaperones respectively mediating the early stage and late stage of cytoplasmic PalB folding 
would be simultaneously required for boosting both the overall PalB synthesis rate and the cytoplasmic 
folding efficiency. 
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Chapter 4* 
Improvement of PalB Cytoplasmic Expression by Using a Mutant Host 
and/or by Adding a Fusion Tag  
4.1 Introduction 
As mentioned before, PalB expression performance was limited by several factors. PalB is a cold active 
lipase destined to be secreted extracellularly in the original psychrophilic and eukaryotic source of P. 
antarctica. Consequently, the intracellular overexpression might prevent it from being structurally 
adaptable to the mesophilic and prokaryotic expression system of E. coli, resulting in protein misfolding. 
In addition, wild-type PalB has three intramolecular disulfide bonds potentially associated with its folding 
process though they might not be strictly required for developing the bioactivity. Finally, cell growth is 
often arrested due to deteriorated cell physiology associated with high-level expression and misfolding of 
PalB. It was the first report for a functional PalB expression in the cytoplasm of a regular E. coli, as 
showed in Chapter 3. However, a huge amount of inclusion bodies associated with its intracellular 
misfolding were produced that not only limited the PalB expression but also severely deteriorated the cell 
physiology. Although the cell performance in terms of cell growth and PalB expression was significantly 
improved by coexpression of multiple chaperones of TF and GroEL/ES, the overall activity was still too 
low to reach the requirement for PalB production.  
The above results are not surprising. In wild-type E. coli, disulfide bond formation only occurs in 
the oxidative periplasm, but not reductive cytoplasm. The periplasm contains several Dsb-family 
members whose biological functions involved in disulfide bond formation are well defined [40]. Even 
with the pathway available for disulfide bond formation, proteins with complex disulfide patterns are 
generally difficult to express in E. coli. In fact, for many eukaryotic proteins heterologously expressed in 
E. coli, folding and disulfide bond formation, either individually or together, can seriously limit the 
expression performance since correct formation of disulfide bonds can facilitate protein folding, stabilize 
protein structure, and develop protein bioactivity. These limitations will result in intracellular 
accumulation of inactive or insoluble protein species (e.g. inclusion bodies) and/or induce physiological 
stress [43, 174, 236, 237].  
                                                   
* This chapter is based on a paper “Y. Xu, A. Yasin, R. Tang, M. Moo-Young, C. P. Chou, Heterologous Expression 
of Lipase in Escherichia coli is Limited by Folding and Disulfide Formation. Applied Microbiology and 
Biotechnology. 2008” (accepted). 
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Among the strategies for improving expression of recombinant protein in E. coli, no other 
technology has been as effective at improving the solubility of recombinant proteins as fusion tags [86, 
126]. Fusion tag technology is able to improve heterologous expression by overcoming many challenges, 
e.g., the low translation rate, the proteolytic degradation of target proteins, protein misfolding, poor 
solubility, and the necessity for good purification methodologies [87, 126]. While C-terminus fusion tags 
are reported successfully improving the fused protein’s solubility, an N-terminus fusion tag can be more 
effective by enhancing translation initiation and improving solubility at once to reach high activity and 
productivity for recombinant protein expression in E. coli [87]. Several fusion tags have been 
demonstrated to be effective in promoting protein folding so that the solubility of fusion proteins is 
enhanced though the mechanism leading to the enhanced solubility remains unclear [87]. 
While solubility is prerequisite for gene products further being processed on the productive 
pathway, the folding process in a bioactive protein production is the determining factor, which dependes 
on the specificity of the final protein. In other words, without an efficient folding process, a final 
bioactive protein could be only a small portion or even none of the soluble protein. It was discovered that 
disulfide bond formation can occur in strains with the trxB and gor mutations [104, 108, 109, 238-240] 
and these mutant strains, e.g., Origami series commercially available from Novagen, have been widely 
adopted for cytoplasmic expression of proteins with disulfide bonds. Nevertheless, the efficiency of 
disulfide bond formation can still be limited.  
In this chapter, the functional expression of PalB in the cytoplasm with chaperone coexpression or 
fusion tag techniques was explored. Also, the expression performance based on the use of BL21(DE3) 
and Origami B(DE3) as the host was compared. Based on the results, disulfide bond formation was 
identified as an important factor potentially limiting functional PalB expression in E. coli. 
4.2 Materials and Methods 
4.2.1 Strains and Plasmids 
The strains, plasmids and oligonucleotides used in this study are summarized in Table 4.1 and briefly 
described here. BL21(DE3) and Origami B(DE3) were used as the hosts for the expression of 
recombinant PalB and DH5α was the host for cloning. All of the protocols, kits, and chemicals for 
molecular cloning were described previously in Chapter 3. 
DNA fragments containing the leaderless palB gene were PCR-amplified using pfu DNA 
polymerase (Stratagene), the primer pair of P17/P11, P15/P19, and P10/P11 (in Table 4.1), respectively, 
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and P. antarctica chromosomal DNA as the template. The PCR products were cloned into pPCR Script® 
(Stratagene). DNA sequencing was performed to ensure no mutations occurred during PCR. The palB-
containing DNA fragments were obtained by digestion of the above pPCRScript® derivatives with 
NdeI/EcoRI, EcoRI/XmaI, and NcoI/EcoRI, respectively, subcloned into the corresponding restriction 
sites of pET-20b(+), pGEXC4S-6P-1 [241] and pENTR4 (Invitrogen) resulting in pETL, pGEXC4S-M, 
and pENTRG. The palB gene from the palB-containing entry vector of pENTRG was subcloned into 
various destination vectors of pHMGWA [242], pHNWA [242], pHXWA [242], pDest-555 [147], pDest-
556 [147], pET-52A (EMBL, Heidelberg, Germany) using the Gateway technology (Invitrogen) to form 
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Relevant genotype or phenotype^ 
Source and reference 
E. coli   
BL21(DE3) F– ompT dcm lon hsdSB (rB- mB-) gal λ(DE3[lacI ind1 
sam7 nin5 lacUV5-T7 gene 1]) 
Novagen 
DH5α F'/(φ80 lacZ ΔM15) Δ(lacZYA-argF)U169 deoR recA1 
endA1 hsdR17 (rK-, mK+) phoA supE44 λ-thi-1 gyrA96 
relA1 
Lab stock 
Origami B(DE3) F- ompT hsdSB(rB- mB-) gal dcm lacY1 ahpC (DE3) 
gor522::Tn10 (TcR) trxB (KnR)  
Novagen 
P. antarctica   
ATCC 32657 palB source gene ATCC 
Plasmid   
pAR3 Expression vector, ParaB, Ori (pACYC184), CmR Lab stock [233] 
pAR3KJ ParaB::dnaK/J::grpE, Ori (pACYC184), CmR Lab stock [233] 
pAR3GRO ParaB::groEL/ES, Ori (pACYC184), CmR Lab stock [233] 
pARllDsbA ParaB::lldsbA, Ori (pACYC184), CmR This study 
pARllDsbC ParaB::lldsbC, Ori (pACYC184), CmR This study 
pDest-555 Destination vector, PT7::lacOp::strep-II::∆T7PK, Ori 
(pBR322), ApR, CmR 
[147] 
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pDest-556 Destination vector, PT7::lacOp::strep-II::skp, Ori 
(pBR322), ApR, CmR 
[147] 
pENTR4 Entry vector, attL1-rrnB-attL2, Ori (pUC), KnR Invitrogen 
pENTRG palB-containing entry vector, Ori (pUC), KnR This study 
pET-20b(+) Expression vector, PT7, Ori (pBR322), ApR Lab stock 
pETG-50A Destination vector, PT7::lacOp::dsbA::6×his, Ori 
(pBR322), ApR, CmR 
EMBL 
pETG-52A Destination vector, PT7::lacOp::lldsbA::6×his, Ori 
(pBR322), ApR, CmR 
EMBL 
pETllDsbA-G PT7::lacOp::lldsbA::6×his::palB, Ori (pBR322), ApR This study 
pETL PT7::palB, Ori (pBR322), ApR This study 
pETM-80 Expression vector, PT7::dsbC::6×his, Ori (pBR322), 
KnR 
EMBL [72] 
pGEXC4S-6P-1 Expression vector, Ptac::gst, Ori (pBR322), ApR [241] 
pGEXC4S-M Ptac::gst::palB, Ori (pBR322), ApR This study 
pG-KJE8 ParaB::dnaK/J::grpE, Pzt-lp::groEL/ES, Ori 
(pACYC184), CmR 
T. Yura [76] 
pG-Tf3 ParaB::tig, Pzt-lp::groEL/ES, Ori (pACYC184), CmR T. Yura [76] 
pHMBP-G PT7::lacOp::6×his::mbp::palB, Ori (pBR322), ApR This study 
pHMGWA Destination vector, PT7::lacOp::6×his::mbp, Ori 
(pBR322), ApR, CmR 
[242] 
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pHNGWA Destination vector, PT7::lacOp::6×his::nusA, Ori 
(pBR322), ApR, CmR 
[242] 
pHNusA-G PT7::lacOp::6×his::nusA::palB, Ori (pBR322), ApR This study 
pHTRX-G PT7::lacOp::6×his::trx::palB, Ori (pBR322), ApR This study 
pHXGWA Destination vector, PT7::lacOp::6×his::trx, Ori 
(pBR322), ApR, CmR 
[242] 
pSkp-G PT7::lacOp::strep-II::skp::palB, Ori (pBR322), ApR This study 
pT7PK-G PT7::lacOp::strep-II::∆T7PK::palB, Ori (pBR322), 
ApR 
This study 
pTf16 ParaB::tig, Ori (pACYC184), CmR T. Yura [76] 
Oligonucleotide*   
P10 5' – GGCCATGGGTCTACCTTCCGGTTCGG – 3' This study 
P11 5' – CTGAATTCTCAGGGGGTGACGATGCCGGAGCAGG – 3' This study 
P15 5' - CGGAATTCCTACCTTCCGGTTCGG - 3'  
P17 5' – TGCATATGCTACCTTCCGGTTCGG – 3' This study 
P19 5' – GGCCCGGGTTAGGGGGTGACGATGCCGGAG – 3’ This study 
PfllDsbA/PrDsbA 5' – CCATGGAACAGTACACTACCCTGG – 3' and 
5' – AAGCTTTCATTTCTCGCTTAAGTATTTC – 3' 
primer pair for amplification of lldsbA 
This study 
PfllDsbC/PrDsbC 5' – CCATGGTTGATGACGCGGCAATTC – 3' and 
5' – AAGCTTTCAACCAGAACCACTAGT – 3' 
primer pair for amplification of lldsbC 
This study 
^ Designed restriction sites are underlined and the introduced mutations are in italic. 
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The coexpression plasmids containing a selection of cytoplasmic chaperone gene(s) were 
derivatives of pAR3 [233]. pAR3GRO [233] and pAR3KJ [233], and pTf16 [76] contain the gene of 
groEL/ES, dnaK/J-grpE, and tig (encoding TF), respectively fused with the araB promoter. pG-Tf3 [76] 
contains tig and groES/EL, respectively fused with the araB and zt-lp promoters. pG-KJE8 [76] contains 
the dnaK/J-grpE and groES/EL, respectively fused with the araB and zt-lp promoters. The coexpression 
plasmid containing the leaderless dsbA gene (ll-dsbA), and ll-dsbC (e.g., pARllDsbA, and pARllDsbC) 
was also derived from pAR3. To construct them, ll-dsbA and ll-dsbC were PCR-amplified using Pfu DNA 
polymerase, the primer pair PfllDsbA/PrDsbA, and PfllDsbC/PrDsbC, and pETG-50A and pETM-80 as the 
template, respectively. The PCR product was cloned into pPCRScript® and DNA sequencing was 
performed to ensure no mutations occurred during PCR. The ll-dsbA and ll-dsbC-containing DNA 
fragments flanked with NcoI/HindIII were subcloned into the corresponding restriction sites of pAR3 to 
form pARllDsbA, and pARllDsbC, respectively. All the chaperone-gene(s)-containing plasmids have a 
pACYC184 replication origin and a chloramphenicol-resistant (CmR) marker and, therefore, are 
compatible with the PalB expression plasmid (e.g., pETL) containing a pBR322 replication origin and an 
ampicillin-resistant (ApR) marker. 
4.2.2 Cultivation and Analytical Methods 
The cultivation and analytical procedures were identical with the procedures described in Section 3.2.2 
and 3.2.3. 
4.3 Results 
4.3.1 Effect of host on functional expression of PalB in the cytoplasm  
Since trxB and gor mutation used kanamycin and tetracycline as the selection marker, respectively, in 
Origami B(DE3), the expression plasmid pETKnL, which has a kanamycin marker and had been 
characterized in Chapter 3, could not be used in Origami B(DE3). For consistent comparison, pETL, 
which has a same backbone with pETKnL but an ampicillin marker, was constructed (Figure 4.1) and 
used in this Chapter. We assume pETL and pETKnL have the same behavior for expression PalB in the 
cytoplasm of E. coli. 
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Figure 4.1 Construction of palB expression plasmid of pETL. The DNA region from nucleotides 76 
to 1029 of the wild-type palB gene on the chromosome of P. antarctica ATCC 32657 was PCR-
amplified with primer pairs of P17/P11, respectively. The PCR products were cloned into pET-
20b(+) using NdeI/EcoRI to form a transcriptional fusion of pETL. MCS, multiple cloning sites. 
RBS, ribosome binding site. 
  
To evaluate the effect of the host strain on cytoplasmic PalB expression, pETL expression 
performance using the host of BL21(DE3) and its mutant derivative, Origami B(DE3), is summarized in 
Figure 4.2. Halos were developed on the tributyrin plate for both expression systems (e.g., #2 on both a 
and b plates in Figure 4.2A), indicating that PalB was functionally expressed in the cytoplasm. Since the 
area and transparency of the halo potentially correlate with the expressed PalB activity, the results suggest 
that Origami B(DE3) outperformed BL21(DE3) as the host for cytoplasmic PalB expression. The specific 
PalB activity of Origami B(DE3) harboring pETL was more than 3-fold that of BL21(DE3) harboring 
pETL at 28 °C (Figure 4.2C). In general, Origami B(DE3) grew slower than BL21(DE3) under the same 
culture condition with a lower biomass yield (Figure 4.2B). A slight growth arrest was observed upon 
PalB expression. Though PalB can be functionally expressed, inclusion bodies at a significant amount 
were observed, implying that functional PalB expression could be limited by proper folding. Lowering 
the cultivation temperature to 15 °C slightly increased the specific PalB activity (#1 in Figure 4.2C) for 
Origami B(DE3) harboring pETL though PalB solubility appeared to be significantly improved (#1 in 
Figure 4.2D).  
 












            63 
 
 
Figure 4.2 The expression performance for non-fused PalB and the effect of folding factors on the 
expression. Panel A: Qualitative visualization of PalB activity using the tributyrin plate for 
recombinant BL21(DE3) (plate a) and Origami B(DE3) (plate b), respectively. Expression plasmids 
are labeled in separate legend. Panel B: Cell density for various expression systems. Panel C: 
Specific PalB activity for various expression systems. Panel D: Western blotting analysis of the 
soluble (S) and insoluble (I) fractions for various expression systems. Panel E: SDS-PAGE analysis 
of the soluble (S) and insoluble (I) fractions for PalB expression system hosted in Origami B(DE3) 
at 28 °C. M: protein molecular weight marker. Coexpression plasmids for Panels B, C, D, and E: 
0&1/ none; 2/ pTf16; 3/ pG-Tf3; 4/ pG-KJE8; 5/ pAR3KJ; 6/ pAR3GRO; 7/ pARllDsbA. Inducer 
supplementation: 1/ IPTG; 2~7/ IPTG and arabinose. The error bar in Panels B and C represents a 
range of the data variance. 
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4.3.2 Effect of folding factors  
Since functional expression of PalB appeared to be limited by folding even in the oxidative cytoplasm of 
Origami B(DE3) which could mediate effective disulfide bond formation, coexpression of various folding 
factors (including TF, GroEL/ES, DnaK/J-GrpE, and DsbA) was performed to identify potential factors 
limiting the expression performance and the results are summarized in Figure 4.2. In general, functional 
PalB expression for all recombinant Origami B(DE3) strains outperformed the corresponding 
recombinant BL21(DE3) strains in terms of specific PalB activity (Figure 4.2A and C) though the 
biomass yield was slightly reduced for recombinant Origami B(DE3) strains. The results imply that the 
oxidative environment could mediate proper formation of disulfide bonds in the cytoplasm of Origami 
B(DE3). Among the folding factors investigated, the effect of coexpression of DsbA and DsbC (e.g., 
pARllDsbA, and pARllDsbC) were pronounced in both BL21(DE3) and Origami B(DE3) backgrounds, 
though the effect of coexpression of TF and GroEL/ES also appeared to be observable in BL21(DE3) 
background. Lowering the cultivation temperature to 15 °C also assisted the function expression by 
boosting the specific PalB activity. The synergetic effect mediated by the oxidative cytoplasm of Origami 
B(DE3) and the folding factor of DsbA and DsbC on improving PalB bioactivity support the above 
argument that functional expression of PalB could possibly be limited by disulfide bond formation. 
4.3.3 Effect of fusion tags  
Since functional expression of PalB in the cytoplasm appeared to be limited by protein solubility even 
with the coexpression of folding factors, fusion tags were explored to enhance PalB folding. Since the 
expression performance based on the use of fusion tag technique is unpredictable [87], seven N-terminal 
tags, including GST, MBP, NusA, TRX, T7PK, Skp, and DsbA, were selected to construct various 
translational fusions with PalB for evaluation, resulting in seven expression plasmids, including 
pGEXC4S-M, pHMBP-G, pHNusA-G, pHTRX-G, pT7PK-G, pSkp-G, and pETDsbA-G. Except GST-
PalB whose expression was regulated by the tac promoter, the expression of all the other PalB fusions 
was regulated by the T7 promoter. Using BL21(DE3) harboring these PalB fusion expression plasmids for 
cultivation, PalB expression performance was summarized in Figure 4.3. Qualitative visualization of the 
PalB activity on the tributyrin plate was conducted (Figure 4.3A). Visible halos were developed only for 
three PalB fusions, GST-PalB (#3), and DsbA-PalB (#9). Note that growth arrest was observed upon the 
expression of non-fused PalB and T7PK-PalB, but was not observed for the other PalB fusions (Figure 
4.3B), implying that PalB toxicity could be reduced by most of the fusion tags. However, the specific 
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PalB activities for most of the PalB fusions were either approximately the same as or lower than the non-
fused PalB except DsbA-PalB (Figure 4.3C). Note that, among these tags investigated here, MBP and 
T7PK significantly improved PalB solubility but not PalB activity, whereas DsbA significantly improved 
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Figure 4.3 The expression performance for various PalB fusions using BL21(DE3) as the host. 
Panel A: Qualitative visualization of PalB activity using the tributyrin plate. Expression plasmids 
are labeled in separate legend. Panel B: Cell density for various PalB-fusion expression systems. 
Panel C: Specific PalB activity for various PalB-fusion expression systems. Panel D: Western 
blotting analysis of the soluble (S) and insoluble (I) fractions for various PalB-fusion expression 
systems. Lipase fusions: 0&1/ PalB; 2/ GST-PalB; 3/ NusA-PalB; 4/ MBP-PalB; 5/ TRX-PalB; 6/ 
Skp-PalB; 7/ T7PK-PalB; 8/ DsbA-PalB. Inducer supplementation: 1~8/ IPTG. The error bar in 
Panel B and C represents a range of the data variance. 
 
Compared to BL21(DE3), functional expression of PalB fusions in the cytoplasm of Origami 
B(DE3) (summarized in Figure 4.4) was more effective since visible halos were developed on the 
tributyrin plate for all the PalB fusions (Figure 4.4A). The results again suggest the importance of 
disulfide bond formation for functional expression of PalB. The growth arrest associated with the 
expression of non-fused PalB was alleviated upon the expression of all PalB fusions (except T7PK-PalB) 
in Origami B(DE3) (Figure 4.4B). Note that, compared to the use of BL21(DE3) as the host, both the 
solubility and specific PalB activity of GST-PalB were significantly improved when expressed in Origami 
B(DE3). On the other hand, while T7PK tag appeared to be effective in solubilizing PalB in both 
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BL21(DE3) and Origami B(DE3) backgrounds, PalB activity was minimally induced out of this fusion, 
implying that solubilization of PalB does not necessarily develop PalB activity. Compared to the non-
fused PalB as the control, only DsbA tag could enhance functional expression in terms of boosting the 
specific PalB activity; whereas the other tags could at most enhance PalB solubility (Figures 4.3 and 4.4). 
The specific PalB activity for DsbA-PalB could reach as high as 50 U/liter/OD600, resulting in the highest 
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Figure 4.4 The expression performance for various PalB fusions using Origami B(DE3) as the host. 
Panel A: Qualitative visualization of PalB activity using the tributyrin plate. Expression plasmids 
are labeled in separate legend. Panel B: Cell density for various PalB-fusion expression systems. 
Panel C: Specific PalB activity for various PalB-fusion expression systems. Panel D: Western 
blotting analysis of the soluble (S) and insoluble (I) fractions for various PalB-fusion expression 
systems. Lipase fusions: 0&1/ PalB; 2/ GST-PalB; 3/ MBP-PalB; 4/ NusA-PalB; 5/ TRX-PalB; 6/ 
T7PK-PalB ; 7/ Skp-PalB; 8/ DsbA-PalB. Inducer supplementation: 1~8/ IPTG. The error bar in 
Panel B and C represents a range of the data variance. 
 
4.3.4 Bioactive PalB was obtained by purification of PalB from GST-PalB cytoplasmic 
expression system  
Purification of PalB fusion by using Origami B(DE3) harboring pGEXC4S-M was demonstrated as an 
example. Basically, the GST-PalB binds to an affinity chromatographic column (e.g., GSTrap FF, GE 
Healthcare, Piscataway, NJ, USA) to be separated from the other E. coli proteins and then the GST tag 
was on-column digested using a protease (e.g., PrescissionTM protease, GE Healthcare). The purification 
flowchart was shown in Figure 4. 5. 
 
 
            71 
 
 
Figure 4.5 Flowchart for production of recombinant PalB in E. coli. The palB was fused with the gst 
gene to form a translational fusion in pGEXC4S-M. PalB is overexpressed as a GST fusion protein 
(e.g., GST-PalB) under the regulation of the tac promoter. The GST-PalB was captured using an 
affinity chromatographic column and subsequently processed with PrescissionTM cleavage to release 
the moiety of PalB as a target protein. 
The cultivation was performed with 100 ml of culture in a 500 ml of flask which was incubated at 
15 °C, 200 rpm for 24 h after induction by supplemented 0.1 mM IPTG. The paste was collected, 
resuspended into 50 mM Tris-HCl (pH 7.0) buffer, and sonicated. The lysate was separated by high-speed 
centrifugation. All the procedures were the same as for preparing the sample for analysis purposes 
described before. The GST-PalB was captured in a 1 ml of GSTrap affinity chromatography from the 
lysate. Instead of being eluted, GST-PalB was in-situ cleaved by injecting 80U of PrescissionTM protease 
in 1 ml of cleavage buffer (50 mM Tris-HCl, pH7.0, 150 mM NaCl, 1 mM ETDA, 1mM dithiothreitol) 
following the instructs given by GE Healthcare. After 3 h of incubation at room temperature, PalB was 
released into the bulk liquid phase, and collected by injecting 1ml of 50 mM Tris-HCl buffer. GST tag 
was removed from the GSTrap column by using glutathione solution (50mM Tris-HCl, 10 mM 
glutathione, pH8.0). The GSTrap column was cleaned with 6 M guanidine HCl. 
The samples taken along the purification processing were analyzed by SDS-PAGE and results are 
shown in Figure 4.6B. Apparently, the enzymatic cleavage was not optimized and the purified PalB may 
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need to go through more separation steps to clean out the contaminants, e.g., uncut GST-PalB and GST 
tag. The released PalB moiety showed a 3-fold bioactivity compared with lysate GST-PalB.  
 
 
Figure 4.6 Panel A, comparison of PalB activity between GST-PalB and purified PalB. Panel B, 
results of SDS-PAGE stained by Coomassie blue for the sample along the purification process of 
PalB from GST-PalB. M, protein molecular weight marker. The samples loaded on the gel are 
labeled as: 1/ lysate; 2/ flow-through GSTrap column; 3/ elute sample after thrombin cutting; and 
4/ elute with injection of glutathione. 
 
4.4 Discussion 
Though E. coli contains an oxidative compartment in the periplasm in which disulfide bonds can be 
formed, the expression performance can be limited by other steps such as translocation or periplasmic 
folding. The Origami strains with the mutations on thioredoxin reductase and glutathione reductase offer 
an alternative for overexpression of proteins with disulfide bonds in the oxidative cytoplasm [104, 238]. 
The Origami series had been widely used as a host in various recombinant protein expression in the 
cytoplasm [29, 110, 111, 137]. In this study, PalB expressed in the cytoplasm of BL21(DE3) harboring 
pETL could still develop PalB activity though at a low level, implying that disulfide bond formation was 
not strictly required for functional expression. The specific PalB activity was significantly enhanced by 
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using Origami B(DE3) harboring pETL, suggesting that disulfide bond formation could still be a critical 
step limiting the expression performance. Nevertheless, it appeared that PalB solubility (or PalB folding) 
was not necessarily improved with the enhanced PalB activity or disulfide bond formation. Similar to the 
expression of non-fused PalB, the specific PalB activity was significantly enhanced by using Origami 
B(DE3) as the host cell for all the PalB fusions, but the solubilization effect was not necessarily reflected 
by improved PalB activity. Given such unparallel but intertwined effects on PalB solubilization and 
activity, Origami B(DE3) was demonstrated to be a suitable host for functional expression of either non-
fused PalB or PalB fusions, presumably due to effective disulfide bond formation. 
In fact, the oxidizing environment might not be sufficient for disulfide bond formation. It is has 
been shown that a system consisting of at least two cellular envelope proteins, DsbA and DsbB, is 
necessary for the formation of disulfide bonds in the periplasm [40]. DsbA is a periplasmic protein (21 
kDa) with oxidoreductase activity catalyzing direct bridging of disulfide bonds within newly translocated 
proteins and DsbC (homodimer, 23 kDa per monomer) is an isomerase for correcting the intra- and 
intermolecularly misfolded disulfide bonds. Though with distinctively major activities, the two proteins 
might share biological functions under certain conditions [104, 215-217]. Coexpression of DsbA and/or 
DsbC enhanced functional expression of several recombinant proteins, e.g., ribonuclease I [243], human 
leptin [244], insulin-like growth factor-I [215], human tissue plasminogen activator [104, 213], 
horseradish peroxidase [245] and human nerve growth factor β [212]. In addition, it has reported that 
DsbA and DsbC may have chaperone activity [90, 218]. Among the folding factors being coexpressed 
with PalB, DsbA and DsbC presented almost the similar positive effects on developing PalB activity and 
such effects were more pronounced in Origami B(DE3) than BL21(DE3), suggesting that DsbA and 
DsbC functioned properly in an oxidative environment. Such mediation was presumably more effective in 
the oxidative cytoplasm of Origami B(DE3). The results also suggest that both folding and disulfide bond 
formation could be critical for developing PalB activity.  
Cells expressing non-fused PalB suffered growth arrest presumably due to physiological stress 
mediated by the toxicity of the gene product. Such growth arrest could be alleviated to a certain degree by 
expressing most PalB fusions except T7PK-PalB. The solubility of most PalB fusions, such as MBP-
PalB, T7PK-PalB, and DsbA-PalB, was significantly higher than non-fused PalB, particularly in Origami 
B(DE3). However, only DsbA tag successfully induced PalB activity upon the fusion with PalB even 
though the solubility of most PalB fusions was enhanced. 
It is interesting to observe that functional expression of PalB was enhanced using DsbA either as an 
independent folding factor or as a fusion tag. DsbA was previously explored as a fusion tag for enhancing 
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the functional expression of several proteins, such as bovine enterokinase [246], proinsulin [247], CD8+ 
cytotoxic T lymphocyties (CTL) [248], and human perforin [249], with an assumption that DsbA tag can 
potentially solubilize and stabilize its fusion partner. Nevertheless, DsbA has not been as common as 
other fusion tags due to the lack of proper affinity chromatography for purification of fusion proteins. The 
role of DsbA tag for improving the solubility of its fusion partner has been demonstrated using the DsbA 
mutant lacking its oxidoreductase activity [250]. However, it is still unclear whether DsbA tag could 
assist disulfide bond formation for its fusion partner via the oxidoreductase activity. 
The current result that DsbA tag could enhance both the solubility and PalB activity (possibly via 
correct disulfide bond formation) upon the fusion with PalB strongly suggests that both protein folding 
and disulfide bond formation play critical roles for developing PalB activity. The DsbA-PalB expression 
performance observed in BL21(DE3) should purely reflect the effect of DsbA tag on solubilization, 
whereas the expression performance observed in Origami B(DE3) should reflect the synergistic effect on 
both solubilization and disulfide bond formation. Note that solubilization of PalB fusions did not 
necessarily result in the development of PalB activity which could be associated with correct disulfide 
bond formation. In other words, the use of DsbA tag can enhance both the solubility and disulfide bond 
formation for functional expression of PalB in Origami B(DE3) though the mechanism by which DsbA 
tag can assist correct formation of disulfide bonds for its fusion partner of PalB remains unclear. 
The purification for PalB is not difficult as showed in the purification of PalB from GST-PalB. 
Before and after the cleavage, GST-PalB and PalB all showed the PalB activity, although the PalB 
activity with the tag could be underestimated. If the fusion tag was not interfered with PalB activity too 
much, it could be more benefit to directly use PalB fusion as an enzyme in the biodiesel production. 
4.5 Abstract of the submitted paper 
Functional expression of lipase B from Pseudozyma antarctica (PalB) in the cytoplasm of Escherichia 
coli was explored using BL21(DE3) and its mutant derivative Origami B(DE3) as the host. Coexpression 
of DsbA was found to be effective in enhancing PalB expression and such improvement was more 
pronounced in Origami B(DE3), suggesting that both folding and disulfide bond formation could be the 
major factors limiting PalB expression. Fusion tag technique was also explored by constructing several 
PalB fusions for evaluation of their expression performance. While the solubility was enhanced for most 
PalB fusions, only DsbA tag was effective in boosting PalB activity possibly via both enhanced solubility 
and correct disulfide bond formation. Our results suggest that solubilization of PalB fusions did not 
necessarily result in the development of PalB activity which could be closely associated with correct 
disulfide bond formation. 
Keywords: disulfide bond formation, fusion tag, Escherichia coli, lipase, recombinant protein production  
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Chapter 5* 
Effect of Folding Factors in Rescuing Unstable Heterologous PalB to 
Enhance its Overexpression in the Periplasm of Escherichia coli 
5.1 Introduction 
The bacterium Escherichia coli remains popular as a workhorse for recombinant protein production. 
Formation of active proteins involves a series of intracellular steps for gene expression (e.g., transcription 
and translation) and posttranslational processing (e.g., translocation, folding). While strategies based on 
boosting gene expression steps are often adopted to enhance recombinant protein production [31, 38, 92], 
it is not uncommon that any of the overexpressed polypeptide species, including precursors, 
intermediates, and mature gene products, cannot be suitably processed during posttranslational 
processing, resulting in protein misfolding and cellular stress. The cell defense system is activated in 
response to the stress, either by degradation or refolding of the misfolded gene products [136]. Misfolded 
proteins are often degraded by proteases in quality control processes [134, 135]. However, such protein 
degradation is still possible in protease-deficient strains [251-253], implying the existence of protease-
independent pathways in E. coli [254]. When the amount of misfolded protein exceeds the cell’s 
degradation capacity, insoluble protein aggregates known as inclusion bodies form in the cytoplasm 
and/or periplasm [134, 136, 255]. This brings up a technical issue that, in addition to improving the 
efficiency of each gene expression step, a ‘balanced’ protein synthesis flux throughout these steps should 
be properly maintained to avoid the degradation and accumulation of any protein species along the 
protein formation pathway. 
Lipases (triacylglycerol acylhydrolase, E.C.3.1.1.3) are enzymes that catalyze the synthesis or 
hydrolysis of glycerol esters (e.g., triglycerides), such as fats and oils [14]. Microbial cells, including 
bacteria, fungi, and yeasts, are the major source for lipases with various enzymatic characteristics, such as 
synthetic and hydrolytic activity, stability, substrate specificity, for numerous applications in organic 
chemistry and biotechnology [20, 21]. Our interest in lipase arises from its application on 
biotransformation as an alternative to chemical conversion for biodiesel production. Lipase B from 
Pseudozyma antarctica (PalB) is a cold active microbial lipase with the transesterification activity and its 
                                                   
* This chapter is based on a paper “Y. Xu, D. Lewis, C. P. Chou, Effect of Folding Factors in Rescuing Unstable 
Heterologous Lipase B to Enhance its Overexpression in the Periplasm of Escherichia coli. Applied Microbiology 
and Biotechnology. 2008” (accepted). 
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corresponding immobilized form (e.g., Novozyme 435 commercially available from Novozyme A/S, 
Bagsvaerd, Demark) has been recognized as the most common biocatalyst for biodiesel production. While 
the biocatalyst is gaining more attention and has a potential to outperform chemical catalysts, extensive 
application remains impractical due to its high cost and several technical issues (e.g., inactivation by 
alcohol). To make the bioprocess economically feasible, there is a motivation to overexpress PalB.  
Previously, recombinant PalB was expressed heterologously in Aspergillus oryzae [25], Pichia 
pastoris [224], and Saccharomyces cerevisiae [27]. Given the popularity of E. coli as a workhorse for 
recombinant protein production, functional expression of PalB in this host was not demonstrated until 
recently [28, 29] and the expression performance stands improvement. A major technical issue limiting 
PalB expression in E. coli is associated with its intracellular misfolding. PalB is a cold active lipase 
destined to be secreted extracellularly in the original psychrophilic and eukaryotic source of P. antarctica. 
Consequently, the intracellular overexpression might prevent it from being structurally adaptable to the 
mesophilic and prokaryotic expression system of E. coli, resulting in protein misfolding. In addition, 
wild-type PalB has three intermolecular disulfide bonds potentially associated with its folding process 
though they might not be strictly required for developing the bioactivity. Finally, cell growth is often 
arrested due to deteriorated cell physiology associated with high-level expression and PalB misfolding. 
Nevertheless, from an application standpoint, developing effective PalB expression strategies in E. coli is 
still worthy of exploration. 
In contrast to the cytoplasm where all the proteins are first synthesized, the periplasm offers several 
advantages as a destination for heterologous protein expression, such as its oxidizing environment 
suitable for disulfide bond formation and a less amount of contaminating proteins in this compartment so 
that downstream purification would be facilitated [88, 90]. Due to the possible impact of disulfide bond 
formation on PalB bioactivity, it would be advantageous to express PalB in the periplasm. In this study, a 
key factor limiting functional expression of PalB in the periplasm of E. coli was identified. The use of 
various periplasmic folding factors to eliminate the limiting factor was explored to improve PalB 
expression performance. 
5.2 Material and Methods 
5.2.1 Strains and Plasmids 
The strains, plasmids and oligonucleotides used in this study are summarized in Table 5.1 and briefly 
described here. BL21(DE3) was used as the host strain for PalB expression. Molecular cloning was 
performed according to standard protocols [61] using DH5α as the cloning host. P. antarctica strain 
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ATCC 32657 containing the palB source gene was purchased from ATCC (Manassas, VA, USA). P. 
antarctica chromosomal DNA was extracted and purified by using DNeasy® tissue Kit (Qiagen, Valencia, 
CA, USA). PCR was performed in an automated thermal cycler (GeneAmp® PCR System 9700; Applied 
Biosystems, Foster City, CA, USA). The PCR product was purified by StrataPrep® PCR purification kit 
(Stratagene). Restriction enzymes were purchased from New England Biolabs (Ipswich, MA, USA). 
Plasmid DNAs were purified using a spin column kit (Clontech, Mountain View, CA, USA). Plasmid 
transformation was carried out using an electroporator (Bio-Rad, Hercules, CA, USA). All the chemicals 
used in this study were purchased from Sigma-Aldrich (Oakville, ON, Canada) unless otherwise 
specified. 
 




Relevant genotype or phenotypea 
Source and 
reference 
E. coli   
BL21(DE3) E. coli B, F– ompT [dcm][lon] hsdSB(rB– mB–) gal 
(λcIts857 ind1 Sam7 nin5 lacUV5-T7 gene 1) 
Novagen 
[256] 
DH5α F'/(φ80 lacZ ΔM15) Δ(lacZYA-argF)U169 deoR recA1 




P. antarctica   
ATCC 32657 The source of palB gene ATCC  
Plasmid   
pAR3 Expression vector, ParaB, Ori (pACYC184), CmR Lab stock 
[233] 
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pARDegP ParaB::degP, Ori (pACYC184), CmR This lab [187] 
pARDegPS210A ParaB::degPS210A, Ori (pACYC184), CmR This lab [187] 
pARFkpA ParaB::fkpA, Ori (pACYC184), CmR This lab [195] 
pARDsbA ParaB::dsbA, Ori (pACYC184), CmR This study 
pARDsbC ParaB::dsbC, Ori (pACYC184), CmR This study 
pET-20b(+) Expression vector, PT7::pelBsignal, Ori (pBR322), ApR Lab stock Y. 
P. Chao 
pETG PT7::pelBsignal::palB, Ori (pBR322), ApR This study 
pETG-50A Destination vector, PT7::lacOp::dsbA::6×his, Ori 
(pBR322), ApR, CmR 
EMBL 
pETM-80 Expression vector, PT7::dsbC::6×his, Ori (pBR322), KnR EMBL [72] 
pETL PT7::palB, Ori (pBR322), ApR This study 




pG-KJE8 ParaB::dnaK/J::grpE, Pzt-lp::groEL/ES, Ori (pACYC184), 
CmR 
T. Yura [76] 
pG-Tf3 ParaB::tig, Pzt-lp::groEL/ES, Ori (pACYC184), CmR T. Yura [76] 
Oligonucleotide   
P10 5'-GGCCATGGGTCTACCTTCCGGTTCGG-3' This study 
P11 5'-CTGAATTCTCAGGGGGTGACGATGCCGGAGCAGG-3' This study 
P17 5'-TGCATATGCTACCTTCCGGTTCGG-3' This study 
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PfDsbA /PrDsbA 5'-CCATGGAAAAGATTTGGCTGGCGC-3' and 
5'-AAGCTTTCATTTCTCGCTTAAGTATTTC-3'; 
primer pair for amplification of dsbA 
This study 
PfDsbC/PrDsbC 5'-CCATGGAGAAAGGTTTTATGTTG-3' and 
5'-AAGCTTTCAACCAGAACCACTAGT-3'; 
primer pair for amplification of dsbC 
This study 
a Designed restriction sites are underlined and the introduced mutations are in italics. 
 
The two DNA fragments containing the leaderless palB gene were PCR-amplified using Pfu DNA 
polymerase (Stratagene), the primer pairs of P10/P11 and P17/P11, respectively (Table 5.1), and P. 
antarctica chromosomal DNA as the template. The PCR products were cloned into PCR-Script® 
(Stratagene), respectively. DNA sequencing was performed to ensure no mutations occurred during PCR. 
The palB-containing DNA fragments were obtained by digestion of the above PCR-Script® derivatives 
with NcoI/EcoRI and NdeI/EcoRI, respectively, gel-purified and subcloned into the corresponding 
restriction sites of pET-20b(+), resulting in a translational fusion of pETG (Figure 5.1A) for periplasmic 
expression and a transcriptional fusion of pETL (Figure 5.1B) for cytoplasmic expression. Due to the 
design of the restriction site in the sense primers, the N-terminus of the heterologously expressed PalB is 
expected to have two extra amino acids (e.g., Met and Gly) for pETG and one extra amino acid (e.g., 
Met) for pETL. The coexpression plasmids containing a selection of cytoplasmic chaperone gene(s) were 
derivatives of pAR3 [233]. pG-Tf3 [76] contains tig and groES/EL, fused with the araB and zt-lp 
promoters, respectively. pG-KJE8 [76] contains the dnaK/J-grpE and groES/EL, fused with the araB and 
zt-lp promoters, respectively. Except pTUM4 [258], the coexpression plasmids containing a selection of 
periplasmic folding factor gene(s) were also derivatives of pAR3. Two of them, e.g., pARDsbA and 
pARDsbC, were constructed in this study. The dsbA gene was PCR-amplified using Pfu DNA 
polymerase, the primer pair PfDsbA/PrDsbA, and pETG-50A (EMBL) as the template. The dsbC gene was 
PCR-amplified using Pfu DNA polymerase, the primer pair PfDsbC/PrDsbC, and pETM-80 [72] as the 
template. The PCR products were cloned into PCR-Script®. DNA sequencing was performed to ensure no 
mutations occurred during PCR. The dsbA-containing and dsbC-containing DNA fragments, both flanked 
with NcoI/HindIII, were subcloned into the corresponding sites of pAR3 to form pARDsbA and 
pARDsbC, respectively. The design of the NcoI site in the sense primers resulted in a change in the 
second amino acid of the signal peptide (e.g., Lys→Glu) for both DsbA and DsbC, and the mutations did 
not appear to affect translocation. pARDegP [187], pARDegPS210A [187], and pARFkpA [195] contain the 
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gene of degP, degPS210A, and fkpA, respectively fused with the araB promoter. pTUM4 harbors two 
artificial dicistronic operons: one with the structural genes of dsbA and dsbC under the control of the 
constitutive dsbA promoter and the other one with the structural genes of fkpA and surA under the control 
of the constitutive fkpA promoter [258]. All the folding-factor-gene-containing plasmids have a 
pACYC184 replication origin and a chloramphenicol-resistant (CmR) marker. Therefore, they are 
compatible with pETG, which has a pBR322 replication origin and an ampicillin-resistant (ApR) marker. 
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Figure 5.1 Construction of two PalB expression plasmids of pETG (Panel A: periplasmic 
expression) and pETL (Panel B: cytoplasmic expression), and comparison of their DNA sequence’s 
differences from T7 promoter to T7 terminator portion (Panel C).The DNA region from 
nucleotides 76 to 1029 of the wild-type palB gene on the chromosome of P. antarctica ATCC 32657 
was PCR-amplified with primer pairs of P10/P11 and P17/P11, respectively. The PCR products 
were cloned into pET-20b(+) using NcoI/EcoRI and NdeI/EcoRI, respectively, to form a 
translational fusion of pETG and a transcriptional fusion of pETL. MCS, multiple cloning sites. 
RBS, ribosome binding site.  
 
5.2.2 Cultivation and Analytic Methods 
The cultivation and analytical procedures were identical with the procedures described in Section 3.2.2 
and 3.2.3. 
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5.3 Results 
5.3.1 Comparison of Cytoplasmic and Periplasmic Expression of PalB  
To compare cytoplasmic and periplasmic expression of PalB in parallel, two similar expression plasmids 
of pETL and pETG were constructed (Figure 5.1). They both contain the palB gene from P. antarctica 
ATCC 32657 whose expression is under the regulation of the T7 promoter. However, pETG contains the 
pelB signal peptide ahead of the palB gene for secretion of PalB into the periplasm, whereas pETL does 
not. With this design, the cytoplasmic and periplasmic PalB will contain an extra residue (e.g., Met) and 
two extra residues (e.g., Met and Gly), respectively, in the N-terminus of the expressed gene product. 
Using BL21(DE3) as the host to harbor these two expression plasmids, qualitative visualization of 
PalB activity of the recombinant cells was conducted on the tributyrin plate and the results are 
summarized in Figure 5.2A. In general, the area and transparency of the halo potentially correlate with the 
expressed PalB activity corresponding to the applied sample. A visible halo was observed for BL21(DE3) 
harboring pETL, indicating PalB was functionally expressed in the cytoplasm of E. coli. Surprisingly, 
BL21(DE3) harboring pETG did not show a visible halo though functional PalB was expected to be 
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Figure 5.2 Comparison of PalB expression performance. Panel A: Qualitative visualization of PalB 
activity using the tributyrin plate. 1/ BL21 (DE3); 2/ BL21(DE3) (pETL); 3/ BL21(DE3) (pETG). 
Panel B: cell density and Panel C: specific PalB activity for cultivation of BL21(DE3) (pETL) and 
BL21(DE3) (pETG) at 28 °C. Panel D: Western blotting analysis of the soluble (S) and insoluble (I) 
fractions for various culture samples. 0/ BL21(DE3); 1/ BL21(DE3) (pETL); 2/ BL21(DE3) (pETG). 
The error bar in Panels B and C represents a range of the data variance. 
 
The PalB expression performance for BL21(DE3) harboring pETL and BL21(DE3) harboring 
pETG is summarized in Figure 5.2B~D. Though PalB was functionally expressed in BL21(DE3) 
harboring pETL, PalB activity was relatively low and most of the expressed gene product accumulated in 
cells as inclusion bodies. The non-productive pathway was favored for PalB expression possibly due to 
the reductive environment of the cytoplasm unsuitable for disulfide bond formation. In addition, cell 
growth was severely arrested due to the physiological deterioration upon induction. In principle, 
expression of PalB in the oxidative periplasm should not be worse, if not better, than that in the reductive 
cytoplasm. However, PalB activity was minimally detected for BL21(DE3) harboring pETG even though 
cell growth was not arrested upon induction. In addition, no PalB-related gene product was detected in 
soluble or insoluble fraction when Western blotting was conducted. The result suggests two possible 
expression issues, e.g., (i) an ineffective translation or (ii) the instability of the PalB gene product in the 
cytoplasm and/or the periplasm. In order to identify the factor(s) limiting PalB expression in the 
periplasm, coexpression of cytoplasmic and periplasmic folding factors to rescue the potentially unstable 
gene products was conducted. 
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5.3.2 Effect of Folding Factors on Rescuing PalB Gene Product 
A selection of cytoplasmic chaperones (e.g., the TF, GroEL/ES, and DnaK/J-GrpE) and their 
combinations were coexpressed with the periplasmic expression of PalB with pETG as the expression 
plasmid and the results are summarized in Figure 5.3. Apparently, coexpression of any of these 
cytoplasmic chaperones or their combinations hardly improved PalB expression performance. PalB 
activity was not qualitatively visualized on the tributyrin plate. In addition, similar to the control culture 
of BL21(DE3) harboring pETG, neither PalB activity was increase (Figure 5.3C) nor PalB-related gene 
products were detected (Figure 5.3D), although the chaperones or their combinations were expressed 
(Figure 5.3E). The results suggest that PalB expression using pETG as the expression plasmid might not 
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Figure 5.3 Effect of cytoplasmic chaperones on PalB coexpression performance using BL21(DE3) 
(pETG). Panel A: Qualitative visualization of PalB activity using the tributyrin plate. Panel B: cell 
density for cultivation of various expression systems at 28 °C. Panel C: specific PalB activity for 
cultivation of various expression systems at 28 °C. Panel D: Western blotting analysis of the soluble 
(S) and insoluble (I) fractions for various culture samples. Panel E: SDS-PAGE results of the 
soluble fractions for various culture samples. Expression systems: 1&2/ BL21(DE3) (pETG); 3~7/ 
BL21(DE3) (pETG, pG-Tf3); 8~12/ BL21(DE3) (pETG, pG-KJE8). Inducer supplementation: 1, 3, 
8/ no inducer; 2, 4, 9/ IPTG; 5&10/ IPTG and arabinose; 6&11/ IPTG and tetracycline; 7&12/ 
IPTG, arabinose, and tetracycline. M, protein molecular weight marker. The error bar in Panels B 
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In contrast, PalB expression performance was significantly improved upon coexpression of a 
number of periplasmic folding factors, including DegP (and its mutant variant of DegPS210A), FkpA, 
DsbA, DsbC, and a cocktail of SurA, FkpA, DsbA, and DsbC, and the results are summarized in Figure 
5.4. Halos developed on the tributyrin plate for all the cell colonies of BL21(DE3) harboring pETG and 
folding-factor-coexpression plasmids, indicating that PalB was functionally expressed in the periplasm of 
E. coli (Figure 5.4A). Note that, for BL21(DE3) harboring pETG, cell growth was arrested to some extent 
upon IPTG-induction (Figure 5.4B). This physiological burden could be alleviated by coexpression of 
DegP and DegPS210A and such effect was particularly observable at 15 °C. More importantly, the specific 
PalB activity was significantly enhanced by approximately 6-fold (30 U/liter/OD600 for DegP 
coexpression and 33 U/liter/OD600 for DegPS210A coexpression vs. 5 U/liter/OD600 for the control culture 
grown at 15 °C and induced with 0.5 mM IPTG), resulting in a significant improvement in the volumetric 
PalB activity. A similar improvement was observed when cultivations were performed at 28 °C, though 
the improving effect was less significant. On the other hand, coexpression of DsbA or a folding factor 
cocktail (SurA, FkpA, DsbA, and DsbC) had approximately the same or even better improving effect 
compared to the culture with DegP coexpression, particularly in terms of the specific PalB expression 
level. In contrast, the enhancement on PalB expression performance was limited upon coexpression of 
FkpA or DsbC. Compared to BL21(DE3) harboring pETG, the growth arrest became even more severe 
upon coexpression of DsbC and the PalB band became invisible for one culture condition (e.g., 0.1 mM 
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Figure 5.4 Effect of periplasmic folding factors on PalB coexpression performance using 
BL21(DE3) (pETG). Panel A: Qualitative visualization of PalB activity using the tributyrin plate. 
Panel B: cell density for cultivation of various expression systems at 15 and 28 °C. Panel C: specific 
PalB activity for cultivation of various expression systems at 15 and 28 °C. Panel D: Western 
blotting analysis of the soluble (S) and insoluble (I) fractions for various culture samples. Panel E: 
SDS-PAGE results for the soluble (S) fractions for various culture samples. Expression systems: 0, 
1/ BL21(DE3) (pETG); 2/ BL21(DE3) (pETG, pARDegP); 3/ BL21(DE3) (pETG, pARDegPS210A); 4/ 
BL21(DE3) (pETG, pARFkpA); 5/ BL21(DE3) (pETG, pARDsbA); 6/ BL21(DE3) (pETG, 
pARDsbC); 7/ BL21(DE3) (pETG, pTUM4). Inducer supplementation: 1, 7/ IPTG; 2~6/ IPTG and 
arabinose. M, protein molecular weight marker. The error bar in Panels B and C represents a 
range of the data variance. 
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The enhancement in PalB expression performance using periplasmic folding factors was clearly 
demonstrated using Western blotting (Figure 5.4D). The PalB band was slightly visible at 15 °C and was 
hardly visible at 28 °C for BL21(DE3) harboring pETG, implying that PalB might be structurally unstable 
in the periplasm. The PalB band signal was significantly amplified and became clearly visible when 
various periplasmic folding factors were coexpressed, suggesting that unstable PalB was rescued by 
periplasmic chaperones. Note that PalB was detected in both soluble and insoluble fractions, suggesting 
that misfolding of PalB still occurred in the periplasm even in the presence of chaperones. In some 
coexpression cases (e.g., Figure 5.4D, lanes 4, 5, 6 with 0.1 mM IPTG at 28 °C), PalB precursor 
(presumably in the cytoplasm) was visible in both soluble and insoluble fractions.  
5.4 Discussion 
Biochemical and genetic strategies have been developed to enhance various gene expression steps for 
heterologous protein production in E. coli, including transcription, translation, posttranslational 
processing (e.g., translocation, periplasmic processing, and folding). To effectively enhance expression 
performance, the limiting expression step(s) will need to be identified first. This leads to a generic 
concept that not only the efficiency of each gene expression step should be maximized but also the 
expression flux leading to the mature protein should be balanced to avoid any potential diversion into the 
non-productive pathway.  
Up to now, it is well recognized that overexpression of bioactive PalB in E. coli remains 
challenging primarily due to intracellular misfolding which demolishes its bioactivity. In this study, PalB 
was functionally expressed in the cytoplasm of E. coli using pETL as the expression plasmid although 
PalB inclusion bodies in a large amount were also observed. The result suggests that PalB was stable in 
the cytoplasm and disulfide bond formation might not be strictly required to develop the bioactivity. 
However, PalB expression performance was poor using pETG as the expression plasmid though the 
periplasm was presumed to be a more suitable compartment for functional expression of PalB due to its 
oxidative environment facilitating disulfide bond formation. The minor difference in DNA construction of 
the two similar PalB expression plasmids (e.g., pETL and pETG) and the major difference in PalB 
expression performance using these two plasmids leads to a hypothesis that either (or even both) of 
cytoplasmic PalB precursor (e.g., prePalB) and periplasmic PalB might be unstable. Therefore, 
cytoplasmic or periplasmic folding factors were used to identify and even rescue the potentially unstable 
PalB species. 
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Several cytoplasmic chaperones, including TF, DnaK/J-GrpE, and GroEL/ES, were coexpressed, 
either separately or in combination, with PalB expression using pETG. No major improvement was 
observed, implying that the factor limiting PalB expression might not be located in the cytoplasm. In 
contrast, coexpression of several periplasmic folding factors, in particular DegP, DsbA, and a cocktail of 
SurA, FkpA, DsbA, and DsbC, could not only rescue the unstable PalB species in the periplasm but also 
significantly improve PalB expression performance. It has been widely reported that several periplasmic 
folding factors can interact with secreted proteins to enhance functional expression via improved 
translocation and/or polypeptide stabilization [88, 96, 173, 174, 245]. 
DegP primarily acts as a serine protease for breakdown of aberrant periplasmic proteins arising 
upon extracytoplasmic stress [181, 182] and its expression can be activated via both σE and Cpx pathways 
[121]. Wild-type DegP is a periplasmic heat-shock protein with both protease and chaperone activities, 
whereas DegPS210A is a mutant variant with its protease activity being inactivated but chaperone activity 
being retained [183]. Coexpression of degP was applied to relieve the extracytoplasmic stress upon 
overexpression of several periplasmic gene products, such as alkaline phosphatase (PhoA) [184], DsbA’-
PhoA [259], MalS [183], OmpF mutants [260], maltose-binding protein (MBP or MalE) variants [179, 
261], and penicillin acylase [187]. In this study, DegP appears to be effective in stabilizing newly secreted 
and presumably unfolded PalB in the periplasm. Such improvement in PalB expression performance 
remained approximately the same when DegPS210A was coexpressed, suggesting that this improving effect 
was likely mediated by DegP chaperone activity. The stabilization effect associated with chaperone 
activity was further demonstrated by coexpression of other periplasmic folding factors. 
FkpA is another periplasmic heat-shock protein with both cis/trans peptidyl-prolyl isomerase 
(PPIase) and chaperone activities [189, 190, 192]. Expression of fkpA is activated via the σE pathway 
[127, 199] and is capable of reducing the σE-dependent response induced by misfolded proteins in the 
periplasm [179]. Coexpression of fkpA was applied to improve the functional production of recombinant 
antibody fragments [193, 194] and penicillin acylase [195]. In this study, the above improving effect on 
functional PalB expression was also observable when FkpA was coexpressed, supporting the argument 
regarding the role that chaperones could play. 
Many eukaryotic proteins, including PalB, contain disulfide bonds which often mediate the 
stabilization of folding conformation. It would be advantageous for these proteins to be expressed in the 
oxidative periplasm of E. coli to facilitate disulfide bond formation. DsbA and DsbC are two Dsb-family 
members in the periplasm and play important roles in disulfide bond formation [40]. DsbA catalyzes 
direct bridging of disulfide bonds in newly translocated proteins, whereas DsbC assists subsequent 
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rearrangement of aberrant disulfide bonds [40]. Though with distinctively major activities, the two 
proteins might share biological functions under certain conditions [104, 215-217]. Coexpression of DsbA 
and/or DsbC enhanced functional expression of several recombinant proteins, such as ribonuclease I 
[243], human tissue plasminogen activator [104, 213], horseradish peroxidase [245] and human nerve 
growth factor β [212]. In this study, the improvement on PalB expression associated with DsbA 
coexpression was more significant than DsbC, suggesting that initiation of a correct disulfide pattern 
could be critical for functional expression of PalB in the periplasm. Since the three disulfide bonds in 
PalB are quite distant from each other [228], the chance for disulfide bond rearrangement might be slim 
[211, 219, 245] and this could be the reason why the improvement associated with DsbC coexpression 
was not as significant as DsbA. The similar improving effect on PalB expression mediated by DegP 
coexpression and DsbA coexpression could be associated with shared function for the two chaperones 
previously reported [183]. In addition, a synergistic improvement on PalB expression level was observed 
by coexpression of a folding factor cocktail of DsbA, DsbC, SurA, and FkpA though cell growth was 
arrested to some extent. While this synergistic effect is not surprising, the individual contribution from 
SurA coexpression remains to be evaluated. SurA is another periplasmic protein with both chaperone and 
PPIase activities [209] and coexpression of SurA could stabilize and facilitate the folding of several 
periplasmic proteins, including MalE31 [237], OmpA, OmpF, and LamB [208].  
It is somewhat surprising to observe that PalB was stable in the cytoplasm (e.g., for pETL), but was 
unstable in the periplasm (e.g., for pETG). Such periplasmic instability associated with PalB critically 
limited PalB expression performance. This is the first report demonstrating the rescue of very unstable 
polypeptide using folding factor in the periplasm for improving expression performance. Note that the 
specific PalB expression level for pETG with coexpression of periplasmic folding factor was significantly 
higher than that for pETL (Figure 5.2C vs. Figure 5.4C), suggesting that the periplasm is a more 
appropriate compartment for functional expression of PalB than the cytoplasm. In fact, we have a few 
expression plasmids with other signal peptides, leading to the production of stable PalB variants with 
modified N-terminus in the periplasm (data not shown). In addition, we had the expression results similar 
to those in this study (e.g., unstable PalB variant that can be rescued by coexpression of periplasmic 
chaperones) by using another expression plasmid (e.g., pGPSH, data not shown) containing the same 
signal peptide as pETG (e.g., pelB) but a different promoter (e.g., Ptet). These observations suggested that 
the choice of the signal peptide could possibly affect PalB stability in the periplasm. 
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5.5 Abstract of the submitted paper 
Functional expression of recombinant Pseudozyma antarctica lipase B (PalB) in Escherichia coli was 
explored. While PalB was stably expressed in the cytoplasm, most of the expressed gene product 
aggregated in cells as inactive inclusion bodies. In contrast, PalB was extremely unstable when expressed 
in the periplasm, also leading to poor expression performance. Such unstable PalB can be rescued by 
coexpression of several periplasmic folding factors, such as DegP, FkpA, DsbA, and DsbC, but not 
cytoplasmic ones. As a result, the performance for functional PalB expression in the periplasm was 
significantly improved. To our knowledge, this is the first report demonstrating the use of folding factors 
to rescue the extremely unstable gene product that is otherwise completely degradable. 
Keywords: chaperone, Escherichia coli, folding factor, gene expression, lipase B, Pseudozyma antarctica, 
recombinant protein production  
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Chapter 6* 
Using Fusion Tags to Enhance Functional Expression of 
Heterologous PalB in the Periplasm of E. coli 
6.1 Introduction 
The periplasm, in contrast to the cytoplasm where all proteins are first synthesized, offers several 
advantages as a destination for heterologous protein expression, such as its isolated and oxidative 
environment facilitating protein purification and disulfide bond formation, respectively [88, 90]. Just like 
the cytoplasm, protein misfolding can still occur in the periplasm [174, 262]. Several periplasmic 
proteins, such as DegP, FkpA, and Dsb-family members, can potentially act as folding factors to increase 
the solubility, mediate the stability, prevent the aggregation of secreted proteins [43, 173]. The previous 
results (Chapter 5) indicated that PalB was extremely unstable in the periplasm, leading to poor 
expression performance. Though the unstable PalB species could be rescued for functional expression by 
several periplasmic folding factors, the expression performance was far from optimized. 
Fusion tags, originally developed for protein purification and immobilization, offer another 
powerful tool to enhance the folding and stability of the target protein moiety because fusion tags can 
rapidly attain a native conformation [86]. Several fusion tags, such as maltose-binding protein (MBP) 
[137, 139], N-utilization substance protein A (NusA) [146], FLAG [28], Thioredoxin (TRX) [94], and 
DsbA/DsbC [72], have been demonstrated to be effective in practical applications. While the tags 
theoretically can be fused with the target protein at either the N- or C-terminus, the N-terminus has been 
adopted for most applications due to potentially more effective initiation for translation and a higher 
solubility of gene products [38, 86, 87, 126, 131, 134-138]. The solubility can also be increased by using 
a larger tag though such strategy could possibly limit the expression yield of the fusion protein [126]. On 
the other hand, fusion proteins can be used directly as enzymes without removing the tag provided the tag 
moiety is small and hardly affects the bioactivity [86, 87]. 
In this study, functional expression of PalB in the periplasm of E. coli was explored using four N-
terminal fusion tags. In addition, coexpression of various periplasmic folding factors was used to enhance 
the PalB expression performance. 
                                                   
* This chapter is based on a paper “Y. Xu, A. Yasin, T. Wucherpfennig, C. P. Chou, Using Fusion Tags to Enhance 
Functional Expression of Heterologous Lipase in the Periplasm of Escherichia coli. World journal of Microbiology 
and Biotechnology. 2008” (accepted). 
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6.2 Materials and Methods 
6.2.1 Strains and Plasmids 
The strains, plasmids and oligonucleotides used in this study are summarized in Table 6.1 and briefly 
described here. BL21(DE3) was used as the host strain for PalB expression. Molecular cloning was 
performed according to standard protocols [61] using DH5α as the cloning host. All the cloning 
techniques and chemicals were the same as described in Chapter 3. 
 




Relevant genotype or phenotypea Source and 
reference 
E. coli   
BL21(DE3) E. coli B, F– ompT [dcm][lon] hsdSB(rB– mB–) gal 
(λcIts857 ind1 Sam7 nin5 lacUV5-T7 gene 1) 
Novagen 
[256] 
DH5α F'/(φ80 lacZ ΔM15) Δ(lacZYA-argF)U169 deoR recA1 




P. antarctica   
ATCC 32657 The source of palB gene ATCC 
Plasmid   
pAR3 Expression vector, ParaB, Ori (pACYC184), CmR Lab stock 
[233] 
pARDegP ParaB::degP, Ori (pACYC184), CmR This lab [187] 
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pARDegPS210A ParaB::degPS210A, Ori (pACYC184), CmR This lab [187] 
pARDsbA ParaB::dsbA, Ori (pACYC184), CmR This study 
pARDsbC ParaB::dsbC, Ori (pACYC184), CmR This study 
pARFkpA ParaB::fkpA, Ori (pACYC184), CmR This lab [195] 
pENTR4 Entry vector, Invitrogen 
pENTRG palB-containing entry vector This study 
pETDsbA-G PT7::lacOp::dsbAsignal::dsbA::6×his::palB, Ori (pBR322), 
ApR 
This study 
pETDsbC-O PT7::dsbCsignal::dsbC::6×his::palB, Ori (pBR322), KnR This study 
pETG-50A Destination vector, PT7::lacOp::dsbAsignal::dsbA::6×his, 
Ori (pBR322), ApR, CmR 
EMBL 
pETM-80 Expression vector, PT7::dsbAsignal::dsbC::6×his, Ori 
(pBR322), KnR 
EMBL [72] 




pFlag-P Ptac::OmpAsignal::flag::palB, Ori (pBR322), ApR This study 
pHisperiMBP Destination vector, Ptac::mbpsignal::6×his::mbp, Ori 
(pBR322), ApR, CmR 
D. Waugh 
[137] 
pHisperiMBP-G Ptac::mbpsignal::6×his::mbp::palB, Ori (pBR322), ApR This study 
pTUM4 PfkpA::fkpA::SurA, PdsbA::dsbA::dsbC, Ori (pBR322), CmR A. Skerra 
[258] 
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Oligonucleotide   
P10 5' – GGCCATGGGTCTACCTTCCGGTTCGG – 3' This study 
P11 5' – CTGAATTCTCAGGGGGTGACGATGCCGGAGCAGG – 3' This study 
P22 5' – CTGAGCTCTCAGGGGGTGACGATGCCGGAG – 3' This study 
P23 5' – GTCTCGAGCTACCTTCCGGTTCGGAC– 3' This study 
PfDsbA /PrDsbA 5' – CCATGGAAAAGATTTGGCTGGCGC – 3' and 
5' – AAGCTTTCATTTCTCGCTTAAGTATTTC – 3' 
primer pair for amplification of dsbA 
This study 
PfDsbC/PrDsbC 5' – CCATGGAGAAAGGTTTTATGTTG – 3' and 
5' – AAGCTTTCAACCAGAACCACTAGT – 3' 
primer pair for amplification of dsbC 
This study 
aDesigned restriction sites are underlined and the introduced mutations are in italic. 
 
DNA fragments containing the leaderless palB gene were PCR-amplified using pfu DNA 
polymerase (Stratagene), the primer pair (P10/P11, P10/22 or P23/P11 in Table 1), and P. antarctica 
chromosomal DNA as the template. The PCR products were cloned into pPCR Script® (Stratagene). DNA 
sequencing was performed to ensure no mutations occurred during PCR. The palB-containing DNA 
fragments were obtained by digestion of the above pPCRScript® derivatives with NcoI/EcoRI, NcoI/SacI, 
and XhoI/EcoRI, and subcloned into the corresponding restriction sites of pENTR4 (Invitrogen), pETM-
80 [72], and pFLAG (Sigma-Aldrich), resulting in pENTRG, pETDsbC-O, and pFlag-P, respectively. 
pENTRG was mixed with the destination vector pET-50A [72], and pHisperiMBP [137], respectively, in 
a LR reaction with LR ClonaseTM using Gateway technology (Invitrogen), resulting pETDsbA-G and 
pHisperiMBP-G.  
Except pTUM4 [258], the coexpression plasmids containing a selection of periplasmic folding 
factor gene(s) were derivatives of pAR3 [233]. Two of them, e.g., pARDsbA and pARDsbC, were 
constructed in this study. The dsbA gene was PCR-amplified using pfu DNA polymerase, the primer pair 
PfDsbA/PrDsbA, and pETG-50A as the template. The dsbC gene was PCR-amplified using pfu DNA 
polymerase, the primer pair PfDsbC/PrDsbC, and pETM-80 as the template. The PCR products were cloned 
into pPCRScript®. DNA sequencing was performed to ensure no mutations occurred during PCR. The 
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dsbA-containing and dsbC-containing DNA fragments, both flanked with NcoI/HindIII, were subcloned 
into the corresponding restriction sites of pAR3 to form pARDsbA and pARDsbC, respectively. The 
design of the NcoI site in the sense primers resulted in changes in the second amino acid of the signal 
peptides (e.g., Lys → Glu) for both DsbA and DsbC, and the mutations did not appear to affect 
translocation. pARDegP [187], pARDegPS210A, [187], and pARFkpA [195] contain the gene of degP, 
degPS210A and fkpA, respectively, fused with the araB promoter. pTUM4 harbors two artificial dicistronic 
operons: one with the structural genes of DsbA and DsbC under the control of the constitutive dsbA 
promoter, and the other with the structural genes of fkpA and surA under the control of the constitutive 
fkpA promoter [258]. All the folding factor-gene(s)-containing plasmids have a pACYC184 replication 
origin and a chloramphenicol-resistant (CmR) marker and are therefore, compatible with all the PalB-
fusion expression plasmids containing a pBR322 replication origin and an ampicillin-resistant (ApR) or 
kanamycin-resistant (KnR) marker. 
6.2.2 Cultivation and Analytic Methods 
The cultivation and analytical procedures were identical with the procedures described in Section 3.2.2 
and 3.2.3. 
6.3 Results 
6.3.1 Effect of Fusion Tags on Functional Expression of PalB  
Results in Chapter 5 suggested that PalB was extremely unstable in the periplasm and functional 
expression of PalB could be possibly limited by certain types of N-terminal sequence. In this study, four 
periplasmic N-terminal tags, e.g., FLAG, MBP, DsbA, and DsbC, were used to modify the N-terminus of 
PalB for more effective expression in the periplasm. To do this, four translational fusion of tags with PalB 
were constructed, resulting in four expression plasmids, e.g., pFlag-P, pHisperiMBP-G, pETDsbA-G, and 
pETDsbC-O. The expression of FLAG-PalB and MBP-PalB was under the regulation of the tac promoter 
whereas the expression of DsbA-PalB and DsbC-PalB was under the regulation of T7 promoter. All the 
fusions used the signal of their corresponding tags for translocation, except FLAG-PalB which used the 
OmpA signal. 
Using BL21(DE3) as the host to harbor these expression plasmids, qualitative visualization of PalB 
activity was conducted on the tributyrin plate and the result is summarized in Figure 6.1. Halos were 
developed for all the recombinant strains, but not for the control strain of BL21(DE3), indicating that all 
PalB fusions were functionally expressed in the periplasm with PalB activity. Since the area and 
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transparency of the halo potentially correlate with the expressed PalB activity of the applied sample, 
FLAG-PalB appeared to be the most active one among the four PalB fusions. Culture performance for the 
expression of DsbC-PalB, DsbA-PalB, MBP-PalB, and FLAG-PalB using BL21(DE3) harboring the 
corresponding expression plasmid is summarized in Figures 6.2~6.5, respectively (e.g., expression system 
1 in each Figure). In general, a slight growth arrest was observed for all the recombinant BL21(DE3) with 
significant levels of PalB induction (e.g., 5 to 11-fold increase in specific PalB activity) upon IPTG 
supplementation. The specific PalB activity reached 2, 36, 47, and 82 U/liter/OD600 for DsbC-PalB, 
DsbA-PalB, MBP-PalB, and FLAG-PalB, respectively. Except MBP-PalB, most of these PalB fusions 




Figure 6.1 Qualitative visualization of PalB activity using the tributyrin plate for various PalB 
fusion expression systems. 
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Figure 6.2 PalB expression performance for BL21(DE3) (pETDsbC-O) and the effect of 
coexpressing various periplasmic folding factors on the expression performance. Panel A: cell 
density and Panel B: specific PalB activity for various expression systems. Panel C: Western 
blotting analysis of the soluble (S) and insoluble (I) fractions for various expression systems. 0, 1/ 
BL21(DE3) (pETDsbC-O); 2/ BL21(DE3) (pETDsbC-O, pARDegP); 3/ BL21(DE3) (pETDsbC-O, 
pARDegPS210A); 4/ BL21(DE3) (pETDsbC-O, pARFkpA); 5/ BL21(DE3) (pETDsbC-O, pARDsbA); 
6/ BL21(DE3) (pETDsbC-O, pARDsbC); 7/ BL21(DE3) (pETDsbC-O, pTUM4). Inducer 
supplementation: 1, 7/ IPTG; 2~6/ IPTG and arabinose. The error bar in Panels A and B represents 
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Figure 6.3. PalB expression performance for BL21(DE3) (pETDsbA-G) and the effect of 
coexpressing various periplasmic folding factors on the expression performance. Panel A: cell 
density and Panel B: specific PalB activity for various expression systems. Panel C: Western 
blotting analysis of the soluble (S) and insoluble (I) fractions for various expression systems. 0, 1/ 
BL21(DE3) (pETDsbA-G); 2/ BL21(DE3) (pETDsbA-G, pARDegP); 3/ BL21(DE3) (pETDsbA-G, 
pARDegPS210A); 4/ BL21(DE3) (pETDsbA-G, pARFkpA); 5/ BL21(DE3) (pETDsbA-G, pARDsbA); 
6/ BL21(DE3) (pETDsbA-G, pARDsbC); 7/ BL21(DE3) (pETDsbA-G, pTUM4). Inducer 
supplementation: 1, 7/ IPTG; 2~6/ IPTG and arabinose. The error bar in Panels A and B represents 
a range of the data variance. 
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Figure 6.4. PalB expression performance for BL21(DE3) (pHisperiMBP-G) and the effect of 
coexpressing various periplasmic folding factors on the expression performance. Panel A: cell 
density and Panel B: specific PalB activity for various expression systems. Panel C: Western 
blotting analysis of the soluble (S) and insoluble (I) fractions for various expression systems. 0, 1/ 
BL21(DE3) (pHisperiMBP-G); 2/ BL21(DE3) (pHisperiMBP-G, pARDegP); 3/ BL21(DE3) 
(pHisperiMBP-G, pARDegPS210A); 4/ BL21(DE3) (pHisperiMBP-G, pARFkpA); 5/ BL21(DE3) 
(pHisperiMBP-G, pARDsbA); 6/ BL21(DE3) (pHisperiMBP-G, pARDsbC); 7/ BL21(DE3) 
(pHisperiMBP-G, pTUM4). Inducer supplementation: 1, 7/ IPTG; 2~6/ IPTG and arabinose. The 
error bar in Panels A and B represents a range of the data variance. 
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Figure 6.5. PalB expression performance for BL21(DE3) (pFlag-P) and the effect of coexpressing 
various periplasmic folding factors on the expression performance. Panel A: cell density and Panel 
B: specific PalB activity for various expression systems. Panel C: Western blotting analysis of the 
soluble (S) and insoluble (I) fractions for various expression systems. 0, 1/ BL21(DE3) (pFlag-P); 2/ 
BL21(DE3) (pFlag-P, pARDegP); 3/ BL21(DE3) (pFlag-P, pARDegPS210A); 4/ BL21(DE3) (pFlag-P, 
pARFkpA); 5/ BL21(DE3) (pFlag-P, pARDsbA); 6/ BL21(DE3) (pFlag-P, pARDsbC); 7/ 
BL21(DE3) (pFlag-P, pTUM4). Inducer supplementation: 1, 7/ IPTG; 2~6/ IPTG and arabinose. 
The error bar in Panels A and B represents a range of the data variance. 
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6.3.2 Effect of Folding Factors on Expression PalB-Fusions  
While these tags appeared to improve the solubility and bioactivity of the expressed PalB, functional 
expression could still be limited by ineffective posttranslational processing in the periplasm, such as 
folding and disulfide bond formation. Coexpression of several periplasmic folding factors, including 
DegP (and its mutant variant of DegPS210A), FkpA, DsbA, DsbC, and a cocktail of SurA, FkpA, DsbA, 
and DsbC, was explored. 
Among the four tags investigated here, DsbC appeared to be the least effective one for assisting 
functional expression of PalB, possibly due to a limited solubility of DsbC-PalB. Nevertheless, the culture 
performance was significantly improved upon coexpression of several periplasmic folding factors and the 
results are summarized in Figure 6.2. The specific PalB activity for the binary-plasmid systems was more 
than 3-fold that of the single plasmid system and the results were consistent with those of Western 
blotting. However, culture performance was limited by physiological stress since cell growth was 
seriously arrested upon coexpression of the periplasmic folding factors, in particular FkpA, DsbA, and 
DsbC. Coexpression of DegP and DsbA appeared to be effective in reducing the formation of inclusion 
bodies. 
The effect of coexpressing periplasmic folding factors on enhancing DsbA-PalB expression 
performance was also noticeable (Figure 6.3). Compared to the single-plasmid system, the specific PalB 
activity was increased by more than 40% upon coexpression of DegPS210A, DsbA, DsbC, and the 
chaperone cocktail without much arrest on cell growth. Nevertheless, there was minimum effect on 
reducing the formation of inclusion bodies by coexpression of periplasmic folding factors. 
MBP appeared to be the most effective tag in solubilizing PalB and inclusion bodies were 
minimally observed upon overexpression of MBP-PalB. The specific PalB activity could be further 
improved without growth arrest by coexpression of periplasmic folding factors except FkpA (Figure 6.4). 
In particular, inclusion bodies were hardly detectable upon coexpression of DegPS210A or DsbA. 
While the specific PalB activity reached a high level of 82 U/liter/OD600 when FLAG-PalB was 
overexpressed, inclusion bodies at a significant amount were observed (Figure 6.5). Compared to the 
single-plasmid system, coexpression of DegP resulted in a slight increase in the specific PalB activity 
with a concomitant decrease in the amount of inclusion bodies. Coexpression of DegPS210A, on the other 
hand, resulted in a slight increase in the specific PalB activity but with a significant increase in the 
amount of inclusion bodies. The results suggest that the DegP protease activity could be responsible for 
in-vivo cleaning up misfolded FLAG-PalB. In general, coexpression of periplasmic folding factors except 
FkpA improved the culture performance. In particular, the specific PalB activity reached 129 
 
            112 
U/liter/OD600 without growth arrest upon DsbA coexpression, resulted in a high volumetric PalB activity 
of 360 U/liter 
6.4 Discussion 
Up to now, it is well recognized that overexpression of bioactive PalB in E. coli remains challenging 
primarily due to intracellular misfolding which demolishes its bioactivity. Though the oxidative periplasm 
theoretically should be more favorable than the reduced cytoplasm for PalB expression, the functional 
expression was ineffective due to the instability of the periplasmic gene products (Chapter 5). In this 
study, four fusion tags were demonstrated to be effective to enhance functional expression of PalB in the 
periplasm with varied efficacies. All these PalB fusions expressed PalB enzyme activity, implying that 
downstream processing to remove these tags is not required for preparing biocatalysts. In addition, the 
functional expression could be further improved by coexpression of periplasmic folding factors. 
DsbA and DsbC play crucial roles in disulfide bond formation in the periplasm of E. coli [40]. With 
certain chaperone activities, the two Dsb-family members were demonstrated to be effective fusion tags 
by increasing the solubility of target proteins, such as bovine enterokinase catalytic subunit [246], 
palmitoyl-tailed helper cytotoxic T-lymphocyte chimeric epitope of respiratory syncytical virus [248], and 
yellow fluorescent proteins [72]. While both DsbA and DsbC tags appeared to be effective fusion partners 
for functional expression of PalB in the periplasm, formation of inclusion bodies was observed. It has 
been reported that 40-kDa MBP, encoded by the malE gene from E. coli, can act as an excellent solubility 
enhancer by enabling the fusion partners to fold into bioactive conformations [86, 137-140], both in the 
cytoplasm (e.g. N-terminal inhibitory domain of human tissue inhibitor of metalloproteinases-2 [139] and 
yellow fluorescent proteins [72]) and the periplasm (e.g. RNaseA [137]). In this study, not only PalB 
activity reached high levels with minimum growth arrest but also the formation of inclusion bodies was 
minimized upon the overexpression of MBP-PalB, implying that MBP was very effective in solubilizing 
PalB for functional expression. However, it appears that the function expression could still be limited by 
the relatively large molecular size of the MBP tag. In contrast, FLAG is a small fusion tag with 
demonstrative applications in protein expression and purification [263, 264]. In this study, FLAG was the 
most effective tag for functional expression of PalB. Formation of inclusion bodies was accompanied by 
the overexpression even though the specific PalB activity was high. The amount of inclusion bodies could 
be reduced by coexpression of several periplasmic folding factors to improve the functional expression.  
It has been widely reported that several periplasmic folding factors can interact with secreted 
proteins to enhance functional expression via improved translocation and/or polypeptide stabilization [88, 
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96, 173, 174, 245]. DegP is a periplasmic heat-shock protein with both protease and chaperone activities 
[183], but primarily acts as a serine protease for breakdown of aberrant periplasmic proteins arising upon 
extracytoplasmic stress [181, 182]. DegPS210A is a mutant variant with DegP protease activity being 
inactivated but chaperone activity being retained [183]. Comparing the contributing effects from DegP 
and DegPS210A in reducing inclusion body formation, DegP appeared to play a role as either protease (for 
DsbC-PalB and FLAG-PalB) or chaperone (for DsbA-PalB and MBP-PalB) in enhancing functional 
expression of PalB. FkpA is another periplasmic heat-shock protein with both cis/trans peptidyl-prolyl 
isomerase (PPIase) and chaperone activities [189, 190, 192] and is capable of reducing the σE-dependent 
response induced by misfolded proteins in the periplasm [179]. However, the effect of FkpA coexpression 
on improving functional expression of PalB was observable only for DsbC-PalB, but not other PalB-
fusions investigated here. Many eukaryotic proteins, including PalB, contain disulfide bonds which often 
mediate the stabilization of folding conformation. It would be advantageous for these proteins to be 
expressed in the oxidative periplasm of E. coli to facilitate disulfide bond formation. With certain types of 
chaperone activities for the two Dsb-family members, DsbA catalyzes direct bridging of disulfide bonds 
in newly translocated proteins, whereas DsbC assists subsequent rearrangement of aberrant disulfide 
bonds [40]. In this study, coexpression of DsbA appeared to be the most effective in reducing the 
formation of inclusion bodies for all the four PalB-fusions, implying that functional expression of PalB 
could be limited by initial bridging of disulfide bonds. On the other hand, coexpression of chaperone 
cocktail (e.g., SurA, FkpA, DsbA, and DsbC) appears to improve functional expression of PalB for all the 
fusions by increasing PalB activities though formation of inclusion bodies was not in particular reduced. 
6.5 Abstract of the submitted paper 
Functional expression of heterologous Pseudozyma antarctica lipase B (PalB) in the periplasm of 
Escherichia coli was explored using four fusion tags, i.e. DsbC, DsbA, maltose binding protein (MBP), 
and FLAG in the sequence of increasing expression efficacy. Amongst these fusion tags, FLAG and MBP 
appear to be the most effective ones in terms of boosting enzyme activity and enhancing solubility of 
PalB, respectively. Overexpression of these PalB fusions often resulted in concomitant formation of 
insoluble inclusion bodies. Coexpression of a selection of periplasmic folding factors, including DegP 
(and its mutant variant of DegPS210A), FkpA, DsbA, DsbC, and a cocktail of SurA, FkpA, DsbA, and 
DsbC, could improve the expression performance. Coexpression of DsbA appeared to be the most 
effective in reducing the formation of inclusion bodies for all the four PalB fusions, implying that 
functional expression of PalB could be limited by initial bridging of disulfide bonds. Culture performance 
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was optimized by overexpressing FLAG-PalB with DsbA coexpression, resulting in a high volumetric 
PalB activity of 360 U/liter.  
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Chapter 7 
Functional Display PalB on the E. coli Cell Surface 
7.1 Introduction 
As described before, whether the PalB was expressed in the cytoplasm or periplasm of E. coli, finally the 
cells need to be collected, lysed, and/or purified before PalB is used as an enzyme to catalyze ester-related 
reactions. Preferably, it could save the effort and the cost for PalB purifications if the enzyme was 
secreted into the extracellular medium or displayed on the cell-surface. Cell surface display is a novel 
technique [91] to display peptides or proteins on the surface of gram-negative [114, 265-267] and gram-
positive [268, 269] bacteria, yeast [270], or even mammalian cells [271] by linking them to surface 
anchoring motifs. Bacterial surface display has found many applications in biotechnology and medicine 
[91, 272], e.g., recombinant enzymes displayed on the bacterial surface and can thus be used as 
biofactories [270, 273, 274], drug delivery of vaccines, antigens or antibodies [275].  
In order to functional display protein on the E. coli cell-surface, usually cell surface displaying 
protein (passenger) needs to be fused to a signal peptide and an anchoring motif (carrier) for the journey 
of translocation of two membranes of E. coli. EstA is an autotransporter protein which consists of an N-
terminal domain harboring the catalytic activity and a C-terminal domain forming a β-barrel-like structure 
inserted into the bacterial outer membrane which mediates the translocation of the N-terminal domain 
(Figure 7.1) [114, 269]. pEst100-FSCut contains the coding sequence for the signal peptide of E. coli 
alkaline phosphatase (phoA) under control of the Plac promoter, followed by the coding sequence of a 
linker peptide, which for inserting the passenger protein, an E-tag epitope, and EstA. YFP and EYFP were 
functionally displayed on E. coli cell surface by using this displaying vector in this lab recently [118, 
276]. 
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Figure 7.1 Schematic drawing of the autotransporter EstA construct used in this study for the 
displaying PalB on E. coli cell surface (modified after [114, 269]). 
 
The displayed protein’s sizes seemed not a big problem, it can be from 10 to 15 amino acids-long 
antigens for vaccines [275], or full size protein of up to 613 amino acids [114]. However, the cell bearing 
severe stresses become a challenge for applying display technology, especially for gram negative bacteria, 
e.g., E. coli [118]. There are also many unclear factors which influence functional display, e.g., the 
passenger protein is unfolded [117], partially folded or completely folded [277, 278] before translocated 
out of the periplasm of E. coli; or the displayed protein is tightly anchored, or cleaved after translocation 
and released in the extracellular milieu [269]. 
Displaying PalB on the cell surface was an experiment for proof of concept, we could not do a 
widely searching for the best expression system, but displaying a plasmid, which we had in this lab. In 
this study, palB was constructed into the display vector pEst100-FSCut and PalB displaying on E. coli 
cell surface was conducted. Upon the predictable cell stresses due to the PalB displaying and disulfide 
bond effect on the PalB expression, coexpression of various periplasmic folding factors were also 
investigated. 
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7.2 Materials and Methods 
7.2.1 Strains and Plasmids 
The strains, plasmids and oligonucleotides used in this study are summarized in Table 7.1 and briefly 
described here. JM109 was used as the host strain for PalB cell surface display and XL10-Gold® was used 
for cloning host. Molecular cloning protocols and the chemicals were used as described in Chapter 3.  
 




Relevant genotype or phenotype^ Source and 
reference 
E. coli   
   ER2925 Ara-14 leuB6 fhuA31 lacY1 tsx78 glnV44 galK2 glaT22 
mcrA dcm-6 hisG4 rfbD1 R(zgb210::Tn10) TetS endA1 
rpsL136 dam13::Tn9 xylA-5 mtl-1 thi-1 mcrB1 hsdR2 
NEB [279] 
   DH5α F'/(φ80 lacZ ΔM15) Δ(lacZYA-argF)U169 deoR recA1 
endA1 hsdR17 (rK-, mK+) phoA supE44 λ-thi-1 gyrA96 
relA1 
Lab stock [257] 
   JM109 F′ traD36 proA+B+ lacIq Δ(lacZ)Μ15/ Δ(lac-proAB) 
glnV44 e14- gyrA96 recA1 relA1 endA1 thi hsdR17 
Lab stock [63] 
   XL10-Gold® TetR Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 
supE44 thi-1 recA1 gyrA96 relA1 lac Hte [F’ proAB 
lacIqZΔM15 Tn10 (TetR) Amy CmR] 
Stratagene 
P. antarctica   
   ATCC 32657 The source of palB gene ATCC 
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Plasmid   
   pACYC177 A cloning vector, Ori (pACYC184), KnR, CmR Lab stock [280] 
   pARDegP ParaB::degP, Ori (pACYC184), CmR This lab [187] 
   pARDsbA ParaB::dsbA, Ori (pACYC184), CmR This study 
   pARDsbC ParaB::skp, Ori (pACYC184), CmR This study 
   pARFkpA ParaB::fkpA, Ori (pACYC184), CmR This lab [195] 
   pARSkp ParaB::skp, Ori (pACYC184), CmR This lab [118] 
   pARSurA ParaB::surA, Ori (pACYC184), CmR This lab  
   pEst100-FSCut Plac::cut::estA, Ori (pBR322), CmR H. Kolmer [114] 
   pESTKnN Plac::palB::estA, Ori (pBR322), KnR This study 
   pESTCmN Plac::palB::estA, Ori (pBR322), CmR This study 
Oligonucleotide   
   P12 5'-CCGGCCCAGCCGGCCCTACCTTCCGGTTCGGACCCTGCC-3' This study 
   P20 5'-CTGGCCCCCGAGGCCGGGGTGACGATGCCGGAGCAG-3' This study 
^ Designed restriction sites are underlined and the introduced mutations are in italic. 
 
The plasmid, pESTCmN and pESTKnN, were used to display PalB on E. coli cell surface. To 
construct the plasmid pESTCmN, the palB gene was PCR-amplified using P. antarctica chromosomal 
DNA as the template, P12 and P20 as the primers, and Pfu polymerase (Stratagene). The PCR products 
were cloned into pPCRScript® (Stratagene). DNA sequencing was performed to ensure that no mutations 
occurred during PCR. The palB-containing DNA fragment was purified and digested with SfiI, gel 
extracted and ligated to the SfiI digested fragment of pEst100-FSCut (H. Kolmer [114]) to obtain 
pESTCmN in which palB under the control of Plac promoter and the plasmid had a CmR marker. In order 
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to make it compatible with the periplasmic folding factors which are also CmR marker, the CmR marker 
was replaced by KnR. To do so, Kn fragment was obtained from pACYC177 [280] by digesting with StuI 
to make a blunt cut at both ends. In order to avoid the Dcm methylation at the two StuI sites, the plasmid 
pACYC177 was isolated from ER2925 [279], a dam mutant strain. pESTCmN was digested by ScaI 
which located in the CDS fragment. The 1.3-kb KnR cassette and 6.8-kb pESTCmN were gel-extracted 
respectively and were ligated together to form pESTKnN (Figure 7.2). The coexpression periplasmic 
folding factors containing a selection of folding gene(s) were derivatives of pAR3 [233]. pARDegP [187], 
pARDsbA (this study, Chapter 5), pARDsbC (this study, Chapter 5), pARFkpA [195], pARSkp [118], 
pARSurA (lab stock) contain the gene of degP, dsbA, dsbC, fkpA, skp, surA, respectively, fused with the 
araB promoter. Plasmid pESTKnN has a pBR322 replication origin and a KnR marker and is, therefore, 
compatible with all the folding-factor-gene-containing plasmids having a pACYC184 replication origin 
and a CmR marker.  
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Figure 7.2 Depict of construction of PalB cell surface display plasmid pESTKnN from pESTCmN. 
The palB gene was under the control of Plac promoter and inserted between signal peptide phoA and 
carrier estA. f1 Ori, f1 replication origin; colE1, ColE1 replication origin; P15A ORI, P15A 
replication origin; cat, chloramphenicol resistance marker; Kn(R), kanamycin resistance marker; 
Apr, ampicillin resistance marker. BamHI, HindIII, PstI, ScaI, SfiI, and StuI are restriction 
enzymes for DNA digestion. 
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7.2.2 Cultivation 
The cultivation procedure was identical with the procedure described in Chapter 3, except the overnight 
culture was incubated at 32 °C and the culture was incubated at 28 °C after inoculated with 1 ml of 
overnight seed culture. 
7.2.3 Sample Preparations 
Three culture samples equivalent to 1.0 OD600 unit each were centrifuged at 6000 × g for 5 min at 4 °C.  
For preparing the sample to estimate the lipase activity, the supernatant from the culture sample 
tube and the pellet was resuspended in 1 ml of PBS buffer were used as the supernatant (1.0 OD600 unit) 
and whole cell sample (1.0 OD600 unit), respectively. 
For immunogold labeling, the pellet from a culture sample tube was resuspended in 100 μl PBS 
buffer (1.0 OD600 unit). A formvar-coated nickel grid was placed with the coating side facing down on the 
surface of a drop (100 μl) of the cell suspension on a parafilm sheet for approximately 10 min. The grid 
was blotted dry and placed on a drop of PBS with 0.3% skim milk powder as a blocking agent for 20 min. 
The grid was incubated in the blocking agent containing the primary antibody (e.g., anti-PalB rabbit, 
diluted in 1/50) for 1 h. The grid was washed with drops of the blocking agent 3 times for 2 min each. 
The grid was incubated on a drop of the secondary antibody (e.g., goat anti-rabbit IgG conjugated with 
gold from Sigma, diluted in 1/50 in DI water) for 1 h. The grid was washed completely with drops of PBS 
3 times for 2 min each, and then washed with DI water 4 times. The grid was stained with 2% aqueous 
uranyl acetate for 1 min and washed with DI water for 1 min. The grid was air-dried and was ready for 
observation under a transmission electron microscope (TEM). All the steps were followed by intermediate 
blot drying of grids on a filter paper. 
7.2.4 Analytical Methods 
PalB assay followed exactly the procedures as described in Chapter 3. For the qualitative visualization of 
PalB activity in the tributyrin plate the samples of supernatant and whole cells were used at 25 µl (0.025 
OD600 unit) and 5 µl (0.005 OD600 unit) respectively. For the pNPP assay the sample of whole cells was 
used at 100 µl (0.1 OD600 unit). 
Immunogold labeling was observed under TEM (Philips CM10, Eidenhoven, Netherlands) in the 
Biology Department at University of Waterloo. 
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7.3 Results 
7.3.1 PalB Displaying on Cell surface of E. coli 
PalB displaying on cell surface of E. coli was conducted by using DH5α (pESTCmN) and JM109 
(pESTKnN) as the host/vector systems under various IPTG inducer concentration conditions and the 
results are summarized in Table 7.2 and Figure 7.3 and 7.4. The cells had been stressed even without 
IPTG supplementation. After induction the stress situation became much worse, and cell growth was 
significantly inhibited due to physiological deterioration. Especially for JM109 (pESTKnN) system, the 
cell densities stayed at the same low value with various IPTG concentration, indicating that the cell could 
not bear the PalB display with even a very mild IPTG induction. It seemed that the DH5α system was 
better than the JM109 system, not only the cell density was higher during the low IPTG concentrations 
(Table 7.2), but also the PalB activity was better for whole cell and lower for supernatant samples 
indicating the PalB was not cleaved and released into medium (Figure 7.3). Unfortunately, due to the low 
PalB activity in the pNPP assay and the limitation of the measurement, the spectrophotometric reading at 
OD410could not be matched well with the PalB activity (data not shown). The result of TEM (Figure 7.4) 
confirms that PalB was successfully displayed on E. coli cell surface albeit at a relatively low level. In 
addition, the pESTCmN has the same resistance marker (CmR) with the plasmids for expressing the 
periplasmic folding factors, therefore, the following coexpression of folding factors were only studied in 
the JM109 (pESTKnN) display system.  
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Table 7.2 Comparison of the performances of PalB displayed on cell surface of DH5α (pESTCmN) 
or JM109 (pESTKnN) under various IPTG inducer concentrations at 28 °C 
IPTG (mM) 0 0.05 0.1 0.2 0.5 1 
Cell Density (OD600) 1&6 2&7 3&8 4&9 5&10 
DH5α 2.98±0.10*      
DH5α (pESTCmN) 2.35±0.10 1.72±0.02 1.35±0.08 1.11±0.10 1.04±0.05 0.99±0.10 
JM109 2.93±0.10     
JM109 (pESTKnN) 1.36±0.05 1.08±0.04 1.09±0.07 1.10±0.09 1.09±0.05 1.07±0.08 
* Indicates the range of OD600 variance of samples taken from three different flasks for the same 




Figure 7.3 Qualitative visualization of PalB activity by using tributyrin plate. The area and 
intensity of the halo corresponding to the lysate sample correlates with the PalB expression level. 
The samples of PalB displaying on E. coli cell surface at various IPTG inducer concentration 
conditions were presented for DH5α (pESTCmN) system (Panel A) and JM109 (pESTKnN) system 
(Panel B). IPTG inducer concentration supplementated in the systems were 1&6/ 0.05 mM; 2&7/ 
0.1 mM; 3&8/ 0.2 mM; 4&9/ 0.5 mM; and 5&10/ 1 mM. Sn, Supernatant sample; W, whole cell 
sample. 
 




Figure 7.4 Results of TEM for immunogold labeling of displayed PalB on E. coli cell-surface. The 
black dots represent the gold particles conjugated with the displayed PalB. Panel A/ JM109; Panel 
B/ JM109 (pESTKnN) induced with 0.05 mM IPTG. A typical picture was taken after visualizing 
the overall images of the cells under TEM. 
 
7.3.2 Coexpression of Periplasmic Folding Factors Improved PalB Display Performance 
Using JM109 (pESTKnN) as the host/vector system for studying the improvement of PalB displaying on 
cell surface with coexpression of the periplasmic folding factors were conducted, and the PalB display 
performances are summarized in Table 7.3 and Figure 7.5 and 7.6. Compared to the individual display 
systems, the cells became unhealthy to some extent after induction at 0.05 mM IPTG and/or 1 g/liter 
arabinose supplementation at 28 °C. However, the folding factors in the test, except Skp, showed 
significant improvement of cell survival (Figure 7.5) and growth (Table7.3) after IPTG-induction. The 
TEM results in Figure 7.6 showed the improvement of PalB display with coexpression of the folding 
factors. It did not show any enhancement for PalB display with coexpression of DegP (Panel E in Figure 
 
            125 
7.6) and Skp (Panel F in Figure 7.6), so good cell surfaces were kept for the cells in these two systems. 
The presence of SurA (Panel A in Figure 7.6) not only improved the display, but also the cell physiology, 
which indicated by more gold dots on the surface and an almost healthy cell surface. A better PalB 
display was shown for coexpression of FkpA (Panel B in Figure 7.6) and DsbC (Panel D in Figure 7.6), 
but poor cell surface. The best PalB display was shown with DsbA coexpression. Cell growth was 
recovered and individual cell appeared to be more robust for display PalB which indicated by high density 
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Table 7.3 PalB display performances with coexpression of the periplasmic folding factors  
 
* 0.05 mM IPTG and/or 1 g/liter arabinose was supplementated in the system for induction of 
PalB display and/or coexpression of folding factors, respectively, at 28 °C. 
# the range of OD600 variance of samples taken from three different flasks for the same expression system.  
 
 
Figure 7.5 Qualitative visualization of PalB activity by using tributyrin plate. The area and 
intensity of the halo corresponding to the lysate sample correlates with the PalB expression level. 
The samples of PalB displaying on E. coli cell surface with various periplasmic folding factors 
(Table 7.3) were presented: Supernatant sample (Panel A), and whole cell sample (Panel B). The 
coexpressed folding factors were 1/ -, control; 2/ DegP; 3/ FkpA; 4/ SurA; 5/ Skp; 6/ DsbA; and 7/ 
DsbC. 8/ JM109and 9/ DH5α in Panel B, respectively, were for negative control. 
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Figure 7.6 Results of TEM for immunogold labeling of displayed PalB on E. coli cell surface using 
JM109 (pESTKnN) as the displaying host/vector system with coexpressed various periplasmic 
folding factors: Panel A/ SurA; Panel B/ FkpA; Panel C: DsbA; Pane D: DsbC; Pane E: DegP; and 
Pane F: Skp. The culture was supplemented with 0.1 mM IPTG and 1 g/liter arabinose. Note that 
the density of the black dots, representing the gold particles conjugated with the displayed PalB. A 
typical picture was taken after visualizing the overall images of the cells under TEM. 
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7.4 Discussion 
Although it looked like the host strain was sensitive, e.g., JM109 was poorer than DH5α, it is the fact that 
displaying PalB on E. coli surface resulted in a detrimental effect on cell physiology, indicating in growth 
arrest and poor display performance. The main reasons are (i) E. coli is not a good secretion host [38]; 
and (ii) in order to reach its destination, the cell surface displaying protein needs to maintain the export-
competent form (no spontaneous folding) for efficiently crossing two membranes (the cytoplasmic and 
periplasmic membrane) [117]. The first obstacle could be minimized by choosing a signal peptide and 
coexpression the periplasmic folding factor. The second one is much harder because it does not depend on 
the carrier but the passenger protein properties. For example, the disulfide bonds could not be formed 
without the assistance of Dsb-family protein, e.g., DsbA [40, 105]. In fact, about this “unfolded and 
devoid of disulfide bonds passenger before translocation” hypothesis was debated and proved wrong 
[277, 278]. Fortunately, we had proved that although the disulfide bond formation was not critical for 
PalB activity (Chapter 3), the disulfide bond formation did improve PalB activity (Chapter 4, 5, and 6). 
The PalB was functionally displayed in E. coli cell surface and highly improved by DsbA coexpression 
indicating PalB was formed 3-D structure before it was secreted out of E. coli. It may need to further 
approve the PalB really displayed on the cell surface by conducting experiments such as trypsin digestion 
or EDTA and SDS sensitivity tests, but a positive feedback for cell surface displayed PalB used as a 
biocatalyst had given in a study conducted by a master student in this lab [276]. In addition, the PalB cell 
surface displaying on E. coli is an experiment proving a concept in this study. The presences of DsbA and 
DsbC showed the positive effects on the PalB expressions in the cytoplasm of a mutant E. coli strain, in 
the periplasm of the regular E. coli host, and cell surface displayed PalB on E. coli, indicating disulfide 
bond is, if not critical, essential for functional PalB formation. In this chapter, it was proved again that the 
presence of DsbC was not crucial as DsbA because the rather simple disulfide bond formation in PalB, 
e.g., three distant consecutive disulfide bonds (even may not be needed all of them). 
Skp is a well characterized periplasmic chaperone that interacts with unfolded proteins translocated 
into the periplasm via the Sec secretion system [179] and is under the control of both σE and Cpx stress 
response systems [178]. Skp has been shown to improve the folding of recombinant proteins or antibody 
fragments in the periplasm of E. coli [111, 203-205]. Skp showed a good enhancer for YFP display on the 
cell surface of E. coli host JM109 [118]. However, the effect of Skp on the increase in the solubility and 
prevention of the premature folding of periplasmic carrier-passenger fusions could not resolve PalB 
folding problem, which needed specific assistance for disulfide bonds formation. 
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DegP is an inducible serine protease activity for breakdown of aberrant periplasmic proteins arising 
upon extracytoplasmic stresses [181, 182] and its expression can be activated via both σE and Cpx 
pathways [121]. It is reputed for improving the periplasmic protein expression by relieving the 
extracytoplasmic stress upon overexpression of several periplasmic gene products, such as alkaline 
phosphatase (PhoA) [184], DsbA’-PhoA [259], MalS [183], OmpF mutants [260], maltose-binding 
protein (MBP or MalE) variants [179, 261], penicillin acylase [187], and PalB expression in the periplasm 
of E. coli (in Chapter 5 and 6 in this study). However, until now there is no evidence of a direct effect of 
DegP in the productive folding of OMPs in vivo and in vitro [173]. That is not surprised for seeing the 
cell physiology improvement but not any enhancement of PalB cell surface display when coexpressed 
with DegP. 
Probably due to both FkpA and SurA having chaperone as well as PPIase activity and relate to σE 
cell tress response, they showed similar [179], but different effects [173]. Coexpression of FkpA, but not 
SurA, increased the amount of fusion protein displayed on the phage and improved single chain antibody 
fragment expression in the periplasm [193, 194]. SurA null mutants showed decreased levels of properly 
folded OMPs [208, 209], however, FkpA did not showed specific assistance for the folding of OMPs 
[173]. They were believed to be most important folding factors in the periplasm of E. coli [258]. The best 
assistant for EYFP cell surface display was reported from FkpA coexpression among the six investigated 
folding factors, e.g., DegP, DegQ, DegS, SurA, DsbA and DsbC [276]. In this study, the presence of both 
FkpA and SurA showed much similar effect on the cell surface displayed PalB in E. coli, but SurA 
seemed more efficient for releasing cell stresses and preventing the cell burst.  
In a summary, cell surface displayed PalB caused severe cell stresses on E. coli. The whole cell 
biocatalyst concept is impressive, but maybe other displaying hosts, e.g., gram-positive bacteria, or yeast, 
are more attractive for cell surface display. However, this topic is beyond the scope of this study and will 
not be discussed further.  
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Chapter 8 
Original Contributions and Recommendations 
8.1 Original Contributions to Research 
Identified Limiting Factors of PalB Expression in the Cytoplasm of E. coli 
Lipase B from Pseudozyma antarctica (PalB) was actively expressed in the reduced cytoplasm of a 
regular Escherichia coli strain of BL21(DE3), implying that disulfide bond formation was not strictly 
required for functional expression. However, the expression was ineffective and was primarily limited by 
the formation of PalB inclusion bodies and growth arrest, both of which were associated with PalB 
misfolding and deteriorated physiology. The culture performance in terms of cell growth and PalB 
expression level could be significantly improved by simultaneous coexpression of multiple chaperones of 
TF and GroEL/ES, but not by individual coexpression of either one of them. It was proposed that the two 
chaperones mediating the early stage and late stage of cytoplasmic PalB folding would be required 
simultaneously for boosting both the overall PalB synthesis rate and the cytoplasmic folding efficiency. 
Addition of Fusion Tag improving the solubility but only DsbA tag improved bioactivity of PalB 
The cytoplasmic expression of PalB ended up with insoluble inclusion bodies and the unstable PalB 
showed the direct expression of the PalB in the periplasm requires improvement. By the addition of 
fusion tag at the N-terminus of PalB, the cell’s physiology and the solubility and bioactivity of PalB were 
surprisingly improved in both the oxidized cytoplasm and periplasm. In addition, the PalB fusions (e.g., 
DsbA-PalB in the oxidized cytoplasm and Flag-PalB in the periplasm) showed high bioactivities. This 
offers a possibility for reducing the cost of biocatalyst production by (i) directly using the PalB fusion as 
enzyme, or (ii) based on the tag’s affinity property to search for carriers in the immobilization process. 
Folding Factors and Fusion Tag Rescuing Unstable PalB and Enhancing its Expression in the 
Periplasm of E. coli 
Functional expression of recombinant PalB in E. coli was explored. While PalB was stably expressed in 
the cytoplasm, most of the expressed gene product aggregated in cells as inactive inclusion bodies. In 
contrast, PalB was extremely unstable when expressed in the periplasm, also leading to poor expression 
performance. Such unstable PalB can be rescued either by the coexpression of several periplasmic folding 
factors, such as DegP, FkpA, DsbA, and DsbC, or by adding fusion tag. As a result, the performance for 
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functional PalB expression in the periplasm was significantly improved. The overall improvement 
reached 40-fold. 
PalB Displayed on Cell surface and its Potential Use in the Whole Cell Immobilization 
When PalB displayed on E. coli cell surface, the cell physiology seriously deteriorated resulting in growth 
arrest, cell lysis and poor display performance. Due to the cultivation condition being too harsh for cell 
surface display (0.05 mM IPTG, 28 °C, 200 rpm, same as other shake-flasks experiments), all the folding 
factors showed limited improvements of either the physiology or in the density of surface-displayed PalB. 
Amongst the folding factors tested, DsbA showed much better assistance than others in improving the 
density of surface-displayed PalB. After immobilization of the whole surface-displayed PalB cells, the 
lipase activity was demonstrated by the lipase enzymatic assay reaction and reached a half of the 
commercial immobilized PalB. This illustrated the feasibility of whole cell PalB immobilization. 
Disulfide bonds’ functions in PalB 
Disulfide bond(s) may not be critical for PalB activity, but disulfide bond formation enhanced PalB 
formation and thus improved PalB activity, which was enhanced by the coexpression of DsbA with PalB 
or addition DsbA-tag to the N-terminus of PalB in the oxidized cytoplasm or the periplasm. 
8.2 Recommendations 
Regarding further improvements in engineering a robust strain and optimizing the cultivation process, 
future studies are recommended on PalB which include the following topics. 
Genetic Engineering PalB Suitable for Expression in E. coli 
Although palB was expressed in E. coli systems, all the various strategies used could not effectively 
overcome either low expression, or huge amount of inclusion bodies due to PalB natural property, e.g., 
cold lipase, three disulfide bonds and a quite hydrophobic surface. Based on systematic studies, the 
disulfide bonds were suspected to constrain PalB bioactivity. Due to technical limitations, the effect of the 
Dsb catalysts on the PalB expression was not completed in this study. After obtaining the plasmid 
DsbABCD set [212, 245], it is necessary to screen in detail the effect of Dsb catalyst on PalB expression. 
Removing useless disulfide bond(s), or at least two of them (e.g., N-terminus and C-terminus ones, far 
from the enzymatic active site) could improve PalB expression in E. coli. In addition changing some 
amino acids on the surface of PalB could reduce its hydrophobicity and also improve PalB expression. 
These studies can be done by site-directed mutagenesis. 
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Some lipase-producing bacteria express lipase with a specific intermolecular chaperone Lif (lipase-
specific foldase) for lowering the energetic barriers during lipase folding [281]. One should try to find 
another way for improving the PalB expression in E. coli. 
Genetic Screening of PalB Suitable for Biodiesel Production 
Although the catalytic mechanism for transesterification has not been studied extensively, it is believed to 
be similar to that for hydrolysis [282] except that the water molecule is replaced by a short-chain alcohol. 
It has been found in biodiesel production that one of the substrates e.g., methanol, tends to inhibit or 
denature immobilized PalB, resulting in a reduced product yield and even a permanent damage of 
biocatalysts [11]. In practical application, methanol is slowly or stepwise added to the bioreactor to 
minimize this inhibition effect [11]. Another substrate, methyl acetate, has been used as an acyl acceptor 
to avoid the above methanol effect [283], but the cost of this substrate might be prohibitive for large-scale 
production. Methods for pretreatment or regeneration of biocatalysts were also proposed [23]. From a 
process viewpoint, it will be of economical benefit to genetic engineer a robust palB that is resistant to 
methanol inhibition. 
The exact mechanism of methanol inhibition of PalB is unclear. On the basis of its protein structure 
[221, 222, 228], a restricted entrance into the active site was proposed for its substrate specificity and high 
degree of stereospecificity. It is believed that the presence of methanol blocks the primary substrate (e.g., 
triglyceride) from entering the active site. On the other hand, there are several microbial lipases that are 
more methanol-resistant though their transesterification activities might not be as effective as that of 
PalB. For example, methanolysis using C. rugosa and P. fluorescens lipases can be activated by the 
surrounding water, implying that water can potentially prevent the inactivation of these lipases by 
methanol [10]. Also, lipases from P. cepacia [10] and Candida parapsilosis [284] activated by a 
minimum amount of water activity exhibit a potential resistance to methanol upon methanolysis. 
Analyzing the protein sequences of these lipases would shed light on developing genetic strategies for 
designing methanol-resistant lipases. Gene shuffling involving the wild-type or mutant PalB [285] and the 
above methanol-resistant lipases can be explored by constructing hybrid lipase variants with the desired 
properties for biodiesel production. Digesting and reassembling the DNA region corresponding to lipase 
B genes will be conducted to generate random mutations. In addition, error-prone polymerase chain 
reaction (PCR) will be used to generate mutations particularly in the domain near the substrate binding 
site. Directed evolution [286] will also be possible for searching PalB variants resistant to methanol 
inhibition and it will be critical to establish an effective system for high-throughput screening of lipase 
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mutants. Similar genetic approaches were previously made for improving the thermal inactivation for 
PalB [27, 227].  
Optimization of Cultivation Condition for PalB Production 
Cultivation condition is very important for developing a high yield process. By using a bioreactor with 
fully controlled pH, dissolved oxygen (DO), temperature, the cell stress from the environmental effects 
will be mitigated. Various culture parameters, such as medium recipe, pH, dissolved oxygen (DO), 
temperature, and induction conditions could be evaluated to optimize culture performance for 
simultaneous high-level PalB gene expression and high-cell-density cultivation using developed 
host/vector systems.  
A product oriented approach is proposed for modeling the cell specific productivity of E. coli. In 
order to get the feasibility evaluation, a simple, time honored modeling approach could be applied [287]. 




 , to the specific growth rate and 
biomass concentration as follows: 
 





                                                                                                (1) 
where: 
X = biomsss concentration (g/liter) 
P = PalB concentration (g/liter) 
α = growth associated productivity constant 
µ = specific growth rate (h-1) 
β = non-growth associated productivity constant 
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Immobilization of PalB Fusion or Cell surface Displayed PalB 
Reducing manufacturing and processing costs is a big challenge for biocatalysts competing with chemical 
catalysts. From the results obtained in this study, it is possible to reduce the cost by directly using PalB 
fusion or cell surface displayed PalB in an immobilization process. The study of the enzyme 
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Appendix A 
DNA Sequencing Results 
A1. DNA Sequencing for pPCRScriptAmpDsbA 
An “A” at 3’-end of HindIII side was missed in pPCRScriptAmpDsbA, but it doesn’t affect the 
translation of DsbA in the expression vector pARDsbA. 
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A2. DNA Sequencing for pPCRScriptAmpDsbC 
pPCRScriptAmpDsbC is missing AAG at 3’-end of HindIII side, but doesn’t affect the translation of 
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A3. DNA Sequencing for pPCRScriptAmpllDsbA 
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A4. DNA Sequencing for pPCRScriptAmpllDsbC 





A5. DNA Sequencing for PCR Product of palB without Restriction Sites 
There were 9-codon differences between PCR product of palB and the documented sequence. But 
comparing the different PCR products for different constructions, all these differences are almost the 
same. Therefore, these “mutations” might come from either the host ATCC 32457, or the typos in the 
documentation. Even if these mutations were real, they could not change amino acids because they are all 
silent mutations. 
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A6. DNA Sequencing for pPCRScriptAmpG 
Sequencing is OK, even though the 3’ end is wrong, which does not affect the palB (g) in frame and the 
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A7. DNA Sequencing for pETknL 
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A8. DNA Sequencing for pGEXC4S-M 
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A9. DNA Sequencing for pPCRScriptAmpN 
PCR product of palB(n) is sequenced correctly. 
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A10. DNA Sequencing for pPCRScriptCmO 
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A11. DNA Sequencing for pPCRScriptAmpP 
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Appendix B 
DNA Gel Results for PalB Expression Plasmid 
In order to construct PalB expression plasmid, different PCR products of palB, named G~P, respectively, 
were required to fit into the specific expression vectors. PCR product of palB, G, was also used for PalB 








1 G P10, P11 NcoI-EcoRI The 3’-end was wrong, but does not 
affect protein expression 
2 L P17, P11 NdeI-EcoRI Sequenced correctly 
3 I P14, P11 XmaI-EcoRI  
4 M P15, P19 EcoRI-XmaI Sequenced correctly  
5 N P12, P20 SfiI-SfiI Sequenced correctly 
6 H P12, P13 SfiI-SfiI  
7 O P10, P22 NcoI-SacI Sequenced correctly 
8 P P23, P11 XhoI-EcoRI Sequenced correctly 
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Figure B.3 Restriction analysis of pTrcG  
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Figure B.5 Restriction analysis of pRset-G 
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Figure B.7 Restriction analysis of pT7PK-G 
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Figure B.9 Restriction analysis of pGST-G 
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Figure B.11 Restriction analysis of pMBP-G 
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Figure B.12 Restriction analysis of pHMBP-G 
 
 
Figure B.13 Restriction analysis of pNusA-G 
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Figure B.15 Restriction analysis of pTRX-G 
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Figure B.17 Restriction analysis of pHisperiMBP-G 
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Figure B.19 Restriction analysis of pETDsbA-G 
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Figure B.21 Restriction analysis of pPCRSciptAmpM 
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Figure B.22 Restriction analysis of pGEXC4SM 
 
 
Figure B.23 Restriction analysis of pPCRScriptAmpI 
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Figure B.25 Restriction analysis of pPCRScriptAmpL  
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Figure B.26 Restriction analysis of pETKnL  
 
 
Figure B.27 Restriction analysis of pETL  
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Figure B.29 Restriction analysis of pETDsbC-O  
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Figure B.31 Restriction analysis of pPCRScriptAmpP 
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Figure B.33 Restriction analysis of pPCRScriptAmpN  
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Figure B.35 PCR products for construction of chaperones pARDsbA, pARllDsbA, pARDsbC, 
pARllDsbC  
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Figure B.37 Restriction analysis of pARDsbA  
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Figure B.38 Restriction analysis of pPCRScriptAmpllDsbA  
 
 
Figure B.39 Restriction analysis of pARllDsbA  
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Figure B.40 Restriction analysis of pPCRScriptAmpDsbC  
 
 
Figure B.41 Restriction analysis of pARDsbC  
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Figure B.42 Restriction analysis of pPCRScriptAmpllDsbC  
 
 
Figure B.43 Restriction analysis of pARllDsbC   
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Appendix C 
Protocols for Molecular Cloning 
C1. Isolation of Genomic DNA of Pseudozyma antarctica  
from strain ATCC 32657 (DNeasy® Tissue Kit Catalog no. 69504, Qiagen) 
1. Harvest ATCC 32657 cells from 1 ml of overnight culture (at 30 °C, 220 rpm) by centrifuging for 10 
min at 5000 × g, at room temperature. Discard the supernatant. 
2. Resuspend the cells in 600 μl of 1 M sorbitol buffer. Add 200 units lyticase and incubate at 30 °C for 
30 min.  
3. Spin down spheroplasts at 300 × g for 10 min. 
4. Resuspend the spheroplasts in 180 μl of Buffer ATL. Add 20 μl of proteinase K, vortex, and incubate 
at 55 °C in a shaking water-bath until the cells are completely lysed. 
5. Vortex for 15 s. Add 200 μl of Buffer AL to the sample, vortex, and incubate at 70 °C for 10 min. 
6. Add 200 μl of ethanol (96~100%) to the sample, and vortex. 
7. Pipette the mixture from Step 6 into the DNeasy Mini-spin column placed in a 2 ml collection tube. 
Centrifuge at 6000 × g for 1 min. Discard the flow-through with the collection tube. 
8. Place the DNeasy column in a new 2 ml collection tube, add 500 μl of Buffer AW1, and centrifuge at 
6000 × g for 1 min. Discard the flow-through with the collection tube. 
9. Place the DNeasy in a new 2 ml collection tube, add 500 μl of Buffer AW2, and centrifuge at 15000 × 
g for 5 min to dry the DNeasy membrane. Discard the flow-through with the collection tube. 
10. Place the DNeasy column in a clean 1.5 ml microcentrifuge tube, and pipette 200 μl of Buffer AE 
directly onto the membrane. Incubate at room temperature for 1 min, and then centrifuge at 6000 × g 
for 1 min to elute. 
11. Use the Nanodrop® spectrophotometer to measure the DNA’s concentration, label the sample’s name 
and concentration on the surface of the tube, and store it in -20 °C freezer. 
 
C2. DNA Restriction Digestion 
1. For analysis purpose, set up the reaction mixture in a microcentrifuge tube as follows: 
 
DI Water                  To make up the mixture to 10 µl 
Reaction Buffer  10 X 1 X 1 µl 
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DNA  50-500 ng/µl 50~100 ng/µl y µl 
Restriction Enzyme  1000 U/μl# ~1 U 1 µl# 
 
# The restriction enzymes should be diluted with the appropriate diluents buffer to 1 U/μl.  
* For most of the commercial enzymes, 1 Unit of enzyme is defined as the amount required digesting 
1µg of DNA in 1 h at 37 °C. 
To extract DNA from agarose gel, the amount of DNA can go up to 1 μg per 20 μl of total solution, the 
amount of restriction enzyme is about 5~8 U/μg DNA, and the incubation time is about 2 h, or even 
overnight.  
 
2. Mix the ingredients by pulse-spinning the microcentrifuge tubes. 
3. Incubate the reaction solution at 37°C (or other recommended temperature for specific restriction 
enzymes) for at least 1 hr. 
 
C3. DNA Gel Electrophoresis Analysis 
Stock Solution 
0.5M EDTA, pH 8.0, stored at room temperature 
1. Dissolve 14.61 g EDTA (MW=292.2) into 80ml DI water 
2. Adjust the pH to 8.0 with NaOH and Add DI water to the final volume of 100 ml. 
3. Autoclave the solution for 25 min. 
50X TAE buffer, pH 8.3, stored at room temperature 
1. Dissolve 48.44 g Tris Base (MW=121.1) in 150ml DI H2O 
2. Add 11.42 ml of glacial acetic acid and 20 ml of 0.5 M EDTA (pH 8.0) solution  
3. Add DI H2O to the final volume of 200 ml 
10 mg/ml Ethidium Bromide (EtBr), stored at room temperature 
1. Mix 1 g EtBr with 100 ml DI H2O by stirring on a magnetic stirrer until the dye has been 
completely dissolved. 
2. Wrap the bottle in aluminum foil. 
10X DNA Sample Loading Dye 
1. Mix 5 ml glycerol, 25 μl bromophenol blue and 25 μl xylene cyanole FF.  
2. Add 1 X TAE buffer to the final volume of 10 ml. 
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Procedures  
1. Add 6 ml 50 X TAE buffer into 294 ml DI H2O (300 ml of 1 X TAE buffer). For gel extraction 
purposes, adjust the pH of running TAE buffer with 3M Sodium Acetate buffer (pH 5.2) to less 
than 7.5. Otherwise don’t need to adjust pH before use. 
2. In separate beaker, add 0.225 g of agarose into 30 ml of 1 X TAE buffer. 
3. Assemble the UVTP gel tray on the gel caster properly. 
4. Boil the agarose solution. Pour the agarose solution (~50 ºC) into the tray with comb pre-inserted. 
5. Take out the comb until the gel completely solidified and put the tray into electrophoresis 
apparatus. 
6. Pour 1 X TAE buffer till the level is about 2~4 mm above the gel. 
7. Add 1 μl loading buffer to each DNA sample and mix by pulse-spinning. 
8. Load DNA samples. 
 
Table 1: Well Volume Capacity 
Well Number Thickness (mm) Well Width (mm) Well Volume Capacity (μl) 
8 1.50 5.54 15 
15 1.50  2.59 10 
For higher loading volumes, the wells can be made by combining the tooth of the comb with a tape. 
 
9. Conduct electrophoresis under constant voltage, 100V, for 45 min. 
 
Table 2: DNA Size Migration with Sample Loading Dyes 
Agarose Concentration (%) Xylene Cyanol* Bromophenol Blue* 
0.5~1.5 4~5 Kb 400~500 bp 
* During electrophoresis, Xylene Cyanol is blue and Bromophenol Blue is purple 
 
10. Stain gel with 1 μg/ml EtBr for 10 min. and destain gel with DI H2O for 15 min. The staining solution 
can be reused several times in a week. 
11. Take picture using Kodak DC290 under the UV illuminator. 
Table 3: Gel Volume Requirements 
Gel Size 0.25 cm thick 0.5 cm thick 0.75 cm thick 1.0 cm thick 
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7x10 cm 15 ml 30 ml 45 ml 60 ml 
 
Table 4: Gel Concentration Required for DNA Separation 







*Sieving Agarose such as AmpliSize agarose 
 
Note: This specific instruction is designed for a single, 0.5 cm thick, 7×10 cm Gel with 0.75 
w/v% Agarose Concentration, for DNA size 0.8~12 Kb. Gel volume is adjustable depending 
on the thickness and the size of gel required (Table 3). The agarose concentration depends on 
the size of the DNA fragment analyzed (Table 4). The weight of the agarose required depends 
on the above two factors.  
 
Reference 
Sub-Cell GT Agarose Gel Electrophoresis Systems: Instruction Manual, Bio-Rad. 
 
C4. DNA Agarose Gels Extraction and Purification 
(QIAEX II agarose gels extraction protocol) 
1. Excise the DNA band under the UV illuminator from the agarose gel with a clean sharp cutter. Chop 
it into small pieces and put into a weighted colorless tube. 
2. Get the net gel slice weight. Add 300 μl of Buffer QX1 to 100 mg of gel for the DNA fragments 
0.1~4 kb. For the DNA fragment > 4 kb, add extra 200 μl of DI H2O. 
3. Add 30 μl of QIAEX II to 2~10 μg DNA sample. Incubate at 50 °C water-bath for 10 min to 
solubilize the agarose and bind the DNA. Mix by vortexing every 2 min to keep QIAEX II in 
suspension. The color of the mixture should be yellow. If it is orange or purple, add 10 μl 3 M of 
NaAc (pH5.0) and mix. 
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4. Centrifuge the sample at 12000 × g for 1 min and remove supernatant with a pipette.  
5. Resuspend the pellet with 500 μl of Buffer QX1 and mix by vortexing. Centrifuge the sample at 
12000 × g for 1 min and remove supernatant with a pipette.  
6. Resuspend the pellet with 500 μl of Buffer PE and mix by vortexing. Centrifuge the sample at 12,000 
× g for 1 min and remove supernatant with a pipette.  
7. Repeat step 6 again. 
8. Air-dry the pellet for 10-15 min or until the pellet turns white. 
9. Add 20 μl of 10 mM Tris-HCl (pH 8.5) or DI H2O and resuspend by vortexing. Incubate at room 
temperature for 5 min. If the DNA fragments 4~10 kb, incubate at 50 °C water-bath for 5 min. 
10. Centrifuge for 1 min. carefully pipette the supernatant into a clean tube. This DNA fragment is ready 
for ligation right away or store it at -20 °C freezer. 
 
C5. Ligation Reaction for Constructing Expression Plasmid from PCR Product  
1) Digest the plasmid DNA and the insert DNA with the appropriate restriction enzymes. Isolate the 
desired fragments by gel electrophoresis, and purify them by gel extraction.  
2) Set up the ligation reaction as follows: 
 
Component  Amount  Volume used (µl) 
Insert DNA 0.1-1µg * x 
Vector DNA 0.05-1µg * y 
10X Ligation Buffer  - 1.0 
T4 DNA Ligase Enzyme  0.1 Weiss Units © 0.2 µl  
DI H2O  To make up the reaction volume to 10 µl.  
 
*It is recommended to use equimolar amount of vector and insert DNA for cohesive end ligation.  
©One Weiss Unit is defined as the amount of enzyme that catalyzes the exchange of 1 nmole of 
P32 from pyrophosphate into ATP in 20 minutes at 37 °C. One Weiss Unit corresponds to 60 
cohesive end units as defined by New England Biolabs.  
 
3) Mix the components in a pulse spinner.  
4) Incubate the reaction mixture 1~4 hours at room temperature, or overnight at 16 °C.  
5) Set up two additional control reactions that contain  
 
            180 
i) the vector DNA alone and  
ii) the insert DNA alone.  
6) Take 1 µl of the sample for transformation by electroporation to the E. coli host competent cell 
DH5α. 
 
C6. Gateway® Technology for Constructing Expression Vector  
1) Add the following components to a 1.5 ml microcentrifuge tube at room temperature: 
 
Entry clone             (50~80 ng)                                                        ~1 µl 
Destination vector (100 ng)                                                             ~1 µl 
TE buffer, pH 8.0                   To make up the mixture volume to 4 µl 
2) Thaw the LR ClonaseTM II enzyme mix on ice and vortex it briefly. 
3) Add 1 µl of enzyme mix to the sample in 1), vortex it briefly, and spin down. 
4) Incubate the reaction mixture at room temperature for 1 h. 
5) Add 0.5 µl of the proteinase K solution to the reaction mixture to terminate the reaction by incubating 
the sample at 37 °C for 10 min. 
6) Take 1 µl of the sample for transformation by electroporation to the competent cell DH5α. 
Background of Gateway® technology:  
The traditional cloning, generally speaking, is one PCR product corresponding to one expression 
vector. It is very tedious and time-consuming if cloning one gene in a variety of expression vectors for 
systematically studying protein expression and/or functional analysis, such like palB in this study. Hartley 
et al. first invented a new DNA cloning technique that uses in vitro site-specific recombination to 
accomplish the directional cloning of PCR product and the subsequent automatic subcloning of the DNA 
segment into new vector backbone at high efficiency. The resulting subclone maintains orientation and 
reading frame register, allowing N- and C-terminal fusions to be created for optimized protein expression 
[288].  
Invitrogen commercialized this invention to Gateway® technology. The entry clone is a plasmid 
containing the specific insert gene flanked by attL1-gene-attL2, which serve as a recognition site for the 
LR ClonaseTM enzymes. The destination vector carries the selection ccdB gene flanked by attR1-ccdB-
attR2. In the LR reaction, the entry clone and the destination vector are incubated together with the LR 
ClonaseTM mix, resulting in the expression vector. The Gateway® system consists of two selection 
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schemes. The entry clone is KnR. The destination vector is ApR and CmR with ccdB gene, which inhibits 
growth of E. coli. Therefore transformants selected by ApR, not ApR+CmR, will be the expression vector.  
In this study, a standard restriction digestion with a following ligation using a Gateway® containing 
attL sites, pENTR, was used to construct PalB entry clone. 
 
C7. Transformation of Plasmid DNA into E. coli Strain  
(Modified after the protocol from Bio-Rad) 
There are two methods for transformation of plasmid DNA into E. coli strain, chemical transformation 
and electroporation. For chemical transformation, cells are grown to mid-log phase, harvested and treated 
with divalent cations such as CaCl2. Cells treated in such a way are named to be competent. To 
chemically transform cells, the competent cells are mixed with the plasmid DNA, on ice, followed by a 
brief heat shock. Then, cells are incubated with rich medium and allowed to express the antibiotic 
resistant gene for 30-60 min prior to plating.  
For electroporation, cells are also grown to mid-log phase but are then washed extensively with 
10% of glycerol to eliminate all salts. Aliquot 40 µl competent cells into 1.5 ml of microcentrifuge tube 
and store them at -80 °C freezer. To electroporate DNA into cells, the competent cells are mixed with the 
50~100 ng DNA and then pipetted into a cooled plastic cuvette containing electrodes. A short electric 
pulse, about 2400 volts/cm, is applied to the cells causing small holes in the membrane through which the 
DNA enters. The cells are then incubated with 1 ml of SOS broth before plating. Incubation time depends 
on copy number, high copy number needs less time. Spread 100~200 µl of the incubated cells on an agar 
plate supplemented with antibiotics when necessary and incubate the plate at 37 °C for overnight.  
Note: the success of the electroporation depends greatly on the purity of the plasmid DNA, especially on 
its salt content. Impure solutions might cause a small explosion (known as arcing), in which case the 
bacteria are dead. In general, the efficiency of transformation is much higher by electroporation. 
Therefore, it is always the best choice for plasmid DNA transformation using ligation mixture. For 
regular plasmid DNA transformation by electroporation, the plasmid extracted from kit is too high 
concentrated and needs to be diluted. Otherwise, too many cells will cover all the plate to find a single 
colony.  
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Appendix D 
E. coli Growth Curve and PalB Activity along the Course of Cultivation 
According to the procedure for cultivation, the sample was taken and cell density was measured along the 
course of cultivation for both non-induction and 0.1 mM IPTG induction culture. For the induction 
culture, the sample was also taken for monitoring the PalB activity using both tributyrin plate and pNPP 
enzymatic reaction following the standard protocol given in 3.2.3. The cultivation was conducted using 
BL21(DE3) (pHisperiMBP-G) expression system under 28 °C 200 rpm. The inducer concentration was 
0.1 mM IPTG. The results were summarized in Figure D. The cells have reached the stationary phase 8 h 
later after induction. Due to the overexpression of PalB, cells in the induction system were arrested and 
OD600 was always less than non-induction system. The difference reached the maximum about 20% when 
both systems arrived at stationary phase. The PalB activity was exponentially increased during the first 4 
hour after induction and then stopped. That indicated that the sample taken at 4 h after induction when the 
cultivation was conducted at 28 C is the best point. This conclusion is also confirmed by using tributyrin 
plate (Figure DB). The specific PalB activity reached 40 U/liter/OD600 which is comparable with the 
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A                                                                                                         B 
 
Figure D. E. coli growth curves of the non-induction and the induction PalB expression system 
BL21(DE3) (pHisperiMBP-G) and PalB activity along the course of cultivation after induction. 
Panel A: quantitative PalB assay results by using pNPP enzymatic reaction. The reaction was 
conducted in a shaker at 37 °C, 200 rpm. Panel B: visualization of PalB activity on tributirin plate. 
The plate loaded 20 µl of lysate was incubated in an incubater at 37 °C for 5h. 
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Appendix E 
Coefficient Number for PalB Assay 
PalB enzymatic assay was conducted according the protocol described in 3.2.3. PalB activity was 
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Where a is the slope of the standard curve for pNP concentration to OD410 reading, a = 133.4 (Error! 
Reference source not found.) 
Vreaction is volume of enzymatic reaction (ml), 
Vx is volume of enzyme (ml), 
Vsample is sample volume taken from culture (ml) 
VPB is volume of phosphate buffer in which the cell pellet was resuspended (ml), 
t is enzymatic reaction time (min), 
OD600 is cell’s optical density.  
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Figure E. Standard curve relating pNP concentration to its absorbance at 410 nm (A410) reading. 
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